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Abstract
V-ATPase is a vacuolar (lysosome-like) ATPase-dependent proton pump
necessary for maintaining pH homeostasis in the organelles of the endomembrane system.
It also contributes to regulation of the cytosol pH and the extracellular pH. In specialized
cells (renal intercalated cells, epididymis clear cells, and osteoclasts), V-ATPase proton
transport supports urinary acidification, sperm maturation, and bone resorption. Genetic
mutations of V-ATPase expressed in those tissue-specific cells cause distal renal tubular
acidosis, infertility, and osteopetrosis.
V-ATPases are composed of a peripheral domain (V1), which hydrolyzes ATP,
and a membrane-bound domain (Vo), which transports proton. V-ATPase activity is
tightly regulated in vivo by numbers of mechanisms, including reversible disassembly of
the V1 and Vo domains. Glucose, the nutrient oxidized in glycolysis, modulates reversible
dissociation of V-ATPase. This dissertation was aimed at understanding how subunits of
phosphofructokinase-1 (α subunit and β subunit) regulate V-ATPase function. Our
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results showed that both subunits are important for V-ATPase activity, but β subunit
displayed more significant phenotypes. Deletion of β subunit reduced glucose-dependent
V1Vo reassembly and altered V-ATPase binding to its assembly factor, RAVE. We
additionally investigated the mechanisms by which phosphofructokinase-1 controls VATPase function. We concluded that glucose-dependent V1Vo reassembly and V-ATPase
function at steady state were controlled by the glycolytic flux, independently of
phosphofructokinase-1. Notably, V-ATPase activation in vivo correlated with the
presence of phosphoglycerate kinase at vacuolar membranes. These studies further
advanced our understanding how glucose controls V-ATPase pumps in vivo.
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Chapter I
Introduction to the Vacuolar ATPase (V-ATPase)

1.1 Structure and function of the V-ATPase enzyme complex
V-ATPase, a vacuolar (lysosomal-like) ATP-dependent proton pump, is a highly
conserved multi-subunit complex that hydrolyzes ATP to transport protons across the
membrane (Forgac 2007). V-ATPase is responsible for maintaining the differential acidic
pH of organelles throughout the endomembrane system. Regulation of the pH of the
extracellular space, cytoplasm, and intracellular compartments is tightly linked to VATPase function (Forgac 2007). Cellular processes that require normal V-ATPase
activity include endocytosis, membrane trafficking, membrane fusion, protein processing,
autophagy, and proton-coupled transport of diverse nutrients and ions (Forgac 2007).

V-ATPase pumps are composed of 14 different subunits that comprise two domains: V1
and Vo. V1, the ATP-hydrolytic domain, is makeup of subunits A, B, C, D, E, F, G and H.
Vo, the proton-translocation domain is makeup of subunits a, d, e, c, c’ and c’’ (Fig. 1),
the subunit c’ is found exclusively in fungi (Kane 2006). In the V1 domain, three copies
of subunit A and B comprise a hexamer structure in alternating arrangement. The
interface of A and B subunits form three catalytic sites to hydrolyze ATP and the subunit
A is mainly responsible for ATP binding and hydrolysis. There are three ATP hydrolytic
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Figure 1. Structure of the yeast V-ATPase complex. The V-ATPase is composed of
14 different subunits and contains two major domains: The V1 complex (A, B, C, D,
E, F, G, H) is responsible for ATP hydrolysis and the Vo complex (c, c’, c’’, a, d, e)
translocate protons across the lipid bilayer by a rotary mechanism. The mechanism of
proton transport through Vo. Protons binds to an Arg residue of subunit a (shown in
grey) that transfers the proton to a Glu residue of c, c’ and c’’ subunits in the
proteolipid ring (shown in yellow) by passing through a hemi-channel of subunit a.
After the V1 domain hydrolyzes ATPs, the rotation of the c-ring releases protons into
the lumen.
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sites located in subunit A. Three noncatalytic nucleotide-binding sites (interacting with
ATP but do not direct catalyze) in subunit B appear to play a regulatory role (Vasilyeva,
Liu et al. 2000) (MacLeod, Vasilyeva et al. 1999).

The subunits E and G form three

peripheral stalks attached to subunit B that assist binding the hexamer to Vo. The subunits
D and F are localized in the center of A3B3. Subunits D and F also connect the catalytic
hexamer to Vo at the membrane by forming a central stalk. The central stalk not only
connect the V1 and Vo domains but also is involved in a rotary mechanism by which VATPase couples ATP hydrolysis and active proton transport. The V1 subunits H and C
have regulatory roles, as they modulate V-ATPase function by a mechanism involving
V1Vo reversible disassembly (see Chapter 1.2.3). There are two forms of V1 in cells:
cytosolic V1 without Vo and V1 attached to Vo at membranes.

In the Vo domain, the c, c’ and c’’ proteolipid subunits containing highly hydrophobic
amino acids form a ring structure, which translocates protons through the membrane
(Wilkens and Forgac 2001). A Glu residue at one transmembrane helix of each
proteolipid subunit undergoes reversible protonation. Protonation and deprotonation
involves a rotary mechanism that passes protons across the membrane (Nishi and Forgac
2002). Another important subunit, subunit a, interfaces with the c ring structure. It
contains a highly hydrophilic N-terminal domain and a C-terminal transmembrane
domain (Nishi and Forgac 2002). The N-terminal domain of subunit a faces the cytosolic
space, while the C-terminal domain is mainly localized in the membrane. Subunit a has
an Arg residue that participates in proton transport (Forgac 2007). Subunit d is the only
soluble subunit of Vo. It sits on the top of the c ring structure and functions to connect the
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central stalk of V1 and the proteolipid c subunits of Vo (Drory, Frolow et al. 2004). There
is another highly hydrophobic subunit, subunit e, that is localized in the membrane and
the function of this subunit is still unclear (Sambade and Kane 2004). As showing Figure
1, V1 contains three copies of the catalytic hexamer subunits A and B, and the stator
(peripheral stalk) subunits E and G, one copy of the regulatory subunits C and H, and one
copy of the central stator subunits D and F (Ohira, Smardon et al. 2006); Lee, Lee et al.
(2014).

V-ATPase proton transport sustains pH homeostasis and energizes cellular membranes,
because it activates secondary transport systems including nutrients and ions (Forgac
2007). V-ATPase-mediated pH homeostasis controls the pH of intracellular
compartments, the cytoplasm, and the extracellular environment (Forgac 2007). The
acidification of the Golgi Apparatus, endosomes and lysosomes by V-ATPase is required
for fundamental cellular processes, including endocytosis, membrane trafficking and
fusion, protein processing, and autophagy (Forgac 2007). Since V-ATPase transports
cytosolic protons into the organelle lumen, and/or outside the cells, V-ATPase also
sustains the cytosolic pH homeostasis. Proton secretion by plasma membrane associated
V-ATPase pumps in specialized cells, such as the kidney α-intercalated cells and bone
osteoclasts, maintain the systemic acid-base balance and bone resorption, respectively
(Breton and Brown 2007).
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1.2 Regulation of the V-ATPase complex
V-ATPase function is crucial for numerous and fundamental processes, and its activity is
precisely and efficiently controlled by multiple stimuli and signaling pathways. VATPase activity is regulated by reversible disassembly of V1 and Vo (Kane 1995),
reversible disulfide-bond formation at the catalytic sites (Feng and Forgac 1992; Feng
and Forgac 1994), modification of the number of protons transported per ATP
hydrolyzed (coupling efficiency) (Muller, Jensen et al. 1999; Muller and Taiz 2002),
changes in V-ATPase membrane localization (Toyomura, Murata et al. 2003), protein
density (Hinton, Bond et al. 2009) and post-translational modifications (Kane 2006;
Forgac 2007; Alzamora, Thali et al. 2010; Hughes and Gottschling 2012; Lee, Lee et al.
2014; Parra, Chan et al. 2014). In the following sections, the details of each regulatory
mechanism will be discussed.

1.2.1 Control of V-ATPase coupling efficiency.
In order to transport protons the V-ATPase needs to hydrolyze ATP as energy. The
coupling efficiency relates to each ATP per proton transport across the membrane.
Various degrees of coupling efficiency between ATPase hydrolysis and proton transport
have been proposed to regulate the acidification of intracellular compartments in
mammalian cells (Nishi and Forgac 2002; Nelson 2003). Several biochemical studies
support this idea (Moriyama and Nelson 1988; Arai, Pink et al. 1989; Owegi, Pappas et al.
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2006; Ediger, Melman et al. 2009). This suggests that the coupling efficiency of VATPase acts an important regulatory model for cellular pH homeostasis.

It has been shown V-ATPase functional coupling can be controlled by the concentration
of its substrate, ATP. In bovine clathrin-coated vesicles, the V-ATPase coupling rate is
reduced at ATP concentrations greater than 0.3mM (Arai, Pink et al. 1989). The coupling
efficiency in the lemon fruit is responsible for the steep vacuolar pH gradient, compared
to other parts of the plant (Muller, Jensen et al. 1999). V-ATPase coupling efficiency is
determined by citrate (stored in vacuolar lumen) and malate (in the vacuole)
concentrations (high concentration increasing the coupling efficiency) in the lemon tree
(Muller and Taiz 2002). The lemon fruit cells that generate more organic acids have
higher levels of citrate and malate in the vacuole, suggesting that intracellular metabolites
can modulate V-ATPase activity by modulating the number of protons transported per
ATP hydrolyzed. Our studies (Chapter II) suggest that phsphofructokinase-1 can control
V-ATPase proton transport in vivo in yeast, but whether it involves coupling alterations
has yet to be determined.

Differences in coupling efficiency can be dictated by the V-ATPase subunit isoforms
assembled in different membranes. In eukaryotic cells, different isoforms of V-ATPase
subunits can be membrane-specific and cell-specific. Different combinations of subunit
isforms may have different coupling capacity. In fungi, there are only two isoforms of
subunit a (Vph1p at the vacuolar membrane and Stv1p at the Golgi Apparatus membrane).
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The yeast Golgi V-ATPase pumps exhibit lower coupling ratios than the vacuolar VATPase pumps (Kawasaki-Nishi, Nishi et al. 2001). Thus, the two yeast V-ATPase
subunit isoforms control coupling efficiency according to the pH requirement in different
organelles. Higher eukaryotic cells have more isoforms of subunit a and various VATPase subunits that fulfill different functions in specific cells.

Structure and function studies are shedding light on the mechanism by which coupling
efficiency may be changed. Site-directed mutations of conserved amino acids have
revealed a coupling role a domain of the V1 catalytic subunit A (non-homoloous domain
(Shao, Nishi et al. 2003; Shao and Forgac 2004) and the central stalk Vo subunit d (Owegi,
Pappas et al. 2006). While the mutations P217V in V1 subunit A and F94A in Vo subunit
d reduced coupling efficiency, other mutations in V1 subunit A (P223V and P233V) and
Vo subunit d (D217A, D261A E317A and E329A) increased the coupling ratio of proton
transported per ATP hydrolyzed. These studies indicate that different coupling states may
occur to adjust the proton transport by either up-regulating or down-regulating the ratio
proton : ATP. Overexpression of the regulatory V1 subunit H displays an uncoupling
phenotype, which prevents proton transport without significantly decreasing ATP
hydrolysis. These results suggest that subunit H is also involved in tuning the coupling
efficiency, in addition to regulating the V-ATPase (Keenan Curtis and Kane 2002).
However, the mechanism(s) involved in the regulation of coupling efficiency in vivo are
still elusive.
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1.2.2 Modulation of reversible disulfide bond formation at the catalytic site.
V-ATPase regulation by disulfide bond formation between conserved Cys residues in the
catalytic sites of V1 subunit A (Cys-261 and Cys-539) has been proposed in yeast.
Formation of the disulfide bond inactivates V-ATPase by blocking ATP hydrolysis (Feng
and Forgac 1992; Feng and Forgac 1992). The disulfide bond can be broken by changing
other cysteine residue in the subunit A, suggesting that different pairs of disulfide bonds
of subunit A control V-ATPase activity (Feng and Forgac 1994). It has also been shown
that cys4Δ cells, which lack of the gene CYS4 responsible for synthesis of cystathionine
in the first step of cysteine biosynthesis, display a vacuolar membrane ATPase (Vma-)
growth phenotype (sensitivity to alkaline pH), suggestive of malfunction of V-ATPase. It
has been proposed that cys4 mutant cells display a reduction in glutathione levels (redox
state), which leads to a generalized more reduced cellular state and affects Cys-Cys
formation in the catalytic sites. Accordingly, decreased glutathione levels and mutations
at the conserved cysteine residue of the catalytic site of V1 subunit A partially suppress
the Vma- growth defects of cys4Δ cells (Oluwatosin and Kane 1997). This type of
reversible disulfide bond formation in V1 subunit A has also been found in other
organisms. However, in plant cells the disulfide bridge (Cys 134 and Cys 186) is
localized in the V1 subunit E (Gruber, Radermacher et al. 2000). Together these studies
suggest that the redox state of the cytoplasm can regulate V-ATPase activity via
reversible disulfide bond formation in the catalytic sites of the yeast V-ATPase complex.
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1.2.3 Regulation of V-ATPase activity by reversible V1Vo dissociation.
An important mechanism that regulates V-ATPase is its reversible dissociation, which
controls the level of V1Vo assembly in a cell. This process was first described in yeast and
insects (Kane 1995; Sumner, Dow et al. 1995). It also has been shown that V-ATPase
activity is modulated through disassembly and reassembly in mammalian cells
(Trombetta, Ebersold et al. 2003; Nakamura 2004), suggesting that reversible
disassembly of V1Vo is a conserved mechanism from yeast to mammals.

During disassembly, the peripheral domain V1 (except subunit C) and V1 subunit C detach
from the integral membrane domain Vo. Disassembly adjusts the amount of functional
V1Vo complexes in response low glucose and other extracellular signals (Fig. 2). This
response occurs in less than 5 minutes without new protein synthesis (Kane 1995). The
V1 subunit C, V1 (in the cytosol) and Vo (at the membrane) stay intact during dissociation
and re-associate upon glucose re-addition and other extracellular stimulations in less than
5 minutes. The V1 subunit C, which localizes at the interface between the V1 and Vo
subcomplexes, is required for controlling the assembly of V-ATPase (Drory, Frolow et al.
2004; Inoue and Forgac 2005). However, overexpression of subunit C decreases VATPase activity without changing assembly of V-ATPase, suggesting that subunit C may
also be involved in other regulatory mechanism (Keenan Curtis and Kane 2002).
Additionally, to prevent unnecessary ATP hydrolysis and leakage of protons
conformational changes in V1 subunit H and Vo subunit a, respectively, silence free V1
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Figure 2. Glucose dependent reversible disassembly. V-ATPases can
reversibly dissociate into V1 (-C), Vo, and the C subunit. In yeast and
kidney cells, glucose removal triggers dissociation, and this process is
reversible upon glucose re-addition. This process does not require new
protein to be synthesized and is a quick response to environmental changes.
The dissociation of V-ATPase prevents proton transport and ATP
hydrolysis under low glucose (energy) conditions preserving energy for
cells. During dissociation, conformational changes occur in V1H to avoid
non-functional ATP hydrolysis and leakage of protons through the
membrane.

10	
  

and Vo (Parra, Keenan et al. 2000; Wilkens and Forgac 2001; Qi and Forgac 2008)
(Figure 2).

Glucose changes constitute a major trigger of V1Vo disassembly and reassembly (Toei,
Saum et al. 2010; Kane 2012), which appears to involve diverse mechanisms and
signaling pathways (described below). Disassembly is a fast and effective mechanism to
regulate V-ATPase activity, which is crucial for preserving cellular ATP level when
glucose is limiting. Free V1 cannot hydrolyze ATP during glucose depletion (low energy
status). The V1Vo reversible disassembly is a response to acute and chronic changes in
growth environments, assisting cells to adapt to stress. The PI3 Kinase activity that
phosphorylates the hydroxyl group of phosphatidylinositols at membranes is also
involved in glucose-induced V1Vo reassembly in the kidney cells (Nakamura 2004; Sautin,
Lu et al. 2005). This enzyme probably changes the lipid compositions of membrane,
which affects the V1Vo assembly state. In yeast cells, mutants of PI3 kinase or PI(3P) 5kinase, Fab1, also increase the vacuolar pH, suggesting that reversible disassembly is also
sensitive to the membrane composition (Weisman 2003).

Other extracellular stimuli, such as extracellular pH (Padilla-Lopez and Pearce 2006;
Diakov and Kane 2010) and osmotic stress (Li, Diakov et al. 2012), also modulate VATPase assembly.

In yeast, V1Vo dissociation resulting from glucose depletion is

suppressed at alkaline extracellular pH (higher than pH=7.0), which also enhances VATPase activity in isolated vacuolar membranes (Diakov and Kane 2010). An adaption
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to hyperosmotic stress is an increase in V1Vo assembly that in turn activates V-ATPase,
because V-ATPase and the high-osmolarity glycerol (HOG) pathway work in parallel as
cellular detoxification mechanisms (Li, Diakov et al. 2012). The signaling lipid
phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) regulates salt-induced V1Vo assembly
(high osmotic stress). In general, the phosphoinositides act as signaling molecules by
recruiting effectors from the cytosol to control assembly and/or activate nearby proteins
(DeCamilli, Emr et al. 1996; Strahl and Thorner 2007). As more PI(3,5)P2 is present at
the membrane, more Vph1p (subunit a) is recruited to the vacuolar membrane. The
binding between Vph1 and PI(3,5)PI stabilizes V1Vo assembly and enhances V-ATPase
activity (Li, Diakov et al. 2014).

An assembly complex in yeast, RAVE (Regulator of ATPase of Vacuole and Endosome),
is necessary for V1Vo reassembly in response to glucose (Seol, Shevchenko et al. 2001;
Smardon, Tarsio et al. 2002; Smardon and Kane 2007; Smardon, Diab et al. 2014). The
RAVE complex is composed of three proteins, Rav1p, Rav2p and Skp1p (Seol,
Shevchenko et al. 2001). The Rav1p and Rav2p subunits are essential for glucoseinduced V1Vo reassembly and for biosynthetic assembly of V1Vo (Smardon, Tarsio et al.
2002; Smardon and Kane 2007). Deletion of RAV1 and RAV2 prevented growth on
alkaline pH media containing calcium at millimolar concentrations when exposed to 37oC
(Seol, Shevchenko et al. 2001). However, this Vma- phenotype was partial because the
cells grew on pH 7.5 plates. Partial Vma- growth phenotype suggests that the RAVE
complex may cooperate with other regulatory factors to control V-ATPase or another
parallel pathway may be involved. However, a later study showed that RAVE is a
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chaperone exclusive for Vph1p-containing V-ATPase complexes (Smardon, Diab et al.
2014). As a result V1Vo complexes containing Stv1p remained intact in the RAVE
mutants, which caused the partial Vma- growth defect.

As expected, non-acidic vacuoles were present in RAVE deficient cells. Vacuolar
staining by the pH sensitive dye, quinacrine was absence at 37oC (Seol, Shevchenko et al.
2001), suggesting that loss of function of V-ATPase happened after RAV1 and RAV2
deletion. The roles of the subunit Skp1p in RAVE function are not clear. Skp1p is best
known for its function as a component of the SCF (Skp1-cullin-F-box) E3 ubiquitin
ligase, but the RAVE complex containing Skp1 does not function as ubiquitin ligase
(Seol, Shevchenko et al. 2001).

The RAVE complex most likely functions as a chaperone that facilitates V1Vo assembly
(Kane 2012). RAVE not only binds to cytosolic V1, through interactions with V1 subunits
E and G (Smardon and Kane 2007) but also the N-terminal domain of Vph1 (Smardon,
Diab et al. 2014). However, RAVE is not the glucose sensor because the interaction
between V1 and RAVE is not glucose dependent; stable V1-RAVE complexes are formed
if V1 is constitutively present in the cytosol. The vma3Δ strain, which lacks Vo complexes
and only contains cytosolic V1 has stable cytosolic V1-RAVE complexes independent of
the extracellular glucose levels (Smardon and Kane 2007).
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The V1 subunit C, which dissociates from V1 and Vo upon disassembly, also binds to the
RAVE complex (Smardon and Kane 2007). The crystal structure of the C subunit reveals
two globular domains, Chead and Cfoot, connected by a flexible helix structure (Drory,
Frolow et al. 2004). During reassembly, these two domains bind to different EG
heterodimers with different affinity (Oot and Wilkens 2010), as V1 subunit C reassociates with V1 and Vo to form active V1Vo complexes (Kane 1995). Deletion of V1
subunit C resembles the assembly phenotype of RAVE mutants (Smardon and Kane
2007), suggesting that V1 subunit C-RAVE binding may also be involved in RAVEdependent regulation of V1Vo biosynthetic assembly. The deletion of RAVE complexes,
like the deletion of V1 subunit C, leads to unstable and inactive V1Vo structures (Smardon
and Kane 2007). RAVE bound to V1 and V1 subunit C may play a docking role to assist
the peripheral stalk to re-attach onto Vo domain at the vacuolar membrane. In order to
reassemble subunit C into V1Vo, structural stress between C and one of the three EG
dimers occurs (Fig. 1) (Oot, Huang et al. 2012). Meanwhile, the RAVE complex appears
to be the only assembly factor in V1Vo reassembly (Parra, Chan et al. 2014).

Glucose regulation of V1Vo is intertwined with glycolysis. There is evidence that glucosedependent reversible disassembly is not an all-or-none response. In yeast, the level of
V1Vo assembly is dictated by the concentration of glucose in the media (Parra and Kane
1998) with increasing concentrations of glucose gradually increasing V1Vo reassembly.
Thus, the glucose level fine-tunes V-ATPase activity by changing the V1Vo assembly
state. A phosphoglucose isomerase (pgi1) deficient mutant strain, which cannot convert
glucose-6-phosphate into fructose-6-phosphate fails to reassemble V1Vo in response to
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glucose. However, pgi1 supports V1Vo reassembly after addition of fructose (Parra and
Kane 1998). This suggests that glucose metabolism through glycolysis is required for
reversible disassembly.

Some glycolytic enzymes are involved in V1Vo reassembly. The V1Vo complexes interact
with the glycolytic enzymes aldolase, phosphofructokinase-1 and GAPDH (Lu, Holliday
et al. 2001; Su, Zhou et al. 2003; Lu, Sautin et al. 2004; Lu, Ammar et al. 2007; Su,
Blake-Palmer et al. 2008; Chan and Parra 2014). The binding between aldolase and V1
subunits B and E and Vo subunit a is glucose-dependent; disruption of these interactions
causes V1Vo dissociation. Aldolase mutants (R303W and H108A) that abolish its
catalytic function in vitro do not affect V-ATPase assembly and function (Lu, Ammar et
al. 2007), suggesting that aldolase-V-ATPase binding is required for V-ATPase function
but not aldolase enzymatic activity. Notably, those experiemnts were performed in vitro
in isolated vacuolar membranes in which excess ATP was added to the reactions. In vivo,
decreased glycolytic-ATP in the aldolase mutants may affect V-ATPase function. Lu et al.
have shown that V1 subunit B and GAPDH co-immunoprecipitate from purified yeast
vacuolar membranes, suggesting that GAPDH interacts with the V-ATPase complex as
well.

The human phosphofructokinase-1 enzyme interacts with C-terminus of the Vo subunit
isoform a4 (isoform experessed in α-intercalated cells) and a1 (ubiquitously expressed
isoform) in kidney cells (Su, Zhou et al. 2003). Mutations of the renal V-ATPase Vo
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subunit a isoform a4 (G820R) alter its interactions with human phosphofructokinase-1and
caused distal renal tubular acidosis (dRTA) in human. Phosphofructokinase-1 catalyzes a
rate-limiting reaction in glycolysis and constitutes an important regulatory step that
integrates main energy metabolic pathways (glycolysis, Krebs Cycle, and lipid
metabolism). Together these studies support the concept that glycolytic enzymes can
form a super-complex with V-ATPase at the vacuolar membrane. It is possible that this
super-complex plays a role as the glucose sensor. Another possibility is that the supercomplex locally makes glycolytic-ATP for use in proton transport by V-ATPase.
However, to make glycolytic ATP, the phosphoglycerate kinase enzyme has to be present
at the vacuolar membrane to activate V-ATPase. Chapter III describes Pgk1p presence at
vacuolar membranes, suggestive of the concept that locally made glycolytic-ATP may be
coupled to V-ATPase proton transport.

Protein kinase A (PKA) modulates various cellular functions, including energy
metabolism, glucose sensing and osmotic shock tolerance (Estruch 2000; Norbeck and
Blomberg 2000; Santangelo 2006). PKA is involved also in V1Vo reversible disassembly
in yeast and insects (Bond and Forgac 2008; Tiburcy, Beyenbach et al. 2013). In this
glucose-sensing pathway, glucose induces PKA to hyperphosphorylate the RGT1 gene,
which represses the genes HXTs (glucose transporters) and HXK2 (hexokinase that
phosphorylates glucose in the first step of glycolysis. Yeast mutants that stimulate PKA
activity and increase cAMP levels (ira1Δ, ira2Δ, and RAS2val19) result in defective
disassembly of the V-ATPase under glucose starvation (Bond and Forgac 2008). This
suggests that the PKA pathway regulates glucose-dependent V1Vo assembly in yeast. An
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independent study indicates that glucose-dependent V1Vo reassembly functions upstream
of the PKA pathway (Dechant, Binda et al. 2010). Although at first these two studies
appear contradictory, we have considered the possibility that the PKA pathway and V1Vo
reassembly could influence each other by a positive feedback mechanism (Parra, Chan et
al. 2014).

Lastly, cytosolic pH changes has been shown to modulate V1Vo assembly in response to
glucose (Dechant, Binda et al. 2010). It has been proposed that cytosolic pH could act as
a second messenger that controls glucose-dependent reversible disassembly (Dechant,
Binda et al. 2010; Dechant and Peter 2011). The authors believe that rapid changes in the
cytosol pH are caused by glucose metabolism and that V-ATPase senses the level of
protons in the cytosol to control the levels of V1Vo assembly. In this model, glucose
depletion leads to low cytosol pH that triggers V1 dissociation from Vo; increased cytosol
pH caused by glucose re-addition leads V1Vo reassembly (Dechant, Binda et al. 2010).

1.3 Rationale for dissertation studies.
Glucose-dependent V1Vo disassembly is an universal mechanism to rapidly and
efficiently control V-ATPase function in different cells types and organisms (Kane 2012).
Independent studies have shown that glycolysis controls V-ATPase assembly (Parra and
Kane 1998). The glycolytic enzyme phosphofructokinase-1 catalyzes an important
regulatory step in the glycolytic pathway, suggesting that phosphofructokinase-1 function
may influence V-ATPase function. Additionally, human phosphofructokinase-1 binds to
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the C-terminal domain of the Vo subunit a4 of V-ATPase, and mutants of a4 that block
this interaction cause dRTA. Perhaps binding of phosphofructokinase-1 to V-ATPase, is
required for V-ATPase function (Su, Zhou et al. 2003; Su, Blake-Palmer et al. 2008).
Chapters II and III provided new insights into the mechanisms by which organisms
regulate V-ATPase in response to glucose.

We studied the role of the yeast phosphofructokinase-1 subunits separately, Pfk1p (α
subunit) and Pfk2p (β subunit). The reasons why we analyzed the interrelation of
individual subunits of yeast phosphofructokinase-1 and V-ATPase function are based on
several results from previous studies. First, Su et al. showed that human
phosphofructokinase-1 (muscle isoform) interacts with V-ATPase and that yeast
phosphofructokinase-1 co-immunoprecipitated with V-ATPase (Su, Blake-Palmer et al.
2008). However, the authors did not specify which phosphofructokinase-1 subunit binds
to V-ATPase. We asked whether both subunits of the yeast phosphofructokinase-1
enzyme interact with V-ATPase and play the same role in controlling V-ATPase function.
Second, the double deletion strain, pfk1Δ pfk2Δ, was used in those studies. The pfk1Δ
pfk2Δ strain cannot utilize glucose or grow on media containing glucose as the sole
carbon source (Arvanitidis and Heinisch 1994). The blockage of glycolysis and several
glucose-dependent signals may mask the effects of Pfk1p and Pfk2p in regulating VATPase activity in this strain. However, strains carrying individual deletions of the yeast
genes encoding phosphofructokinase-1 subunits can metabolize glucose, which makes the
single deletion strains suitable for our studies. Third, the authors maintained the
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pfk1Δ pfk2Δ strain in 0.2% glucose media instead of 2% glucose, but at this low level of
glucose only 20~30% V1Vo assembly could be sustained (Parra and Kane 1998). This
low level of assembly at steady state makes difficult to determine whether defective VATPase function is caused by reduced assembly or defective interactions between
phosphofructokinase-1 and V-ATPase. Finally, the human a4 subunit mutants (G820R
and G807) lack V-ATPase activity (Su, Blake-Palmer et al. 2008). Those mutants may
not only block phosphofructokinase-1 and V-ATPase binding but also affect V-ATPase
structure and activity, independently of phosphofructokinase-1. This dissertation
examined the phenotypes of phosphofructokinase subunit single deletion yeast strains
(pfk1Δ and pfk2Δ); they are appropriate for studying the interplay between
phosphofructokinase-1 and V-ATPase.

The first part of this dissertation describes in vivo and in vitro studies designed to
evaluate how each subunit of the yeast phosphofructokinase-1 enzyme regulates VATPase function and assembly. The results of this work indicated that subunits Pfk1p and
Pfk2p are necessary for V-ATPase –mediated vacuolar acidification and pH homeostasis
in vivo. Only Pfk2p is necessary for glucose-dependent V1Vo reassembly and normal
Rav1p-V1 interaction. The details of this work are described in Chapter II and in a
published reference (Chan and Parra 2014).

The second part of this dissertation characterizes the mechanism by which yeast
phosphofrctokinase-1 subunit Pfk2p controls V-ATPase function and V1Vo reassembly in
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response to glucose. We showed that defective V1Vo reassembly in cells lacking the
PFK2 gene (pfk2Δ) can be rescued by increasing the concentration of glucose in the
growth media from 2% (normal yeast media concentration) to 4% glucose. Since our
studies also suggested that the glycolytic flow was increased in pfk2Δ cells exposed to
4% glucose, we proposed that V-ATPase reassembly is controlled by glycolytic flow in
vivo. Notably, these results showed that the phosphofructokinase-1 subunits PFK1 or
PFK2 are dispensable for V1Vo reversible disassembly. These studies also suggest that
glucose-dependent V-ATPase-mediated vacuolar acidification (no reassembly) can be
controlled by additional factors such as the level of Pgk1 at the vacuolar membrane. Thus,
we concluded that reassembly and reactivation are independently controlled events. The
details of this work are described in Chapter III. In Chapter IV, conclusions and future
directions are presented.
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2.1 Introduction

The vacuolar ATP-dependent proton pump, V- ATPase2, is a highly conserved protein
complex that maintains pH homeostasis and energizes membranes in all eukaryotic cells
(Kane 2006); Forgac (2007). V-ATPase is distributed throughout the endomembrane
system and V-ATPase mediated proton transport is required for receptor-mediated
endocytosis, protein sorting and processing, and vacuolar and lysosomal functions (Kane
2006; Forgac 2007). Cells specialized for active proton secretion such as kidneyintercalated cells, clear cells of the epididymis, and bone osteoclasts, also have V-ATPase
pumps on the plasma membrane. Plasma membrane associated V-ATPases lower the
extracellular pH and are necessary for maintenance (Breton and Brown 2013), sperm
maturation (Breton and Brown 2013), and bone resorption (Sobacchi, Frattini et al. 2001),
respectively.

V-ATPases operate as molecular motors that use mechanical rotation of subunits to
couple ATP hydrolysis and proton transport. Composed of 14 different subunits, VATPases are organized into two domains, V1 and Vo. Eight subunits (named A-H) form
the ATP-hydrolyzing domain (V1) that is peripherally attached to the cytosolic side of the
membrane. Six subunits (named a, c, c’, c” d, and e) form the proton-translocating
domain (Vo), which is embedded in the membrane (Sun-Wada, Wada et al. 2003; Forgac
2007; Muench, Trinick et al. 2011).
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An important regulatory mechanism that controls V-ATPase activity in vivo is its
reversible disassembly. Yeast (Kane 1995; Sumner, Dow et al. 1995; Kane 2006), insects
(Sumner, Dow et al. 1995; Voss, Vitavska et al. 2007; Tiburcy, Beyenbach et al. 2013),
and mammalian (Trombetta, Ebersold et al. 2003; Liberman, Bond et al. 2014) cells
disassemble and reassemble V1Vo complexes to reversibly inhibit V-ATPase proton
transport. Disassembly stops ATP hydrolysis and ceases organelle acidification. The VATPase complexes separate into three parts: V1 subunit C, V1 (without subunit C), and
Vo (Kane 1995; Kane and Parra 2000). Reassembly, which entails rapid re-association of
these three components, restores V-ATPase catalytic activity.

At steady state, when glucose is abundant, cells contain assembled and disassembled VATPase pumps (Kane 1995; Parra and Kane 1998); about 70% of the pumps are
assembled into V1Vo complexes. The ratio of assembled to disassembled V-ATPases is
dynamic and responds to variations in glucose concentration. Glucose removal leads to
V1Vo disassembly, which helps reserve energy when glucose is limiting. Once energy is
restored, after glucose re-addition, V1Vo reassembles (PM. 2006).

It has been proposed that V-ATPase pumps are structurally primed to disassemble, so that
disassembly occurs easily and promptly when energy is low (Oot, Huang et al. 2012;
Stewart and Stock 2012). However, V1Vo reassembly may require some form of energy
(e.g., ATP) to introduce structural changes necessary to reform the subunit-subunit
interactions in V1Vo complexes.
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Reassembly is facilitated by a V-ATPase exclusive assembly factor in yeast, the
Regulator of ATPase of Vacuoles and Endosomes (RAVE) complex (Seol, Shevchenko
et al. 2001; Kane and Smardon 2003). The RAVE complex consists of three subunits,
Skp1p, Rav1p, and Rav2p; Rav1p aids in the re-association of cytosolic V1 with Vo at the
membrane (Smardon, Tarsio et al. 2002; Smardon and Kane 2007; Smardon, Diab et al.
2014).

Although the mechanisms involved in yeast reversible disassembly remain

elusive, components of the glycolytic pathway and Ras/cAMP/PKA pathway are
involved (Parra and Kane 1998; Bond and Forgac 2008). The cytosol and extracellular
pH also have been shown to affect yeast V-ATPase reassembly in response to glucose
(Dechant, Binda et al. 2010; Diakov and Kane 2010).

Glycolytic enzymes interact with V-ATPase and may functionally couple glycolytic ATP
production and V-ATPase proton transport (Lu, Holliday et al. 2001; Peters, Bayer et al.
2001; Su, Zhou et al. 2003; Lu, Ammar et al. 2007; Su, Blake-Palmer et al. 2008). There
is evidence that glycolysis itself could regulate yeast V1Vo reassembly and/or V-ATPase
activity (Parra and Kane 1998). First, reassembly can be triggered by fructose and
mannose that are rapidly fermentable sugars like glucose. Second, glucose oxidation
beyond glucose-6 phosphate formation is required for reassembly. Third, the ratio of
assembled to disassembled V-ATPase pumps gradually increases as the glucose
concentration increases, indicating that reversible disassembly is not an all-or-none
response.
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The interplay between glycolysis and V-ATPase is conserved; it has been described in
renal epithelial cells (Sautin, Lu et al. 2005), viral infections (Kohio and Adamson 2013),
and the metabolic switch in cancers (Avnet, Di Pompo et al. 2013; Fogarty, O'Keeffe et
al. 2013). Two glycolytic enzymes can modulate the V-ATPase function, aldolase and
phosphofructokinase-1. Aldolase associates with yeast (Lu, Holliday et al. 2001; Lu,
Sautin et al. 2004; Lu, Ammar et al. 2007), plant (Konishi, Yamane et al. 2004), and
mammalian (Merkulova, Hurtado-Lorenzo et al. 2011) V-ATPases. The interaction with
aldolase is glucose-dependent in yeast and necessary for stable V1Vo assembly.
Phosphofructokinase-1 interacts with V-ATPase in vacuolar membranes and directly
binds to V-ATPase Vo subunit a in vitro (Su, Zhou et al. 2003; Su, Blake-Palmer et al.
2008). Phosphofructokinase-1 also co-localizes with the V-ATPase Vo subunit a isoform
a4 (Voa4) in the a-intercalated cells of the cortical collecting duct. This interaction may
be physiologically relevant. A genetic mutation in the human subunit Voa4 that causes
hereditary

distal

renal

tubular

acidosis

also

prevents

Voa4

binding

to

phosphofructokinase-1 (Su, Blake-Palmer et al. 2008).

The yeast ortholog of human phosphofructokinase-1 consists of two tetramers, each made
of two subunits, Pfk1p (α subunit) and Pfk2p (β subunit) (Banaszak, Mechin et al. 2011).
Deletion of both subunits prevents yeast growth on glucose, but the single deletion strains
metabolize glucose (Heinisch 1986). They are therefore suitable to study the interplay
between phosphofructokinase-1 and V-ATPase; we anticipated V1Vo complexes to be
assembled in pfk1Δ and pfk2Δ mutants.
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This study examined V-ATPase functions at steady state and under disassembly and
reassembly conditions in the pfk1Δ and pfk2Δ mutants. Each mutant failed to acidify
vacuoles, even though V-ATPases were catalytically active in vitro. Overall V-ATPase
function was significantly more affected in pfk2Δ than pfk1Δ. The pfk2Δ cells exhibited a
partial Vma- growth phenotype, enhanced Rav1p-V1 binding, and abnormal V1Vo
reassembly after re-addition of glucose to cells briefly deprived of glucose.

2.2 Materials and Methods

Materials and strains. Zymolase 100T was purchased from Seikagaku (Tokyo, Japan),
Concanamycin A from Wako Biochemicals (Richmond, VA), and Ficoll from United
Stated Biologicals (Swampscott, MA). The antibody to the Myc antigen was from
Invitrogen (Carlsbad, CA). DSP was purchased from Pierce (Rockford, IL), and
Tran[35S]-label from MP Biomedicals (Santa Ana, CA). Alkaline phosphatase-conjugated
secondary antibodies from Promega (Madison, WI) and horseradish peroxidase
secondary antibodies from Invitrogen (Carlsbad, CA). All other reagents were from
Sigma (St. Louis, MO). The Saccharomyces cerevisiae strains referred to throughout are
listed in Table 1. The mutant strains were verified by PCR. The primers used in this study
are listed in Table 2.
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Construction of the pfk2Δ Rav1p-Myc strain. The pfk2Δ Rav1p-Myc mutant was made by
disrupting the PFK2 gene using PCR based homologous recombination, in which LEU2containing cassettes were generated using the PFK2D primers (Table 2) and pRS315 as
template. The Rav1p-Myc strain (Smardon, Tarsio et al. 2002) was transformed directly
with the PCR product using the lithium acetate method. Transformants were selected on
fully supplemented synthetic complete (SC) medium lacking leucine (SC-Leu) plates.
The mutant was tested for integration by PCR.

Growth phenotype. Overnight cell cultures were grown to stationary phase, diluted to 0.1
OD Abs600/mL in fresh YEPD or selective medium buffered to pH 5.0, and cells grew for
4-6 hours. Cultures were washed twice with sterile ddH2O and 2.5 OD Abs600 cells
resuspended into 1 mL sterile ddH2O. Ten-fold serial dilutions were stamped onto YEPD
or SC plates lacking uracil (SC-Ura) buffered to pH 5.0 with 50 mM, succinic acid 50
mM, sodium phosphate pH 7.5 with 50 mM MES, 50 mM MOPS, or pH 7.5 with 100
mM calcium chloride added. The plates were incubated for three days at 30 oC and 37 oC.
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Table 1. S. cerevisiae strains used in this study

Strain
(Ref)

Parent

Relevant Phenotype

WT

BY4742

MATα ; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0

pfk1∆

BY4742

MATα ; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0
pfk1 Δ:: KanMX6

pfk2D

BY4742

MATα ; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0
pfk2 Δ:: KanMX6

vma6∆

BY4742

MATα ; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0
vma6 Δ:: KanMX6

vma2∆

BY4742

MATα ; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0
vma2 Δ:: KanMX6

vma3∆

BY4742

MATα ; his3Δ 1; leu2Δ 0; lys2Δ 0; ura3Δ 0
vma3 Δ:: KanMX6

Rav1-Myc SF838(Smardon, 5A
Tarsio et
al. 2002)

Matα ; ura3-52 ; leu2-3,112 ; his4-519 ade6 ; RAV1-Myc13::
kanMX6

pfk2∆
Rav1-Myc

Matα ura3-52 leu2-3,112 his4-519 ade6 RAV1-Myc13::
kanMX6 pfk2 Δ:: Leu2

SF8385A
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Table 2. Primers used in this study

Primer

Sequence (5’-3’)

Purpose

pfk2Δ-5’

GAC ATT AAT A AT AGA AAG TG T Generate
Rav1AAT AAA AGG TCA TTT TCT T TTA 13myc, pfk2∆
AGC AAG GAT TTT CTT AAC

pfk2Δ-3’

AGAGACTAGT
TTAGCATTGG Generate
Rav1CCAAGAACTA
ACCATACGCAATG 13myc, pfk2∆
TCT GCC CCT ATG TCT GC

PFK2-XhoI

GGG CTC GAG CTC ATG TTT CTT Clone
ATT AGG
PFK2

pRS316-

PFK2-XmaI

GGG CCC GGG TTA ATC AAC TCT Clone
CTT TCT TCC
PFK2

pRS316-

Cytosol and vacuolar pH measurements. For cytosol pH measurements, the lithium
acetate method (Elble 1992) was used to transform the cells with a 2µ pHLuorin plasmid
under control of the phosphoglycerate kinase promoter (Tarsio, Zheng et al. 2011; Chan,
Prudom et al. 2012). Cells were maintained in SC-Ura medium buffered to pH 5.0.
Fluorescence (ex 405, ex 485; em 508) was monitored and the cytosol pH measured as
described before using a FluoroMax 4 spectrofluorometer (Horiba Jobin Yvon Inc., NJ)
(Chan, Prudom et al. 2012). The pHLuorin plasmid was created by Dr. Rajini Rao
(Department of Physiology, Johns Hopkins University) and was a generous gift from
Patricia Kane (SUNY Upstate Medical University, Syracuse).
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Vacuolar pH was measured using the ratiometric fluorescent dye BCECF-AM (Brett,
Tukaye et al. 2005; Martinez-Munoz and Kane 2008; Johnson, Allen et al. 2010).
Glucose-dependent vacuolar pH changes were continuously monitored 20 min after
addition of 2% glucose (final concentration) to cells briefly (10 min) depleted of glucose.
The fluorescence intensity (490nm/450nm) was measured in a FluoroMax 4
spectrofluorometer (Horiba Jobin Yvon Inc., NJ).

Immuniprecipitations. Non-denaturing immunoprecipitations from whole cell lysates
were performed as described previously (Ediger, Melman et al. 2009), except that the
monoclonal antibodies 13D11 (anti V1 subunit B) and 10D7 (anti Vo subunit a, Vph1p
isoform) were used. To conduct immunoprecipitations from the cytosol, cytosolic
fractions were isolated by high-speed centrifugation (100,000 xg for 1hr in a Beckman
optima L-100 XP) and 4 µg total protein was used per immunoprecipitation. Protein was
separated in 10% SDS-PAGE and analyzed by Western blots. The nitrocellulose
membranes were scanned using a Bio-Rad ChemiDoc XRS+ and the intensity of protein
bands quantified using the Multi Gauge and GraphPad Prism 5 software. Protocols
previously described were followed (Parra and Kane 1998) to conduct the
immunoprecipitations from whole cell lysates and biosynthetically radiolabeled cells.
Except that the chases were performed at the indicated times and the antibodies 13D11
and 10D7 were used. The SDS-PAGE gels (13% acrylamide) were dried, scanned in a
Fuji Scanner FLA-5100, and analyzed using the Multi Gauge and GraphPad Prism 5
software.
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Other methods. Vacuolar membrane vesicles were isolated by Ficoll density gradient
centrifugation (Owegi, Carenbauer et al. 2005; Ediger, Melman et al. 2009; Chan,
Prudom et al. 2012). ATP hydrolysis was measured by monitoring NADH oxidation
spectrophotometrically (Owegi, Carenbauer et al. 2005; Ediger, Melman et al. 2009;
Chan, Prudom et al. 2012) using 5mg of total vacuolar membrane protein in the presence
and absence of 100 nM concanamycin-A. Proton transport was measured by monitoring
9-amino-6-chloro-2-methoxyacridin (ACMA) quenching after addition of MgATP
(Forgac, Cantley et al. 1983; Chan, Prudom et al. 2012). Protein concentration was
measured by the Bradford assay (Bradford 1976).

2.3 Results

Studying V-ATPase functions in a phosphofructokinase-1 null mutant strain (pfk1Δ
pfk2Δ) is not straightforward because pfk1Δpfk2Δ cells cannot metabolize glucose
(Heinisch 1986), which causes V1Vo disassembly (Parra and Kane 1998). The single
deletion strains pfk1Δ and pfk2Δ are suitable for these studies. They grow on glucose as
the only carbon source, because each phosphofructokinase-1 subunit Pfk1p and Pfk2p (a
and b, respectively) has catalytic and regulatory functions (Heinisch 1986; Arvanitidis
and Heinisch 1994). Thus, upon deletion of one subunit, the other subunit retains
catalytic activity sufficient to support glycolysis. We examined the roles of individual
phosphofructokinase-1 subunits for V-ATPase activity, assembly, and regulation.
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Phosphofructokinase-1 subunits Pfk1p and Pfk2p co-precipitate with V-ATPase. First, we
asked if the individual phosphofructokinase-1 subunits retain binding to V-ATPase in the
single deletion mutants. We immunoprecipitated V-ATPase and conducted immunoblots
using a polyclonal antibody that recognizes both phosphofructokinase-1 subunits. Yeast
pfk1Δ and pfk2Δ cells and an isogenic wild-type strain were grown in rich media in the
presence of 2% glucose (YEPD, normal yeast growth media). The cells were lysed and
the V-ATPase complex immunoprecipitated under nondenaturing conditions using the
monoclonal antibody 13D11 to the V-ATPase V1 subunit B (anti-B) (Ediger, Melman et
al. 2009).

As expected, both phosphofructokinase-1 subunits co-precipitated with V-ATPase in
wild-type cells (Fig. 1A). So did each individual subunit in pfk1Δ and pfk2Δ. Deletion of
one phosphofructokinase-1 subunit did not prevent interaction of the other subunit with
V-ATPase. The subunit expressed in pfk1Δ cells (subunit Pfk2p) and pfk2Δ cells (subunit
Pfk1p) can associate with V-ATPase.
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Figure 1. V-ATPase associates with phosphofructokinase subunits Pfk1p and Pfk2p. A. VATPase co-immunoprecipitates with Pfk1p and Pfk2p from whole cell lysates. Isogenic wild-type,
pfk1Δ and pfk2Δ cells were grown overnight to mid-log phase (0.8 -1.0 OD Abs600/ml). Cells
were converted to sheroplast by zymolase treatment and V-ATPase immunoprecipitated under
non-denaturing conditions using the monoclonal antibody 13D11 to subunit B of V1 and protein
A sepharose. The immunoprecitated protein was separated by 10% SDS-PAGE and
immunoblotted with antibodies to phosphofructokinase and V1 subunits A and B using
horseradish peroxidase secondary antibodies. HC: antibody heavy chain; LC: antibody light chain.
B. Pfk1p and Pfk2p subunits co-purify with vacuolar membrane fractions. Vacuolar membrane
vesicles (0.25 mg total membrane protein) were purified from pfk1Δ, pfk2Δ , and wild-type cells
by density gradient centrifugation. Membranes were immunoblotted as described above.
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Next, we asked if the subunit expressed in the pfk1Δ and pfk2Δ mutants was present at the
vacuolar membrane. We purified vacuolar membrane fractions from pfk1Δ, pfk2Δ, and
wild-type cells by density gradient centrifugation and conducted Western blots (Fig. 1B).
Both subunits were detected in wild-type membranes. The subunit Pfk1p was in pfk2Δ
membranes and Pfk2p in pfk1Δ membranes. Given that individual phosphofructokinase
subunits retained binding to V-ATPase and that pfk1Δ and pfk2Δ cells metabolize glucose
(Heinisch 1986), we asked if V-ATPase was functional in pfk1Δ and pfk2Δ.

The pfk2Δ mutants exhibit partial Vma- growth phenotype. V-ATPase inactivation leads
to a conditionally lethal growth phenotype that is pH-dependent in yeast, the vacuolar
membrane ATPase (Vma-) phenotype. The vma mutants grow at pH 5.0, but cannot grow
at either pH 7.5 or at pH 7.5 in the presence of high concentrations of calcium chloride
(Kane 2006).

We plated pfk1Δ and pfk2Δ cells on YEPD media buffered to pH 5.0, pH 7.5, and pH 7.5
plus calcium chloride to determine whether deletion of one subunit altered normal VATPase function (Fig. 2). For reference, we compared pfk1Δ and pfk2Δ growth to VATPase mutants (vma2Δ and vma6Δ). The vma2Δ and vma6Δ mutants lack all V-ATPase
activity because the structural genes VMA2 and VMA6 that encode subunits B of V1 and d
of Vo, respectively, were deleted (Bauerle, Ho et al. 1993; Doherty and Kane 1993). As
expected, vma2Δ (Fig. 2A) and vma6Δ (Fig. 2B) did not grow at pH 7.5 and pH 7.5 plus
calcium chloride.
34	
  

A
YEPD pH5

YEPD pH7.5+CaCl2

YEPD pH7.5

WT

vma2Δ
30oC

pfk1Δ
pfk2Δ
WT
vma2Δ

37oC

pfk1Δ

10#4

10#3

10#1
10#4

10#2

1
10#3

10#4

10#3

10#2

10#1

1

10#4

10#3

10#2

10#1

1

pfk2Δ

YEPD pH7.5+CaCl2

B

30oC

37oC

WT

pfk1Δ
pfk2Δ
vma6Δ

10#2

10#1

1

10#4

10#3

10#2

10#1

1

pfk2Δ (PFK2)

Figure 2. The pfk2Δ mutant exhibits partial Vma- growth phenotype. A. Growth of the pfk2Δ
strain is sensitive to pH 7.5 with calcium chloride. Cell cultures were grown overnight to mid-log
phase and ten-fold serial dilutions stamped onto YEPD plates adjusted to pH 5.0, pH 7.5, and pH
7.5 plus 100 mM CaCl2. Cell growth was monitored for 3 days at 30oC and 37oC. B. PFK2
rescues the Vma growth phenotype of pfk2Δ. The wild-type strain and the mutant strains pfk1Δ,
pfk2Δ and vma6Δ were transformed with the empty CEN plasmid pRS316. The pfk2Δ and
vma6Δ were transformed with the gene PFK2 expressed from the same plasmid under control of
its endogenous promoter (pfk2Δ (PFK2)). Serial dilutions of the cells were stamped onto SC-Ura
plates adjusted to pH 7.5 plus 100 mM CaCl2 and allowed to grow for 3 days at 30oC and 37oC.
Shown are representative plates of triplicates.
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The pfk2Δ cells exhibited a partial Vma- growth phenotype, in which the growth defect
was evident at pH 7.5 plus calcium chloride and accentuated at 37oC (Fig. 2A, right
panel). This growth defect was much subtler in the pfk1Δ mutant. At the less stringent
growth condition, pH 7.5, the pfk2Δ cells grew normally, as did pfk1Δ and the isogenic
wild type strain. To address if Vma- growth defects in pfk2Δ were specific to PFK2, we
expressed the PFK2 gene from a CEN plasmid in pfk2Δ cells. As expected, the empty
vector did not rescue growth on pH 7.5 plus calcium chloride plates (vma6Δ, Fig. 2B).
Exogenously expressed PFK2 rescued pfk2Δ growth (pfk2Δ (PFK2), Fig 2B), indicating
that the Vma- growth phenotype of pfk2Δ was caused by lack of PFK2 expression. These
results suggest that the phosphofructokinase-1 subunit Pfk2p is necessary for normal VATPase function.

Vacuolar and cytosolic pH are significantly altered in pfk2Δ cells. Having shown that
lack of PFK2 leads to growth defects typical of cells with impaired V-ATPase activity
(Vma- phenotype), we asked if pH homeostasis was altered. V-ATPase mutants have
alkalinized vacuoles and acidified cytosol, because V-ATPase proton transport is
necessary to sustain yeast vacuolar and cytosolic pH homeostasis (Martinez-Munoz and
Kane 2008).

We used fluorometric assays and pH-sensitive fluorescent dyes to measure vacuolar
(BCECF) and cytosolic (pHLuorin) pH (Johnson, Allen et al. 2010; Tarsio, Zheng et al.
2011; Chan, Prudom et al. 2012) in pfk1Δ and pfk2Δ cells in vivo (Fig. 3). As expected,
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pH homeostasis was aberrant in a control strain that lacks all V-ATPase function
(vma2Δ). The vacuolar pH of vma2Δ cells was considerably more alkaline and its cytosol
more acidic than wild-type cells.
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A

B

Figure 3. pfk1Δ and pfk2Δ mutants have altered vacuolar and cytosol pH homeostasis at
steady state. A. The vacuolar lumen is alkalinized in live pfk1Δ and pfk2Δ cells. Overnight midlog phase cultures from wild-type cells, mutant cells (pfk1Δ, pfk2Δ, vma2Δ), and the mutant
pfk2Δ expressing exogenous PFK2 from the CEN plasmid pRS316 (pfk2Δ (PFK2)) were stained
with 50mM BCECF-AM for 30 minutes at 30oC. The ratio of fluorescent emission (535 nm)
excited at 490 and 450 nm was measured in a fluorometer to quantitatively assess vacuolar pH.
The average fluorescence over 6 minutes was compared to a standard curve to generate absolute
pH values. B. The cytosol pH is acidified in live pfk1Δ and pfk2Δ cells. The wild-type, pfk1Δ,
pfk2Δ, and vma2Δ cells expressing cytosolic pHLuorin were grown overnight to mid-log phase
(0.4-0.6 OD Abs600/mL). The cells were transferred to 1 mM HEPES/MES buffer pH 5.0
containing 2% glucose at a cell density of 5.0 OD Abs600/mL. The ratio of fluorescent emission
(508 nm) excited at 405 nm and 485 nm was measured for 6 min at 1 min intervals. The average
fluorescence was estimated and calibration curves made in parallel used to calculate pH values in
a fluorometer. Vacuolar and cytosol data is presented as average pH values from three
independent experiments, error bars= +/- standard deviation, * p<0.05, *** p<0.001 compared to
wild-type control as measured by two-tailed unpaired t-test.
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We detected vacuolar and cytosolic pH alterations suggestive of V-ATPase dysfunction
in the pfk1Δ and pfk2Δ cells. The vacuolar lumen was alkalinized and the cytosol
acidified. Vacuolar pH increased by 0.4 pH units in pfk1Δ (pH=6.2 +/-0.04) and 0.6 pH
units in pfk2Δ (pH=6.4 +/-0.06), compared to wild-type cells (pH=5.8+/-0.05) (Fig. 3A).
Reciprocally, the cytosol pH decreased. It dropped from pH 7.4 (+/-0.06) in wild-type
cells to pH 7.1 (+/-0.10) in pfk2Δ , and pH 6.8 (+/-0.03) in pfk2Δ (Fig. 3B). Vacuolar
acidification, which is a direct indicator of V-ATPase activity, was rescued by expression
of exogenous PFK2 (pfk2Δ (PFK2)). Together, these results indicate that the pH defects
in pfk2Δ are specific to V-ATPase malfunction caused by lack of PFK2.

The fact that pH alterations were milder in pfk1Δ than pfk2Δ, and more severe in the
vma2Δ mutant is consistent with the extent of the growth defects observed in these strains
(Fig. 2). Together these phenotypes suggest that subunit Pfk2p is more critical than Pfk1p
to sustain optimal V-ATPase proton transport at steady state in vivo.
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V-ATPase is catalytically competent in pfk2Δ. To directly address the effect that deletion
of PFK1 and PFK2 has on V-ATPase catalytic activity, we purified vacuolar membrane
fractions by density gradient centrifugation. We measured ATP hydrolysis and proton
transport in vitro in the presence and absence of the V-ATPase inhibitor conanamycin A
(Chan, Prudom et al. 2012).

The V-ATPase pumps at pfk1Δ than pfk2Δ membranes were significantly active. The
conanamycin A-sensitive ATP hydrolysis and proton transport were partially reduced by
about 35% in the pfk2Δ membranes (Fig. 4A). They were normal in pfk1Δ. Comparative
membrane protein titrations in Western blots showed equivalent amounts of V1 (subunits
A and B) and Vo (subunit a) subunits in wild-type, pfk1Δ, and pfk2Δ membranes (Fig.
4B), suggesting that V1Vo assembly is normal at the vacuolar membrane.

Subtle alterations of the V1Vo assembly level may not be detected by Western blots. We
further examined if loss of Pfk1p or Pfk2p affected V1Vo assembly by using a more
sensitive approach. We biosynthetically radiolabeled the cells with S35 to estimate the
total fraction of V1Vo complexes assembled in pfk1Δ and pfk2Δ. The radiolabeled VATPase pumps were immunoprecipitated from whole cell lysates with the antibodies
13D11 (anti-B, recognizes V1 and V1Vo) and 10D7 (anti-a, recognizes Vo) and the total
fraction of assembled V-ATPase complexes calculated as described before (Parra and
Kane 1998).
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Figure 4. V-ATPase activity is partially reduced at pfk2Δ vacuolar membrane vesicles. A.
ATP hydrolysis and proton transport are differentially affected in pfk1Δ and pfk2Δ cells.
Vacuolar membrane fractions were purified from the isogenic wild-type, pfk1Δ, pfk2Δ, and
vma2Δ cells. ATP hydrolysis (left) was assayed spectrophotometrically in the presence and
absence of the V-ATPase inhibitor concanamycin A by using an enzymatic coupled assay that
measures NADH oxidation at 340 nm. The wild-type specific activity of the concanamycin Asensitive ATP hydrolysis was 2.5 - 4 µmol of ATP/min/mg of protein. The strains showing
significant activity (wild-type, pfk1Δ and pfk2Δ) were equally inhibited (~80%) by 100 nM
concanamycin-A. ATP-dependent proton transport (right) was measured via fluorescence
quenching of 1µM 9-amino-6-chloro-2-methoxyacridin (ACMA)(Ex 410 nm; Em 490 nm) upon
the addition of 0.5mM ATP/1mM MgSO4 to 5µg of total protein in vacuolar membranes vesicles.
Initial velocities were calculated for 15 seconds following MgATP addition. The average wildtype slope was -1320.32 fluorescence units/15 seconds.
Data represent three independent
vacuolar preps; * p<0.05, *** p<0.001 decreased ATPase activity compared to wild-type
membranes as measured by two-tailed unpaired t-test. B. Wild-type levels of VoV1 complexes are
assembled at the vacuolar membrane of pfk1Δ and pfk2Δ mutants. The purified vacuolar
membrane vesicles were analyzed by quantitative immunoblotting using antibodies against V1
subunits B and A and the Vo subunit a (Vph1p isoform) and alkaline phosphatase-conjugated
secondary antibodies. Serial dilutions of wild-type and mutant membrane fractions were prepared
and the indicated amounts of vacuolar protein loaded per well and separated on 10% SDS-PAGE
gels. A representative gel of three independent vacuolar preps is shown. C. Pfk1Δ and pfk2Δ
assemble wild-type levels of V1Vo complexes at steady state. An isogenic wild-type, pfk1Δ, and
pfk2Δ cells were biosynthetically radiolabeled with Tran35S for 60 minutes and V-ATPase
immunoprecipitated from whole cell lysates under non-denaturing conditions using the antibodies
anti-B (recognizes V1 and V1Vo) and anti-a (recognizes Vo). The protein was separated in 13%
SDS-PAGE gels and assembled V1Vo estimated as the fraction of Vo immunoprecipitated with
anti-B relative to the total immunoprecipitated with both antibodies. Gels from three independent
experiments were analyzed in a Fuji Scanner FLA-5100, and analyzed using the Multi Gauge and
GraphPad Prism 5 software.
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Consistent with previous studies (Parra and Kane 1998; PM. 2006), about 60% of the VATPase pumps were assembled in wild-type cells at steady state (Fig. 4C). A comparable
fraction of assembled V-ATPases was detected in pfk2Δ and pfk1Δ cells, consistent with
the Western blots (Fig. 4B) and further suggesting that absence of either
phosphosfructokinase-1 subunit does not disturb biosynthetic V1Vo assembly. Next, we
asked whether V-ATPase reversible disassembly was normal.

Glucose-dependent V-ATPase reassembly is defective in pfk2Δ mutants. Until now our
studies have been conducted at steady state, in the presence of abundant glucose (2%
glucose). We determined whether the phosphofructokinase-1 subunits were necessary for
V1Vo reversible disassembly in response to glucose depletion and re-addition. It is known
that under disassembly and reassembly conditions the equilibrium [V1Vo] to [V1+Vo] is
changed (PM. 2006); lack of glucose favors disassembly, glucose re-addition promotes
reassembly and restores steady state equilibrium.

The wild-type, pfk1Δ, and pfk2Δ cells were biosynthetically radiolabeled and chased in
the presence (assembly condition) and absence (disassembly condition) of 2% glucose,
and after re-addition of 2% glucose following a brief glucose depletion period
(reassembly condition). We estimated the fraction of assembled V1Vo by nondenaturing
immunoprecipitation experiments using the anti-B and anti-a antibodies (Parra and Kane
1998).
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The pfk1Δ cells disassembled and reassembled V1Vo normally, as wild-type cells (Fig.
5A). Approximately 70-80% of the total V1Vo complexes disassembled upon glucose
depletion. An equivalent proportion of V1Vo complexes reassembled after glucose readdition to pfk1Δ. Notably, disassembly was normal in the pfk2Δ strain but reassembly
was significantly reduced (Fig. 5B). Only 50% reassembly was detected relative to wildtype cells. Maximum reassembly is achieved within 5 minutes in wild-type cells; an
increase of the incubation time from 5 minutes to up to 15 minutes did not lead to an
increase of pfk2Δ assembly after glucose re-addition. These results suggest that the
mechanism(s) of reassembly are defective in pfk2Δ, while the kinetics of reassembly
remains similar to wild type cells.
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Figure 5. Glucose dependent V1Vo reassembly is defective in pfk2Δ . A. Glucose-dependent
disassembly and reassembly is normal in pfk1Δ cells. Biosynthetically radiolabeled wild-type and
pfk1Δ cells were chased in YEP media containing 2% glucose (YEPD) for 20 minutes (1), lacking
glucose for 10 minutes (2), and in medium lacking glucose for 10 minutes followed by an
additional 10 minutes chase after re-addition of glucose to a final concentration of 2% glucose (3).
The cells were lysated, immunoprecipitated, and gels from four independent experiments
analyzed as described for Figure 4C. A representative gel is shown (left). Analyzed results are
expressed as the average ± standard deviation relative to wild-type (right). B. Glucose-dependent
disassembly and reassembly is defective in pfk1Δ cells. Wild-type and pfk2Δ cells were
radiolabeled, chased, immunoprecipitated, and V1Vo assembly levels analyzed as described for
Figures 4C and 5A. Sample (1) was chased in YEPD for 25 minutes, (2) in YEP for 10 minutes,
and (3), (4), and (5) were chased respectively for 5 minutes, 10 minutes, and 15 minutes after
glucose re-addition (2% final concentration). The data is expressed as the average ± standard
deviation relative to wild-type (right). * p<0.05compared to wild-type as measured by two-tailed
unpaired t-test.
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V-ATPase-Rav1p interaction is enhanced in the pfk2Δ strain. Reassembly requires the
RAVE complex, particularly the RAVE subunit Rav1p that connects RAVE with V1,
subunit C, and Vo (Smardon, Tarsio et al. 2002; Smardon and Kane 2007; Smardon, Diab
et al. 2014). Since these interactions are necessary for reassembly of V-ATPase pumps at
the vacuolar membrane, we asked whether the Rav1p-V1 binding was affected in pfk2Δ.
We deleted PFK2 in cells expressing Myc epitope tagged genomic RAV1 (Rav1p-Myc).
It has been shown that wild-type Rav1p-Myc cells retain normal growth and assemble
functional V1Vo complexes at vacuolar membranes (Smardon, Tarsio et al. 2002). Thus,
the Myc tag does not interfere with steady state V-ATPase assembly and activity.

To address if Rav1p binding to V1 was affected in pfk2Δ we immunoprecipitated V1 from
a cytosolic fraction isolated from the pfk2Δ Rav1p-Myc strain. We estimated about 5fold more Rav1p bound to V1 subunits A and B in pfk2Δ than wild-type cells (Fig. 6A).
This increase in Rav1p-V1 binding was not caused by enhanced expression of cytosolic
Rav1p and/or V1 subunits, since these proteins were comparable in whole cell lysates
from pfk2Δ and wild-type cells (input, Fig. 6A). Rather, Rav1p-V1 binding was increased
in the cytosol of pfk2Δ, suggesting an enhanced Rav1p-V1 affinity.
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Figure 6. The interaction between Rav1p and cytosolic V1 is increased in pfk2Δ cells. A.
Cytosolic fractions from pfk2Δ cells contain more Rav1p-V1 than wild-type cells. Overnight midlog phase cultures (0.8~1.0 OD Abs600/ml) of wild-type and pfk2Δ cells expressing Rav1p-Myc
were lysated and the cytosolic fraction prepared by centrifugation (100,000xg for 1 hour).
Cytosolic V1 complexes were immunoprecipited with anti-B antibody. Immunoprecitated protein
(IP) and total cytosolic protein (Input) were loaded on 10% SDS-PAGE gels. Rav1p and V1
(subunits A and B) were detected by immunoblots with anti-Myc, anti-B and anti-A monoclonal
antibodies respectively. A representative gel is shown (left). Gels from three independent
experiments were scanned using a Bio-Rad ChemiDoc XRS+ and data analyzed using Multi
Gauge V3.0 and GraphPad Prism 5 software. Data was expressed as fold-increase Rav1p:V1subunit ratio ± standard deviation relative to wild-type (right). B. Glucose-dependent V1Vo
reassembly is defective in Rav1p-Myc pfk2Δ cells. Isogenic wild-type and pfk2Δ mutant cells
expressing genomic Rav1p-Myc were grown overnight to mid-log phase. Cells were converted to
sheroplast incubated in YEPD media (2% glucose) for 20 minutes (+G), deprived of glucose for
10 minutes (-G), and deprived of glucose for 10 minutes followed by an additional 10 minutes
after glucose re-addition to a final concentration of 2% glucose (-/+G). V-ATPase was
immunoprecipitated (200 OD Abs600/IP) as described for Figure 1A and immunoblots analyzed
with antibodies to Vo subunit a (vacuolar isoform Vph1p) and V1 subunits A and B. One
representative gel is shown (left). Gels from three independent experiments were analyzed, and
total V1Vo estimated as for Figure 4C. The data is expressed as the average ± standard deviation
relative to wild-type. ** p<0.01 compared to wild-type as measured by two-tailed unpaired t-test.
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To eliminate the possibility that the Myc tag itself affected Rav1p-V1 binding, we also
immunoprecipitated V-ATPase complexes from whole cell lysates after brief glucose
depletion and re-addition. As expected for wild-type Rav1p-Myc cells, about 70 % of the
V1Vo disassembled and reassembled after glucose removal and its re-addition,
respectively (Fig. 6B). Only half of the V1Vo complexes reassembled after re-addition of
glucose to pfk2Δ Rav1p-Myc cells. We concluded that tagged Myc did not interfere with
V-ATPase reversible disassembly. Thus, the increased level of RAVE-V1 in the cytosol
of pfk2Δ is a phenotypic trait of the phosphofructokinase-1 mutant pfk2Δ.

Rav1p also interacts with Vo subunit a at the membrane, specifically the subunit a
isoform Vph1p (vacuolar isoform) (Smardon, Diab et al. 2014). We isolated membrane
fractions to determine whether binding of Rav1p to Vo subunit a was also enhanced in
pfk2Δ. We detected similar levels of Rav1p in pfk2Δ and wild-type vacuolar membranes
(not shown). These results suggest that the binding of RAVE to Vo was not altered in
pfk2Δ. A greater affinity of Rav1p-V1 binding could lead to reassembly defects of pfk2Δ.

Glucose-dependent V1Vo reassembly fails to acidify pfk2Δ vacuoles. In wild-type cells,
glucose depletion alkalinizes the vacuoles and glucose re-addition acidifies the vacuolar
lumen (Martinez-Munoz and Kane 2008). These pH changes are V-ATPase-dependent,
because V1Vo reassembly restores ATP hydrolysis and proton transport (Kane 2006;
Martinez-Munoz

and

Kane

2008).

We

monitored

vacuolar

pH

in

the

phosphofructokinase-1 mutants under reassembly conditions. The vacuoles were loaded
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with the pH sensitive fluorophore BCECF-AM and deprived of glucose for 10 minutes,
after which glucose was re-added and the pH continuously measured (Fig. 7).

The wild-type and pfk1Δ cells acidified the vacuolar lumen after glucose re-addition,
indicating that reassembled V1Vo resumed proton transport. Glucose re-addition to pfk2Δ
did not result in vacuolar acidification. Instead the vacuolar pH gradually increased until
reaching approximately pH 6.5, the same pH measured at steady state (Fig. 3). A similar
alkalinization of the vacuolar lumen is obvious in the V-ATPase mutant vma2Δ (Fig. 7)
and other yeast mutants lacking V-ATPase activity. Although the vacuolar pH increased
abruptly in vma2Δ and gradually in pfk2Δ, these results indicate that reassembled VATPase pumps are inactive in the pfk2Δ strain.
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Figure 7. Glucose-dependent vacuolar acidification is impaired in pfk2Δ cells. The pfk1Δ,
pfk2Δ, vma2Δ mutants and a wild-type strain were stained with 50mM BCECF-AM for 30
minutes at 30oC. The cells were depleted glucose for 10 min, after which glucose (2% final
concentration) was added (arrow) and fluorescence monitored for an additional 20 minutes. The
ratio of fluorescent emission (535 nm) excited at 490 and 450 nm was measured as for Figure 3A.
The vacuolar pH was estimated using calibration curves made in parallel
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2.4 Discussion

We studied V-ATPase assembly, activity and regulation in phosphofructokinase-1 single
deletion mutants lacking the phosphofructokinase-1 structural genes PFK1 and PFK2.
Whereas both phosphofructokinase-1 subunits make contributions to V-ATPase activity,
the most critical subunit is Pfk2p.

The pfk1Δ and pfk2Δ mutants are suitable to study V-ATPase. V-ATPase studies using
pfk1Δ pfk2Δ cells are difficult to interpret because the double deletion mutant cannot
metabolize glucose. Although pfk1Δ pfk2Δ tolerates 0.2% glucose (Su, Zhou et al. 2003),
suppression of glycolysis and glucose-dependent signals promotes V1Vo disassembly.
Only 30-40% of the V1Vo complexes are assembled at 0.2% glucose in wild-type cells
(Parra and Kane 1998).

Because there is an equal contribution of Pfk1p (subunit α) and Pfk2p (subunit β) in the
wild-type phosphofructokinase-1 heteromeric complex, each individual subunit can
assemble to an unknown structure that is partially active in vivo (Arvanitidis and
Heinisch 1994; Klinder, Kirchberger et al. 1998). Each single deletion strain grows on
glucose, indicating that pfk1Δ and pfk2Δ have phosphofructokinase-1 activity above a
threshold level that supports sufficient glycolytic flow.
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The phosphofructokinase-1 subunit Pfk2p is necessary for cellular pH homeostasis and
V-ATPase regulation. Heteromeric (wild-type) and homomeric (pfk1Δ and pfk2Δ cells)
phosphofructokinase-1 complexes co-precipitate with V-ATPase. Our study suggests that
phosphofructokinase-1 interacts with V1Vo because Pfk1p and Pfk2 were detected in
vacuolar membrane fractions and co-immunoprecipitated with the anti-B antibody
(13D11). However, we cannot exclude the possibility that it binds to cytosolic V1 as well
because the antibody 13D11 recognizes both V1Voand V1. Additional studies will be
necessary to determine whether the interactions between Pfk2p and V-ATPase are direct
or indirect, for example, involving other glycolytic enzymes.

Pfk2p could bridge interactions involving phosphofructokinase-1 and V-ATPase. Yeast
phosphofructokinase-1 forms stable α4β4 complexes in which β subunits (Pfk2p) are at
the periphery (Banaszak, Mechin et al. 2011), more readily available to form
intermolecular interactions with other proteins, including V-ATPase.

The subunit a is not critical for V-ATPase function, although the vacuole and cytosol pH
homeostasis are altered in vivo. The pfk1Δ strain exhibits wild-type levels of V-ATPase
activity in membrane fractions and V1Vo assembly at steady state. They also disassemble
and reassemble V1Vo normally and resume vacuolar acidification after glucose readdition.
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At steady state, V-ATPase proton transport is somewhat inhibited in vivo; pfk1Δ has
more alkaline vacuoles and acidic cytosol than wild-type cells. Together with the fact
that pfk1Δ growth is slightly reduced on plates buffered to pH 7.5 containing calcium
chloride, these results indicate that V-ATPase proton transport is suppressed in pfk1Δ
vacuolar membranes in vivo at steady state.

The subunit β is critical for V-ATPase function. V-ATPase function and its regulation are
more severely impaired in the pfk2Δ mutant strain. Vacuolar and cytosol pH alterations
are more pronounced in pfk2Δ than pfk1Δ at steady state. The vacuolar and cytosol pH,
respectively, increased and decreased by 0.75 pH unit each. For reference, complete lack
of V-ATPase activity in vma2Δ changes the vacuole and cytosol pH by about 1.0 pH unit.

V-ATPase reversible disassembly is also defective in pfk2Δ. Only half of the V-ATPase
complexes reassemble after glucose readdition compared with wild-type cells.
Notably, pfk2Δ does not acidify the vacuolar lumen after glucose readdition. Because
glucose-triggered vacuolar acidification is a direct outcome of V-ATPase reassembly and
reactivation

(Martinez-Munoz

and

Kane

2008),

these

results

suggest

that

V1Vo complexes do not pump protons after reassembly occurs in pfk2Δ.

One explanation is that pfk2Δ does not acidify the vacuoles because 50% of
V1Voreassembles and those pumps are ∼35% less active. However, wild-type yeast
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vacuoles are acidified when 30–40% of the V-ATPase pumps reassemble after addition
of 0.2% glucose. Another explanation is that RAVE-mediated reassembly is defective
in pfk2Δ.

Enhanced Rav1p-V1 Interaction May Impair pfk2Δ Glucose-dependent ReassemblyThe
The chaperone activity of RAVE directly involves its subunit Rav1p, which binds to
cytosolic V1 and subunit C and connects RAVE and V-ATPase subunits (Smardon,
Tarsio et al. 2002; Smardon and Kane 2007; Smardon, Diab et al. 2014). We estimated
about 5-fold more Rav1p-V1 complexes in the cytosol of pfk2Δ than wild-type cells (Fig.
6). Because these experiments were conducted at steady state, excess Rav1pV1 complexes are not a byproduct of failure to reassemble V1Vo.

RAVE likely facilitates the structural changes necessary to properly reform V1Vo subunit
interactions (Oot, Huang et al. 2012; Parra, Chan et al. 2014). Reassembled
V1Vo complexes can be inactive if reassociation of V1 and/or subunit C with Vo is
structurally flawed or “loose.” Structurally loose complexes will not acidify vacuoles;
they could also break apart V1 and Vo during the immunoprecipitation experiments (Fig.
5).

RAVE exclusively controls assembly of Vph1p-containing V-ATPases, which reside in
the vacuole (Smardon, Diab et al. 2014). Thus, Vph1p-containing V-ATPases are likely
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defective in pfk2Δ. In agreement with this notion, vacuolar pH and glucose-dependent
reassembly are altered in pfk2Δ. In addition, pfk2Δ and rav1Δ mutants share common
growth characteristics, a partial Vma- growth phenotype (Smardon, Diab et al. 2014).
This phenotype suggests that non-vacuolar V-ATPase pumps at other cellular
compartments probably are functional. Like rav1Δ, pfk2Δ may retain normal V-ATPase
function at Golgi and endosomes, which house the second Vo subunit a isoform Stv1p
(Smardon, Diab et al. 2014).

A difference between pfk2Δ and rav1Δ is that biosynthetic V1Vo assembly is normal in
pfk2Δ, but the glucose-triggered re-assembly is partially reduced. Both mechanisms,
biosynthetic assembly and reassembly, are severely defective in rav1Δ cells which also
lacks V-ATPase activity at the vacuolar membrane (Smardon, Tarsio et al. 2002). Our
interpretation of these results is that RAVE activity is partially compromised in pfk2Δ.
Only its function at mediating glucose-triggered reassembly is defective.

Are V-ATPase and glycolysis directly coupled in vivo?

Glycolysis is necessary to

reassemble V1Vo complexes (Parra and Kane 1998). This study suggests that glycolysis
may also modulate V-ATPase activity under steady-state conditions. In vivo vacuolar
acidification is defective in pfk1Δ and pfk2Δ, although the V-ATPase pumps are active in
vitro. Reactivation in vitro could be explained if the mechanism that inhibits proton
transport in vivo is lost during the purification of membrane vesicles.
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Glycolysis is necessary to reassemble V1Vo complexes (Parra and Kane 1998).
Glycolysis may also modulate V-ATPase activity under steady state conditions. In vivo
proton transport is inhibited in pfk1Δ and pfk2Δ, although the V-ATPase pumps are active
in vitro. This discrepancy could be explained if V-ATPase proton transport is inhibited in
the phosphofructokinase-1 mutants in vivo by a mechanism lose during the purification of
membrane vesicles.

Recent crystallographic data of the yeast V-ATPase complex suggest that
V1Voreassembly may require some energy input in addition to RAVE (Oot, Huang et al.
2012; Parra, Chan et al. 2014). It is conceivable that reduced glycolytic flow and
therefore lower energy (e.g. ATP) production contribute to the V1Vo reassembly defects
in pfk2Δ.

There is evidence that the glycolytic flow is reduced in the pfk1Δ and pfk2Δ mutants
compared to wild-type cells (Heinisch 1986). Homomeric complexes consisting of
subunit β (pfk1Δ cells) are more active than the subunit a-containing complexes (pfk2Δ
cells) (Heinisch 1986) The concentration of phosphofructokinase-1 reaction product is
10- to 15-fold lower in the pfk2Δ mutant as compared to wild-type cells; it is only 2-fold
lower in pfk1Δ (Heinisch 1986). In addition, the NADH spike triggered by readdition of
glucose is reduced or absent in pfk2Δ, but not in pfk1Δ (Williamson, Adiamah et al. 2012;
Schroder, Ozalp et al. 2013).

55	
  

Additional studies will be necessary to understand the interplay between V-ATPase and
glycolysis. It likely involves additional glycolytic enzymes. A super-complex consisting
of V-ATPase and glycolytic enzymes has been proposed before (Su, Zhou et al. 2003;
Konishi, Yamane et al. 2004; Lu, Sautin et al. 2004; Lu, Ammar et al. 2007; Su, BlakePalmer et al. 2008). It also could directly provide glycolytic ATP to drive proton
transport. Other rapid energy-consuming processes rely on glycolysis-derived ATP
locally made by glycolytic enzymes at the site where the energy supply is needed. These
processes include, glutamate uptake in synaptic vesicles (Ikemoto, Bole et al. 2003),
regulation of ATP-sensitive K+ channels in cardiac myocytes (Weiss and Lamp 1987;
Dhar-Chowdhury, Harrell et al. 2005), and phototransduction at rod and cone cells (Hsu
and Molday 1991).

In summary, deletion of the structural genes encoding subunits of the glycolytic enzyme
phosphofructokinase-1 interferes with yeast V-ATPase function and regulation in vivo,
despite the fact that V-ATPases are catalytically competent and the cells can metabolize
glucose. V-ATPase proton transport at the vacuole is inhibited by unknown cellular
mechanisms; a reduction of the glycolytic flow is an attractive candidate. Given that
RAVE-V1 binding is enhanced and V1Vo reassembly reduced in pfk2Δ, we concluded that
Pfk2p is necessary for normal RAVE functions
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3.1 Introduction

The vacuolar proton ATPase pump (V-ATPase) is a highly conserved multi-subunit
complex present throughout the endomembrane system. V-ATPase is responsible for
acidification of the Golgi Apparatus and vacuolar/lysosomal and endosomal
compartments in all eukaryotic cells. V-ATPases are also present at the plasma
membrane of certain cells specialized for active proton secretion. These cells include
osteoclasts, intercalated cells of the kidney, and clear cells of the epididymis where VATPases sustain an acidic pH at the extracellular lumen (Nelson 2003; Wagner, Finberg
et al. 2004; Kane 2006; Forgac 2007).

V-ATPase pumps are necessary for a broad spectrum of cellular processes. Intracellular
V-ATPase proton transport generates and maintains the acidic luminal pH necessary for
receptor-mediated endocytosis, membrane trafficking, protein sorting and processing,
zymogen activation, and amino acid sensing in lysosomes (Forgac 2007; Mijaljica,
Prescott et al. 2011; Efeyan, Zoncu et al. 2012). Plasma membrane associated V-ATPase
proton transport at the apical membrane of the kidney proximal tubule cells and
intercalated cells maintain the systemic acid-base balance (Stehberger, Schulz et al.
2003). At the bone osteoclasts, V-ATPases are essential for bone resorption (Yang, Feng
et al. 2012). At the clear cells of the epididymis, V-ATPase-mediated acidification of the
epididymal lumen sustains the low pH necessary for sperm maturation (Brown and
Breton 2000). Mutations of subunit isoforms of the human V-ATPase have been
described in patients with distal renal tubular acidosis (Stehberger, Schulz et al. 2003;
Ochotny, Van Vliet et al. 2006) and osteopetrosis (Stehberger, Schulz et al. 2003;
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Ochotny, Van Vliet et al. 2006; Su, Blake-Palmer et al. 2008). Some human conditions,
including cancers (Fan, Niu et al. 2012; Michel, Licon-Munoz et al. 2013), viral
infections (Kohio and Adamson 2013), and fungal infections (Kohio and Adamson 2013;
Rane, Bernardo et al. 2013; Hayek, Lee et al. 2014) rely on V-ATPase normal or
enhanced proton transport. This collection of studies have made V-ATPase pumps
attractive therapeutic targets.

V-ATPases operate as molecular motors that couple active transport of protons to ATP
hydrolysis by a rotational mechanism (Yokoyama, Nakano et al. 2003; Owegi, Pappas et
al. 2006; Toei, Gerle et al. 2007; Jefferies and Forgac 2008; Lau and Rubinstein 2010).
V-ATPases consist of fourteen different subunits. Eight peripheral subunits (A-H) form
the V1 domain assembled at the cytosolic side of the membrane. ATP binds and is
hydrolyzed in V1. Six subunits (a, d, e, c, c’, c’’) form the membrane Vo domain that
binds the cytosolic protons and forms the path for proton transport (Kane 2006).

An important mechanism that regulates V-ATPase in vivo involves physical separation or
disassembly of the V1Vo complex into three components: V1 subunit C, the V1 domain
without subunit C (V1-C), and the Vo domain (Kane 1995). Disassembly occurs when
glucose is absent (Kane 1995). It inactivates the pumps and alkalinizes the vacuolar
lumen . Since the V1-C sub-complexes cannot hydrolyze ATP (Zhang, Myers et al. 1992;
Parra, Keenan et al. 2000; Kane 2012; Parra, Chan et al. 2014), it also prevents energy
depletion (e.g., ATP) when the main energy source for most organisms, glucose, is absent.
Glucose is the main and strongest external stimulus for reassembly in yeast (Kane 1995).
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Glucose re-addition after a brief period of glucose-depletion triggers V1Vo reassembly,
which can be detected within 2-5 min. Reassembly resumes ATP hydrolysis and proton
transport (Kane 1995; Parra and Kane 1998) and restores the acidic vacuolar pH
(Nakamura 2004; Tarsio, Zheng et al. 2011). Thus, reassembly restores energy utilization
by V-ATPase when glucose is available and metabolism resumes.

Reversible disassembly has been described in yeast (Kane 1995), insects (Sumner, Dow
et al. 1995) and mammalian cells (Trombetta, Ebersold et al. 2003; Sautin, Lu et al. 2005).
However, what is the glucose sensor and the mechanism(s) communicating the presence
of glucose (or its absence) to V-ATPase remains unanswered (Kane 2012). In yeast,
reversible disassembly is intertwined with glycolysis (Kane 1995; Parra and Kane 1998)
and the RAS/cAMP/ PKA pathway (Bond and Forgac 2008), and involves a V-ATPasededicated chaperone complex (the Regulator of the (proton)-ATPase of the Vacuolar and
Endosomal Membranes, RAVE) (Seol, Shevchenko et al. 2001; Smardon, Tarsio et al.
2002; Smardon and Kane 2007; Smardon, Diab et al. 2014).

Several lines of evidence suggest that glycolysis could control V1Vo reassembly: 1) Only
rapidly fermentable carbon sources such as mannose and fructose can substitute for
glucose in triggering reassembly of V-ATPase complexes (Parra and Kane 1998). 2)
Addition of less efficiently fermented carbon sources such as raffinose and galactose, or
non-fermentable carbon sources such as glycerol and ethanol, do not trigger reassembly
(Wick, Drury et al. 1957; Kane 1995; Parra and Kane 1998). 3) Glucose-dependent V1Vo
reassembly is impaired in a phosphoglucose isomerase glycolytic mutant that
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accumulates glucose 6-phosphate and blocks glycolysis; only fructose, which bypasses
the phosphoglucose isomerase step and resumes glycolysis, can trigger V1Vo reassembly
(Parra and Kane 1998). And lastly, 4) Pharmacologic inhibition of glycolysis with 2deoxyglucose causes V1Vo disassembly and 2-deoxyglucose cannot trigger reassembly.
(Parra and Kane 1998).

Glucose-triggered reversible disassembly is not an all-or-none response (Parra and Kane
1998); under steady state conditions, the level of assembled V1Vo is proportional to the
concentration of glucose in the media (Parra and Kane 1998). In addition, cells contain
pools of cytosolic V1 and membrane bound Vo domains that co-exist with fully assembled
V1Vo complexes at the vacuolar membrane (Doherty and Kane 1993; Myers and Forgac
1993; Sumner, Dow et al. 1995). When glucose is abundant, yeast cells contain about
70% of the Vo domains assembled and the remaining 30% disassembled. The equilibrium
V1 + Vo : V1Vo is switched in response to glucose. It favors disassembly (V1 + Vo) if the
glucose level drops; it favors assembly (V1Vo) if the glucose level raises (Parra and Kane
1998). The fact that complete removal of glucose leads to about 75%-80% disassembly
(Kane 1995), suggests that 20-25% of assembled V1Vo is sufficient to maintain basal
levels of V-ATPase function necessary for survival during nutrient scarcity (Kane 1995).

An interplay between V-ATPase and the glycolytic enzymes aldolase and
phosphofructokinase-1 has been described and appears to be important for V-ATPase
function (Lu, Holliday et al. 2001; Su, Zhou et al. 2003; Lu, Sautin et al. 2004; Lu,
Ammar et al. 2007; Su, Blake-Palmer et al. 2008). Aldolase interacts with several V-
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ATPase subunits (subunits B and E from V1 and subunit a from Vo). Aldolase is
necessary for V1Vo assembly (Lu, Ammar et al. 2007) and its overexpression prevents
disassembly in yeast (Lu, Ammar et al. 2007). Human phosphofructokinase-1 binds the
Vo subunit a (isoform a4), and associates with V-ATPase pumps in human kidney cells
(Su, Zhou et al. 2003; Su, Blake-Palmer et al. 2008). Notably, mutations in subunit a4
that prevent V-ATPase binding to phosphofructokinase-1 cause distal renal tubular
acidosis (Su, Blake-Palmer et al. 2008). Phosphofructokinase-1 catalyzes the
phosphorylation of fructose 6-phosphate into fructose 1,6 -bisphosphate, the substrate for
aldolase.

The yeast phosphofructokinase-1 enzyme has two subunits, Pfk1p (α subunit) and Pfk2p
(β subunit), that form a hetero-octameric complex (α4β4) (Banaszak, Mechin et al. 2011).
Although both subunits have catalytic and regulatory functions, the PFK2 deletion has
much more significant metabolic implications. The pfk2Δ cells do not have detectable
glycolytic oscillations (Williamson, Adiamah et al. 2012) and Pfk2p binds the glycolytic
activator, fructose-2,6-bisphosphate (F2,6BP) that is made by PFK26 and PFK27. The
triple deletion strain pfk1Δ pfk26Δ pfk27Δ s t r a i n cannot grow on glucose, but
pfk26Δ pfk27Δ metabolizes glucose (Muller, Zimmermann et al. 1997), suggesting the
F2,6BP-Pfk2p binding is essential for Pfk2p activity. In addition, pfk2Δ cells have 5 - 7.5
fold lower concentration of the phosphfructokinase-1 reaction product, fructose 1,6
biphosphate than pfk1Δ cells.
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Chapter II studied the functional interrelation between phosphofructokinase-1 and VATPase in yeast (Chan and Parra 2014). We characterized the yeast mutant strains
pfk1Δ and pfk2Δ. The pfk2Δ mutant exhibits a number of traits indicative of V-ATPase
functional defects in vivo, despite that V-ATPase pumps are functionally competent in
pfk2Δ vacuolar membrane fractions in vitro (Chan and Parra 2014). In addition, the pfk2Δ
cells have alkalinized vacuoles, reduced glucose-dependent V1Vo reassembly, and growth
sensitivity to pH 7.5 in the presence of calcium (Chan and Parra 2014).

Chapter III investigated the factors that suppress V-ATPase function in the pfk2Δ strain
in vivo. Phosphofructokinase-1 is a rate-limiting step in glycolysis and an allosteric
control point that senses the energetic state of the cell (Farooqui, Kim et al. 1980;
Simonis, Wodak et al. 2004). Thus, we hypothesized that a reduction of the glycolytic
flow in pfk2Δ suppressed V-ATPase function. We examined V-ATPase, Pfk2p, and
glycolysis at steady state and under reversible disassembly conditions in pfk2Δ cells and
cells overexpressing Pfk2p (Pfk2-ov). V-ATPase functions were rescued by increasing
the amount of glucose available from 2% to 4%. Restoration of vacuolar acidification,
V1Vo reassembly, and growth correlated with an increase in the glucose-dependent rate of
NADH formation (metabolic reactivation) and the concentration of ethanol produced.
These results are the first direct evidence that stimulation of the glycolytic flow itself is
sufficient to induce V1Vo reassembly after glucose readdition. Expression of
phosphofructokinase-1 subunits is not essential for reassembly and V1Vo reactivation.
Notably, reactivation after reassembly correlated with an increased level of the ATP
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producing glycolytic enzyme, phosphoglucose isomerase (Pgk1p), at vacuolar
membranes.

3.2 Materials and Methods

Materials and strains. The antibody to the Myc antigen was from Invitrogen (Carlsbad,
CA). DSP was purchased from Pierce (Rockford, IL), and Tran [35S]-label from MP
Biomedicals (Santa Ana, CA). The 10D7 and 13D11 antibodies were from Invitrogen
(Carlsbad, CA). The anti-phosphoglycerate kinase antibody 22C5D8 was from Invitrogen
(Carlsbad, CA). Alkaline phosphatase-conjugated secondary antibody was from Promega
(Madison, WI) and horseradish peroxidase secondary antibody was purchased from
Invitrogen (Carlsbad, CA). Zymolase 100T was purchased from Seikagaku (Tokyo,
Japan), Concanamycin A from Wako Biochemicals (Richmond, VA), and Ficoll and
carbonyl cyanide m-chlorophenyl hydrazone from United States Biologicals (Swampscott,
MA). All other reagents were from Sigma (St. Louis, MO). The ATP assay kit was
purchase from Biovision (K354-100)(Milpitas, CA) and ethanol assay kit was purchased
from Abcam (ab65343)(Cambridge, MA).

The Saccharomyces cerevisiae strains

referred to throughout are listed in Table 1. The mutant strains were verified by PCR
using primers to amplify the PFK2 gene with promoter sequences, Xho I and Xma I
cutting site. We cloned the PFK2 gene into the 2µ vector (pRS426) to overexpress the
PFK2 gene; the primers used are listed in Table 2.

64	
  

Growth phenotype. Cells were grown overnight to 0.4 - 0.6 OD A600/mL in YEPD (1%
yeast extract, 2% peptone and 2% glucose) medium buffered to pH 5.0. Cultures were
washed twice with sterile ddH2O and 2.5 OD A600 cells were resuspended into 1 mL
sterile ddH2O. Ten-fold serial dilutions were spotted onto YEP containing 2% or 4%
glucose. Plates were buffered to pH 5.0 with 50 mM succinic acid/ sodium phosphate, pH
7.5 with 50 mM MES/ MOPS, or pH 7.5 with 100 mM calcium chloride added. The
plates were incubated for three days at 30 oC and 37 oC.

Vacuolar pH measurements. Vacuolar pH was measured using the ratiometric fluorescent
dye BCECF-AM (Martinez-Munoz and Kane 2008). Cells were grown to A600 0.4 - 0.8
and stained with 50 µM BCECF-AM for 30 minutes at 30oC. To generate a pH
calibration curve for each strain, A600 5 OD unit cells were added to 2 ml of buffer pH =
5.5, 5.75, 6.0, 6.25, 6.5, 7.0. Calibration buffers consisted of 50 mM MES, 50 mM
HEPES, 50 mM KCl, 50 mM NaCl, 200 mM ammonium acetate, 10 mM sodium azide,
10 mM 2-deoxyglucose, 50 µM and carbonyl cyanide m-chlorophenyl hydrazone
(CCCP). Cells were incubated in calibration buffer 30 - 45 minutes at 30oC. For steady
state studies, the cells were stained with BCECF and transferred to 1 mM HEPE/MES pH
5.0 buffer with 2% or 4% glucose (final concentration). The BCECF fluorescence was
measured for 10 minutes at 30oC. Vacuolar pH was calculated according to the standard
curve. For studies under reassembly conditions, the vacuolar pH was monitored for 20
minutest after 2% or 4% glucose (final concentration) re-addition to cells deprived of
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glucose for 10 minutest. The BCECF fluorescence intensity (emission 525 nm, excitation
490 nm/450 nm) was measured in a FluoroMax 4 spectrofluorometer (Horiba Jobin Yvon
Inc., NJ).

Immuniprecipitations. Biosynthetically radiolabeled cells. Pulse-chase experiments
followed by nondenaturing immunoprecipitations of V-ATPase complexes were
performed as described previously with the monoclonal antibodies 13D11 (anti V1
subunit B) and 10D7 (anti Vo subunit a, Vph1p isoform), except that the chases were
performed at the indicated glucose concentrations and times. The immunoprecipitated
protein was separated by SDS-PAGE (13% acrylamide gels), the gels were dried,
scanned in a Fuji Scanner FLA-5100, and analyzed using the Multi Gauge and GraphPad
Prism 5 software as previously described (Ediger, Melman et al. 2009; Parra, Chan et al.
2014). Non-radiolabeled immunoprecipitations. Immunoprecipitations were as described
before (Chan and Parra 2014). The immunoprecipitated protein was separated by SDSPAGE in 10% gels and analyzed by Western blots. The nitrocellulose membranes were
scanned using a Bio-Rad ChemiDoc XRS+ and the intensity of protein bands quantified
using the Multi Gauge and GraphPad Prism 5 software.

NADH fluorescence measurement. NADH fluorescence was measured as described by
Poulsen et al with the following modifications (Poulsen, Andersen et al. 2008). Briefly,
cells were grown overnight to A600 0.6 - 0.8 OD in 200 ml YEP+2% glucose, harvested
and 100 OD units resuspended in 50 mM potassium phosphate buffer pH 6.8 up to a
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density of 10% by weight. The cells were starved of glucose by incubation in phosphate
buffer for 3 hours on a rotary shaker at 30oC and placed on ice for 10 minutes before the
NADH measurements were intiated. The NADH fluorescence intensity (excitation at 366
nm; emission at 450nm) was monitored without glucose for 60 seconds and then
continuously recorded for another 90 seconds after re-addition of 2% or 4% glucose at
25oC in a FluoroMax 4 spectrofluorometer (Horiba Jobin Yvon Inc., NJ).

Ethanol conditions assay. For steady state analyses, the cells were cultured overnight to
A600 0.4 - 0.6 OD in YEP pH 5.0 media or in SC-Ura pH 5.0 media containing 2% or 4%
glucose. 2 OD units (per condition) were harvested and the cells were converted to
sheroplasts by zymolase treatment. The spheroplasts were incubated in YEP (containing
2% or 4% glucose) pH 5.0 plus 1.2 M sorbitol for 10 minutes at 30oC and the ethanol
concentration was measured using the Ethanol Assay Kit (Abcam, Cambridge, MA, US)
according to the manufacturer’s instructions. Briefly, spheroplasts were lysed and an
ethanol standard curve with 0, 2, 4, 6, 8, 10 nmol/well in a 96 well plate was prepared.
The reaction mix was contained 94 µl ethanol assay buffer plus 2 µl ethanol probe, 2 µl
ethanol enzyme mix and 2 µl of the cell lysis to final 100 µl/reaction. The reaction was
incubated for 30 minutes at 37oC protected from light and the absorbance (A570)
measured in a micro-plate reader. The ethanol concentration was calculated according to
the standard curve. For glucose-depletion and re-addition analyses, the cells were grown
in media containing 2% glucose overnight and converted to spheroplasts as described
above. The spheroplasts were incubated in YEP pH 5.0 plus 1.2 M sorbitol in the
presence of 2% glucose for 20 minutes (+G), in YEP plus 1.2M sorbital for 10 minutes (67	
  

G), and in YEP plus 1.2M sorbital for 10 minutes followed by re-addition of 2% glucose,
4% glucose or 2% 2-deoxyglucose for 10 minutes at 30oC (-/+G). The cells were lysed
and the ethanol concentration measured as described above.

ATP concentration assay. Cells were grown overnight to A600 0.4 to 0.6 OD in YEP pH
5.0 media containing 2% glucose and converted to spheroplasts as described in the
ethanol concentration assay. The spheroplasts were incubated in YEP pH 5.0 plus 1.2 M
sorbitol media with 2% glucose for 20 minutes (+G), in YEP plus 1.2M sorbital for 10
minutes (-G), and in YEP plus 1.2 M sorbital for 10 minutes followed by addition of 2%
glucose or 4% glucose for 10 minutes at 30oC (-/+G). ATP concentration was measured
by using the ATP Assay Kit according to the manufacturer instructions.

Other methods. Vacuolar membranes fractions were purified by Ficoll density gradient
centrifugation as described (Owegi, Pappas et al. 2006; Ediger, Melman et al. 2009; Chan
and Parra 2014). Protein concentration was measured by the Bradford assay (Parra, Chan
et al. 2014).
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Table 1. S. cerevisiae strains used in this study

Strain

Parent

Relevant phenotype

WT

BY4742

MAT_α; his3 Δ 1; leu2 Δ _0; lys2 Δ 0; ura3 Δ 0

pfk1Δ

BY4742

MAT_α; his3 Δ 1; leu2 Δ _0; lys2 Δ 0; ura3 Δ 0 pfk1Δ:
KanMX6

pfk2Δ

BY4742

MAT_α; his3 Δ 1; leu2 Δ _0; lys2 Δ 0; ura3 Δ 0 pfk2Δ:
KanMX6

vm3Δ

BY4742

MAT_α; his3 Δ 1; leu2 Δ _0; lys2 Δ 0; ura3 Δ 0 vm3Δ :
KanMX6

Table 2
Primers used to clone PFK2 in pRS426

Primer

Sequence (5’-3’)

PFK2-XmaI

GGGCCCGGGCTCATGTTTCTTATTAGG

PFK2-XhoI

GGGCTCGAGTTAATCAACTCTCTTTCTTCC
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3.3 Results

We recently showed that both phosphofructokinase-1 subunits make contributions to VATPase activity, but the most critical subunit is Pfk2p (Chan and Parra 2014). Pfk2p
expression is necessary for optimal V-ATPase function at steady state and under glucosedependent V1Vo reassembly conditions. The PFK2 deletion (pfk2Δ) cells cannot
sufficiently reassemble V1Vo and do not acidify their vacuoles. The enzyme
phosphpfructokinase-1 catalyzes a limiting step of glycolysis and pfk2Δ has reduced
downstream glycolytic intermediates, glucose consumption, and ethanol production
(Heinisch 1986; Heinisch 1986; Arvanitidis and Heinisch 1994). In this study, we
examined the interplay between V-ATPase, Pfk2p, and glycolysis to determine whether
Pfk2p itself or its glycolytic function control V-ATPase function.

Pfk2p overexpression interferes with glucose-dependent vacuolar acidification. We
reasoned that we might alter the V-ATPase function by modulating PFK2 production.
Cells lacking PFK2 had a reduced capacity to reassemble V-ATPase complexes (by 50%)
and cannot acidify the vacuoles after re-addition of glucose following a brief glucose
deprivation period. We overexpressed the PFK2 gene from a 2µ plasmid to get insights
into the functional interrelation between PFK2 and V-ATPase. If Pfk2p itself is crucial
for V-ATPase function and glucose-dependent reassembly, the overexpression of Pfk2p
might enhance V-ATPase activity and/or affect V1 reversible dissociation from Vo.

First, we confirmed overexpression of Pfk2p by Western blots. The presence of Pfk2p in
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whole cell lysates was assessed using a polyclonal antibody to phosphofructokinase-1
that recognizes both Pfk1p and Pfk2p subunits (Fig. 1A). The Pfk2p expression was
increased by about 2.5 fold in the cells transformed with the multi-copy plasmid carrying
the exogenous PFK2 gene, compared to wild type cells transformed with the empty 2m
plasmid.

Next, we asked if the glucose-dependent V1Vo reversible disassembly was affected by
overexpressing Pfk2p. We performed co-immunoprecipitation experiments under
nondenaturing conditions to measure the proportion of V1Vo complexes that reversibly
disassemble in response to glucose depletion and glucose re-addition. V-ATPase
disassembled normally after 10 min of glucose depletion (Fig. 1B, -G condition). The
amount of Vo subunit a co-immunoprecipitated with V1 subunit A by the antibody 13D11
to the V1 subunit B decreased by about 90 % in the wild-type. About 70 % of the V1Vo
complexes disassembled in the Pfk2p overexpressing cells. Re-addition of glucose to a
final concentration of 2 %, which is the amount of glucose present in yeast growth media,
triggered reassembly of the V1Vo complexes in both strains (-/+G condition in Fig. 1B).
Reassembly was evident by the reassociation of the Vo subunit a with V1 subunits A and
B.

We next determined whether the reassembled pump acidified the vacuolar lumen of the
cells overexpressing Pfk2p. We monitored the vacuolar pH in vivo under disassembly and
reassembly conditions using the pH sensitive fluorophore BCECF (Fig. 1C) (MartinezMunoz and Kane 2008; Chan and Parra 2014). Glucose re-addition steadly increased the
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Figure 1. Glucose-dependent V1Vo reassembly and vacuolar acidification in Pfk2p
overexpressing cells. A. overexpression of exogenous Pfk2p. Cells were cultured to mid-log
phase (A600/ml= 0.8). Whole cell extracts were obtained from Pfk2p overexpressing (Pfk2pov), pfk2 deletion (pfk2Δ), and an isogenic wild type cells carrying the empty vector pRS426.
The whole cell extracts were separated in 10% SDS-PAGE gels and immunoblotted with a
polyclonal antibody that recognizes Pfk1p and Pfk2p subunits of yeast phosphofructokinase-1.
B. Glucose-dependent disassembly and reassembly of V1Vo is normal in Pfk2p-ov. Pfk2p-ov
and isogenic wild type cells were grown to 1.0 OD A600/ml. The cells were converted to
sheroplasts by zymolase treatment, incubated in YEPD plus 1.2 M sorbitol for 20 minutes
(+G), YEP plus 1.2 M sorbitol for 10 minutes (-G) and YEP plus 1.2 M sorbitol for 10
minutes after which 2% glucose was added for another 10 minutes (-/+G). V-ATPase was
immunoprecipitated using a monoclonal antibody to V1 subunit B (13D11) and protein A
sepharose beads (Chan and Parra 2014). The imunoprecipitated proteins were separated in
10% SDS-PAGE gel and immunoblotted with monoclonal antibodies to V1 subunit A (V1A),
V1 subunit B (V1B) and Vo subunit a (Voa). HC: antibody heavy chain. Data is representative
of two independent experiments; error bars are standard deviation compared to wild-type C.
Glucose-dependent vacuolar acidification is impaired in Pfk2p-ov cells. Mid-log phase
cultures from wild type, pfk2Δ and Pfk2p-ov cells were grown in YEPD and selective media
(SC-Ura) containing 2% glucose, respectively. Cells were harvested and stained with 50 mM
BCECF-AM for 30 minutes at 30oC, after which cells were depleted of glucose for 10
minutes, and glucose added to a final concentration of 2% (arrow). Fluorescence was
monitored for an additional 20 minutes. The ratio of fluorescent emission (525 nm) excited at
490 and 450 nm was measured in a FluoroMax 4 spectrofluorometer (Horiba Jobin Yvon Inc.,
NJ) and the fluorescence compared to standard curves to generate absolute pH values.
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vacuolar pH of Pfk2p-ov cells resembling lose of function the V-ATPase mutants lacking
a structural gene (Chan and Parra 2014).. These results indicated that the reassembled
pumps did not re-activate at the vacuolar membrane. For reference, glucose re-addition
immediately acidified the vacuolar lumen of the wild-type cells as expected. Thus, that
reassembled pumps resumed proton transport. The absence of Pfk2p (pfk2Δ cells)
partially impaired reassembly (Chan and Parra 2014), but excess Pfk2p (Pfk2p-ov cells)
did not affect disassembly or reassembly. Nonetheless, the reassembled V1Vo complexes
failed to resume proton transport in Pfk2p-ov cells.

Reactivation of glycolysis after glucose re-addition is defective in pfk2Δ cells. Despite
that Pfk2-ov and pfk2Δ cells cannot acidify the vacuole in response to glucose readdition,
an important difference between Pfk2p-ov and pfk2Δ cells is that pfk2Δ cannot
sufficiently reassemble V1Vo in response to glucose (Chan and Parra 2014). In contract,
Pfk2p-ov cells reassembled V1Vo normally (Fig. 1B). Since the phosphofructokinase-1
enzyme catalyzes a limiting step in glycolysis we asked whether a reduced glycolytic
flow could account for defective reassembly in pfk2Δ. We anticipated that pfk2Δ cells
will have lower glycolytic flow than Pfk2p-ov.

In Sacharomyces cerevisiae the final product of glycolysis, pyruvate, is fermented into
ethanol (Leskovac, Trivic et al. 2002). We measured ethanol concentration at steady state,
and under disassembly (10 minutes after glucose depletion) and reassembly (10 min after
glucose re-addition) conditions (Figs. 2A and 2B). At steady state the wild type strain
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Figure 2. Glucose-dependent metabolic reactivation after glucose depletion in
Pfk2p-ov, pfk2Δ , and wild-type cells. A. 2% glucose addition after brief glucosedepletion increases the ethanol concentration in wild type and Pfk2p-ov cells. Cells
were cultured to mid-log phase (0.6 - 0.8 OD Abs600/ml) converted to spheroplasts and
incubated in YEP pH 5.0 plus 1.2 M sorbitol media with 2% glucose for 20 minutes
(+G), in YEP plus 1.2M sorbitol for 10 minutes (-G), and in YEP plus 1.2M sorbitol for
10 minutes followed by addition of 2% glucose for 10 minutes at 30oC (-/+G). Ethanol
concentration was measured using a colorimetric assay from (Abcam Cambridge, MA).
Data represent three independent experiments; error bars= +/- standard deviation. B.
The ethanol concentration is proportional to the amount of glucose added to wild-type
and pfk2Δ cells. Cells were cultured to mid-log phase (0.6 - 0.8 OD A600/ml) in YEP
containing 2% glucose (YEPD), converted to spheroplasts and incubated as described
for Figure 1B in the presence and absence of glucose and after re-addition 2% glucose,
4% glucose, or 2% 2-deoxy-glucose (final concentrations). Ethanol concentrations were
measured as described for Figure 2A. Data represent three independent measurements;
error bars are standard deviation. Statistically significant differnces (p<0.05 *, p<0.01
**) as compared to the presence 2% glucose were determined by two-tailed unpaired ttest. C. Pfk2p-ov NADH synthesis rate after re-addition of 2% glucose resembles wild
type cells. The wild type and Pfk2p-ov cells were grown overnight to 0.6 - 0.8 OD
A600/ml, washed twice in 50 mM potassium phosphate buffer pH 6.8 and resuspended in
the same buffer to 10% wet weight. The cells were incubated with shaking at 30oC for
three hours and kept on ice until use. The NADH fluorescence intensity (450 nm
emission; 366 nm excitation) was monitored for 60 seconds in the absence of glucose
and after 2% glucose (final concentration) was added (arrow) for another 120 seconds.
Velocities were calculated for the initial 15 seconds following glucose addition and
expressed relative to wild-type cells. Data represent two independent experiments; error
bars are standard deviation. Statistically significant differences (p<0.05 *, p<0.01 **) as
compared to the wild type cells in the presence of 2% glucose. D. The NADH synthesis
is significantly reduced in pfk2Δ cells. The wild type and pfk2Δ cells were cultured
overnight in YEPD pH 5.0 (2% glucose media) and the NADH fluorescence intensity
monitored as described for Figure 2C but at 2% glucose and 4% glucose (final
concentration). Data represent three independent experiments; error bars are standard
deviation. Statistically significant differences (p<0.05 *, p<0.01 **) as compared to wild
type cells in the presence 2% glucose and determined by two-tailed unpaired t-test.
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produced 6.6 +/- 0.9 mM, Pfk2p-ov 4.0 +/- 0.1 mM, and pfk2Δ 3.8 +/- 0.2 mM ethanol.
After glucose depletion the ethanol concentration dropped to about 2.5 +/- 0.2 mM in the
three strains. As expected, the concentration of ethanol increased after re-addition of 2%
glucose. The ethanol concentration was 4.1+/-0.2 mM in the wild-type (lower than the
steady state concentration), 3.9 +/- 0.2 mM in Pfk2p-ov cells (same as steady state
concentration), and 2.9 +/-0.2 mM in pfk2Δ (lower than steady state concentration). Thus,
re-addition of 2% glucose resumed glycolysis in the three strains, but glycolysis may
have been stimulated to a lesser extent in pfk2Δ cells.

Because ethanol production is an indirect metric of glycolysis, we examined real-time
glucose-mediated metabolic activation by monitoring a glycolytic intermediate, NADH.
NADH transiently peaks once metabolism resumes (Poulsen, Andersen et al. 2008)
because addition of glucose after nutrient limitation triggers a rapid increase of
NADH/NAD+ that inhibits the glycolytic enzyme triose phosphate dehydrogenase
(Williamson, Adiamah et al. 2012). This NADH spike was similar in the wild-type and
Pfk2p-ov cells, although the relative rate of NADH formation the first 15 seconds after
readdition of 2% glucose was slightly reduced (by 23 +/- 7.1 %) (Fig. 2C). These results
indicate that glucose-mediated metabolic reactivation was comparable in Pfk2p-ov and
wild-type cells. Notably, the NADH synthesis rate was significantly reduced (by 70 %) in
pfk2Δ cells (Fig. 2D), suggesting that the glycolytic flow is considerably defective in
pfk2Δ.
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Addition of 4% glucose increases the glycolytic flow and rescues the reassembly defect in
pfk2Δ. Our data indicate that glucose-dependent glycolytic reactivation is defective in
pfk2Δ cells, which exhibit V1Vo reassembly defects. In contrast, Pfk2p-ov cells have near
wild type glycolytic flow, and reassemble V1Vo normally (Fig. 2D). We asked whether
stimulating the glycolytic flow in pfk2 D could rescue pfk2Δ glucose-dependent V1Vo
reassembly. We increased the concentration of glucose added to pfk2Δ cells, monitored
ethanol and NADH as glycolytic metrics, and calculated the total level of V1Vo that
reassembled. As expected, the ethanol concentration and the rate of NADH formation
rate increased. Ethanol levels and NADH formation increased about 1.5 - 2.0-fold after
increasing the concentration of glucose added to the media from 2% to 4% (Figs. 2B and
2D). The concentration of ethanol was 2.4 +/- 0.1 mM at 2% glucose and to 4.3+/-0.7
mM at 4% glucose. The NADH synthesis rate was enhanced from 31% to 46% relative to
wild-type cells. Thus the metabolic activation rate was increased by about 50% after
doubling the concentration of glucose added to pfk2Δ. These results suggest that 4%
glucose addition stimulated the glycolytic flow in relation to 2% glucose

To measure the proportion of reassembled V1Vo complexes at 4% glucose we
biosynthetically radiolabeled wild-type and pfk2Δ cells with 35S (Fig. 3) (Ediger, Melman
et al. 2009). The radiolabeled cells were chased with i) 2% glucose constitutively present
(steady state condition) (+G, Fig. 3), ii) 10 min after glucose removal (glucose depletion
condition) (-G, Fig. 3), and iii) 10 min after re-addition of glucose at varied
concentrations up to 4% glucose (glucose re-addition condition) (-/+G, Fig. 3). The VATPase complexes were immunoprecipitated under nondenaturing conditions with the
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Figure 3. Glucose-dose dependency of V-ATPase reassembly in pfk2Δ and wild-type cells.
Cells were cultured to mid-log phase (0.4 - 0.6 OD Abs600/ml) in YEPD pH 5.0, converted to
spheroplasts and radiolabeled with Tran35S for 60 minutes (Ediger, Melman et al. 2009).
Biosynthetically radiolabeled wild-type and pfk2Δ cells were chased in the presence of glucose
(+G) for 20 minutes (YEP media containing 2% glucose plus 1.2 M sorbitol), after glucose
depletion (-G) for 10 minutes (YEP media plus 1.2 M sorbitol), and after glucose re-addition at
varied concentrations (0.1, 0.3, 0.5 1, 2, and 4 %) to glucose-starved cells (-/+G) for an additional
10 minutes. The cells were lysed and V-ATPase complexes immunoprecipitated under nondenaturing conditions using anti-V1 subunit B (recognizes V1 an V1Vo) and anti-Vo subunit a
(recognizes Vo) monoclonal antibodies. The immunoprecipitates were separated by SDS-PAGE
in 13% gels and the proportion of V1Vo assembled calculated as the fraction of Vo (coimmunoprecipitated with anti-V1 subunit B) relative to the total Vo (recognized by anti-V1 subunit
B and anti-Vo subunit a). Data was analyzed in a Fuji Scanner FLA-5100, Multi Gauge and
GraphPad Prism 5 software. Results are presented as average from three independent experiments,
and error bars are standard deviation. Statistically significant differences (p<0.05 *, p<0.001 ***)
as compared to presence 2% glucose were determined by two-tailed unpaired t-test.
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antibody 13D11 that recognizes the V1 subunit B (immunoprecipitates V1 and V1Vo) and
the antibody 10D7 (immunprecipitates Vo). 10D7 binds to a cryptic epitope in Vo subunit
a when V1 is not attached to Vo. The proportion of Vo assembled into V1Vo was
estimated by comparing the amount of Vo subunit a immunoprecipitated with 13D11 to
the total immunoprecipitated with both antibodies (V1 subunit B and Vo subunit a) (Kane
1995). About 80% of the assembled V1Vo complexes at steady state disassembled after
10 minutes of glucose depletion (Fig. 3). Glucose re-addition triggered reassembly, which
was proportional to the concentration of glucose added to both cell types (Fig. 3) (Parra
and Kane 1998). However, a higher concentration of glucose was required for pfk2Δ to
reach wild-type reassembly levels. In wild-type cells, addition of 0.3% glucose stimulated
reassembly of 50% the complexes; 0.5% glucose stimulated 100% reassembly. In pfk2Δ
cells, addition of 1% glucose was necessary to achieve 50% reassembly; steady state
levels of assembly (100% reassembly) required 4% glucose. Thus, addition of 4%
glucose rescued the pfk2Δ V1Vo reassembly defect observed at 2% glucose.

4% glucose restores glucose-dependent vacuolar acidification in pfk2Δ cells. We next
asked whether V1Vo complexes that reassembled at 4% glucose were functional in pfk2Δ.
We measured vacuolar pH after addition of 4% glucose to glucose depleted pfk2Δ cells,
because vacuolar acidification is a direct consequence of V-ATPase reactivation (Chan
and Parra 2014). We have previously shown that re-addition of 2% glucose to pfk2Δ cells
did not acidify the vacuoles (Chan and Parra 2014). We loaded the wild-type and pfk2Δ
cells with BCECF and deprived the cells of glucose for 10 minutes, after which 2% or
4% glucose was added and the vacuolar pH measured continuously as a function of time
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Figure 4. Vacuolar pH measurements after re-addition of 2% and 4% glucose to glucosedeprived pfk2Δ cells. Addition of 4% glucose rescues vacuolar acidification in pfk2Δ cells. The
pfk2Δ cells were grown to 0.6 - 0.8 OD Ab600/ml in YEPD pH 5.0 media. The cells were
harvested and stained with 50 mM BCECF-AM for 30 minutes at 30oC. The stained cells were
deprived of glucose (1 mM HEPE/MES pH 5.0 buffer) for 10 minutes after which glucose was
re-added (2% or 4% glucose) (arrow) and the florescence measured for 20 minutes. The vacuolar
pH was estimated as described in Figure 1C. (▲): pfk2Δ, 2% glucose, (▲): pfk2Δ, 4% glucose,
(●): wild type, 2% glucose. (n): wild type, 4% glucose.
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(Chan and Parra 2014). As expected, the wild-type cells acidified the vacuolar lumen
immediately after 2% or 4% glucose addition (Fig. 4), indicating that the V-ATPase
pumps were functional, consistent with previous studies (Martinez-Munoz and Kane
2008). The glycolytic mutant pfk2Δ did not acidify the vacuoles in response to 2%
glucose (Chan and Parra 2014). Notably, addition of 4% glucose to pfk2Δ restored the
vacuolar acidic pH, indicating that proton transport resumed. Together, our results
showed that 4% glucose rescued glucose-dependent regulation, V1Vo reassembly and
reactivation of V-ATPase in pfk2Δ cells.

The presence of 4% glucose at steady state rescues V-ATPase functional defects in pfk2Δ.
In addition to glucose-dependent reassembly defects, the pfk2Δ mutant has alkalinized
vacuoles and a growth phenotype suggestive of V-ATPase impairment at steady state in
2% glucose (Chan and Parra 2014). We asked whether 4% glucose can rescue V-ATPaseassociated phenotypes in pfk2Δ cells at steady state. First, we measured the ethanol
concentration at 2% and 4% glucose in pfk2Δ. As expected, we detected lower ethanol
levels in pfk2Δ cells than the wild-type cells grown in 2% glucose. By increasing the
concentration of glucose in the growth media from 2% to 4%, glycolysis was stimulated;
the concentration of ethanol in Pfk2-ov approached wild type levels.

Defective V-ATPase function leads to growth defects known as the vacuolar membrane
ATPase (Vma-) phenotype. The vma mutant cells grow at pH 5.0 but exhibit severe
growth defects at neutral pH (Nelson and Nelson 1990) and in the presence of calcium
chloride (Ohya, Umemoto et al. 1991). Consistent with previous studies
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Figure 5. Ethanol concentration, growth phenotype and vacuolar pH at steady state in
presence of 4% glucose. A. 4% glucose increased ethanol levels in pfk2Δ cells. Cells were
cultured to 0.6 - 0.8 OD A600/ml in 2% or 4% glucose, converted to spheroplasts, resuspended in
fresh YEP media containing 2% or 4% glucose plus 1.2 M sorbitol (2 OD A600/ml), and incubated
for 20 minutes at 30oC with shaking. The ethanol concentration was measured as described for
Figure 2A. B. 4% glucose rescues pfk2Δ Vma- growth defect. Cells were cultured to mid-log
phase (0.6 - 0.8 OD A600/ml) and ten-fold serial dilutions stamped onto YEP plates adjusted to pH
5.0, pH 7.5, and pH 7.5 plus 100 mM CaCl2 containing 2% or 4% glucose. Cell growth was
monitored for 3 days at 30oC and 37oC. Shown are representative plates of triplicates. C. 4%
glucose rescues pfk2Δ vacuolar pH homeostasis. Wild type and pfk2Δ cells were cultured to midlog phase in YEP containing 2% and 4% glucose. Cells were stained with 50 mM BCECF-AM
for 30 minutes as described for Figure 4. The ratio of fluorescent emission (535 nm) excited at
490 and 450 nm was measured to quantitatively assess vacuolar pH. The average fluorescence
measured over 6 minutes was compared to standard curves to generate absolute pH values. Data
are presented as average pH values from three independent experiments, and error bars are
standard deviation. Statistically significant differnces (p<0.05 *) were determined by two-tailed
unpaired t-test.
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(Chan and Parra 2014), the pfk2Δ mutant displayed the Vma- phenotype at 37oC on plates
containing 100 mM calcium chloride buffered to pH 7.5 (Fig. 5B, left panel). Since those
plates contained 2% glucose, we exposed the cells to the same conditions, except that 4%
glucose was present. We monitored the cell growth on 4% glucose for 72 hours at 30 °C
and 37 °C (Fig. 5B, right panel). The growth of pfk2Δ at neutral pH plus calcium chloride
was rescued in the presence of 4% glucose. As expected, the wild-type strain grew on all
the conditions while the negative control vma3Δ, which completely lacks V-ATPase
function (Ohya, Umemoto et al. 1991) did not grow on pH 7.5 plates regardless of the
presence of calcium. For reference, the mutant pfk1Δ that lacks the phosphofructokinase1 subunit pfk1p was included. The pfk1Δ cells exhibited wild type growth and much mild
phenotypes than pfk2Δ cells (Chan and Parra 2014).

We grew wild-type, pfk2Δ and vma3Δ cells in media containing 2% and 4% glucose and
used BCECF to determine the vacuolar pH (Chan and Parra 2014). As expected, the
vacuolar lumen of the wild-type cells was acidic at 2% and 4% glucose (pH 5.8 +/- 0.1),
because V-ATPase pumps are fully functional (Fig. 5C).

The pfk2Δ vacuoles were

alkalinized (pH 6.6 +/- 0.1) at 2% glucose, resembling the vma3Δ mutant cells (pH 6.8
+/- 0.1) and indicating that V-ATPase proton transport was impaired. Notably, the
vacuolar pH of pfk2Δ cells dropped to wild-type pH levels (pH 5.8 +/- 0.3) after growing
the cells in 4% glucose. From these studies we concluded that V-ATPase proton transport
is coupled to the glycolytic flow at steady state.

85	
  

Phosphoglycerate kinase (Pgk1p) associates with vacuolar membranes in a glucose dosedependent manner.

Until know, our results have shown that 4% glucose restores

vacuolar acidification in pfk2Δ cells. Glucose at 4% also stimulated the glycolytic flow
Because glycolytic enzymes can bind V-ATPase and modulate its function (Kane 2012),
we asked if phosphoglycerate kinase (Pgk1p) was present in vacuolar membranes and
whether Pgk1p could be linked to vacuolar acidification. Pgk1p generates the first ATP
downstream of phsphofructokinase-1

We purified vacuolar membrane fractions from wild-type and pfk2Δ cells grown in 2%
and 4% glucose and conducted Western blot analyses using a monoclonal antibody to
Pgk1p. Pgk1p was detected in the wild-type and pfk2Δ membranes (Fig. 6A), although it
was at much lower levels in the pfk2Δ membranes fractions. The intensity of the band
corresponding to Pgk1p increased at 4% glucose in both strains, so we determined the
level of Pgk1p expression in whole cell lysates. Whole cell lysates from the wild type and
pfk2Δ cells contained similar levels of Pgk1p at 2% and 4% (Fig. 6B). These results
indicated that increased Pgk1p levels at the vacuolar membrane of cells exposed to 4%
glucose were not due to increased expression levels of Pgk1p in the cells.

Unlike pfk2Δ cells, deletion of the other phosphofructokinase-1 subunit, PFK1 gene, had
a moderate effect on vacuolar pH (pHvac = 6.2 +/- 0.04)(Chan and Parra 2014). The pfk1Δ
cells also reassembled and reactivated V1Vo normally after 2% glucose re-addition (Chan
and Parra 2014). We compared Pgk1p levels in vacuolar membrane fractions from pfk1Δ
and pfk2Δ cells, anticipating that pfk1Δ will have more Pgk1p because the vacuolar
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Figure 6. The glycolytic enzyme Pgk1p co-purifies with vacuolar membrane fractions. A.
Pgk1p in vacuolar membrane fractions from wild-type and pfk2Δ cells is proportional to the
amount of glucose in the growth media. Wild-type and pfk2Δ cells were cultured overnight to 1.0
OD Ab600/ml in YEP pH 5.0 media containing 2 % or 4% glucose. Cells were converted to
spheroplasts by zymolase treatment and vacuolar membrane fractions purified by ficoll density
gradient centrifugation (Owegi, Pappas et al. 2006). The vacuolar membrane proteins (0.25 µg
total protein) were separated in 10% SDS-PAGE gels and immunoblotted with anti-V1 subunit A,
anti-V1 subunit B and anti-Pgk1p monoclonal antibodies. B. Pgk1p expression is not enhanced at
4% glucose. Whole cell lysates from wild type and pfk2Δ cells were prepared as described for
Figure 1A, separated in 10% SDS-PAGE gels, and immnunoblotted to detect V-ATPase V1
subunits A and B and Pgk1p. C. Vacuolar membrane fractions from pfk1Δ cells have wild-type
levels of Pgk1p. Vacuolar membrane fractions from wild type, pfk1Δ and pfk2Δ cells were
purified and immunoblotted to detect V-ATPase V1 subunits A and B and Pgk1p as described
above. . A-C: A representative gel from one of three independent experiments is shown.
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lumen has lower pH. Western blots showed wild-type levels of Pgk1p in
pfk1Δ membranes from cells grown in 2% glucose (Fig. 6C), in line with the hypothesis
that Pgk1p could play a role in V-ATPase proton transport. These results also indicate
that the inability of Pfk2p-ov and pfk2Δ cells to acidify vacuoles in the presence of 2%
glucose correlates with a reduction in, but not absence of Pgk1p.

3.4 Discussion

We have studied the interplay between phosphofructokinase-1 subunit Pfk2p and VATPase in yeast. Both phosphofructokinase-1 subunits, Pfk1p and Pfk2p contribute to VATPase function in vivo, but we showed that the subunit Pfk2p has a major impact (Chan
and Parra 2014). V-ATPase assembly at steady state and glucose-dependent reassembly
are normal in pfk1Δ cells (Chan and Parra 2014). The pfk1Δ mutant has 2-fold lower
concentration of the phosphofructokinase-1 reaction product, fructose 1,6 biphosphate,
than wild-type cells (Arvanitidis and Heinisch 1994). By contrast, pfk2Δ cells have 10 –
15 fold lower levels of fructose 1,6 biphosphate (Arvanitidis and Heinisch 1994).
Consistent with other studies (Heinisch 1986; Arvanitidis and Heinisch 1994), we
showed that pfk2Δ has significantly reduced ethanol levels (30 - 40% lower concentration)
than wild-type cells at steady state, indicative of a reduced glycolytic flow in pfk2Δ cells.
The fact that pfk2Δ exhibited a partial Vma- growth phenotype, severely altered pH
homeostasis, and defective glucose-dependent V-ATPase reassembly, prompted us to ask
whether Pfk2p itself regulates V-ATPase. This study showed that Pfk2p is dispensable
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for V-ATPase function. Instead, changes in the glycolytic flow are communicated to VATPase, which modify V-ATPase function in vivo.

The relationship between V1Vo regulation by reversible disassembly and glycolysis has
been described in yeast (Parra and Kane 1998). Glucose metabolism beyond glucose-6phosphate formation is required for reassembly of V1Vo (Parra and Kane 1998). Poorly
fermentable carbon sources such as raffinose and galactose and non-fermentable carbon
sources such as ethanol and glycerol cannot substitute for glucose in triggering
reassembly (Kane 1995). Our results further support these studies by indicating that
glycolysis controls V1Vo reassembly. V1Vo reassembly is proportional to the amount of
glucose added to the medium (Fig. 3). By increasing the glucose concentration from 2%
to 4% we restored the Vma- growth defects, glucose-dependent V1Vo reassembly, and
vacuolar acidification in the pfk2Δ cells. Glucose at 4% also stimulates glycolysis. The
pfk2Δ cells in 4% glucose mimic the wild-type strain in 2% glucose with regards to VATPase function. We have extended previous findings by showing that glycolytic flow
stimulation is sufficient to induce reassembly of V1Vo complexes after glucose readdition. Our data also showed that phosphofructokinase-1 binding to V-ATPase is not
required for V1Vo reassembly and reactivation, despite that the enzyme subunits coprecipitate with V-ATPase (Chan and Parra 2014).

Reactivation of glycolysis under reassembly conditions is significantly impaired in
pfk2Δ cells, which cannot sufficiently reassemble V1Vo. The rate of NADH formation
after re-addition of 2% glucose to glucose-deprived pfk2Δ cells is reduced by about 70%,
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compared to wild-type cells so its metabolic reactivation is significantly impaired.
Addition of 4% glucose stimulated pfk2Δ metabolic reactivation up to ~50% of the wildtype rate (Fig. 2D). Addition of 4% glucose additionally restored glucose-triggered V1Vo
reassembly (Fig. 3) and vacuolar acidification (Fig. 4). These results suggest that 50% of
the wild-type reactivation (NADH formation rate) can be the metabolic threshold to
reassemble V1Vo normally. Future studies will be necessary to validate this observation.
For example, it will be required to measure NADH formation after addition of 0.5%
glucose to wild type cells, because at 0.5% glucose wild-type cells showed complete
V1Vo reassembly (Fig. 3) (Parra and Kane 1998).

How does the glycolytic flow communicate to V-ATPase? Remains an open question.
One possibility is that the glycolytic flow, perhaps changes of the ATP levels, directly
communicate with RAVE to promote V-ATPase reassembly. RAVE interacts with
cytosolic V1-C complexes (Smardon, Tarsio et al. 2002), free V1 subunit C (Smardon and
Kane 2007) and the membrane-bound Vo subunit a (Smardon, Diab et al. 2014). We
showed that binding of RAVE to cytosolic V1-C is enhanced in pfk2Δ cells exposed to
2% glucose. It has to be determined whether this RAVE-(V1-C) binding is responsive to
glycolytic flow changes. (Chan and Parra 2014).

Enhancing glycolysis prompts downstream signals proposed to stimulate V1Vo
reassembly. These signals include a transient cytosolic alkalinization (Martinez-Munoz
and Kane 2008; Dechant, Binda et al. 2010), activation of the plasma membrane ATPase
Pma1p (Rao, Drummond-Barbosa et al. 1993; Lecchi, Nelson et al. 2007), and
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Ras/cAMP/PKA signaling (Bond and Forgac 2008). Cytosol pH changes resulting from
stimulation of the glycolytic flow could be a signal for V-ATPase reassembly. The
alkalinization of the cytosol by activation of glycolysis can be a sensitive readout of the
glycolytic flow to control V1Vo reassembly (Dechant, Binda et al. 2010). Pma1p, like VATPase, is activated by glucose (Rao, Drummond-Barbosa et al. 1993; Garcia-Arranz,
Maldonado et al. 1994; Lecchi, Nelson et al. 2007) and glucose-dependent activation of
both enzymes contribute to alkalinization of the cytosol pH (Ambesi, Miranda et al. 2000;
Morsomme, Slayman et al. 2000).

Although additional studies will be necessary to further define the molecular mechanisms
by which the glycolytic flow communicates to V-ATPase, our results are in good
alignment with the hypothetic model summarized in the Figure 1 of Chapter 4. The pfk2Δ
cells have significantly more acidic cytosolic pH than wild type cells (Chan and Parra
2014) and lower glycolytic re-activation capacity in response to 2% glucose (Fig. 2D).
These two phenotypes combined could contribute to preventing normal V1Vo reassembly
at 2% glucose. Addition of 4% glucose stimulates the metabolic flow restoring ~ 50% of
wild type glycolytic rate (Fig. 2D). This glycolytic stimulation alkalinizes the cytosol via
Pma1p activation and supports reassembly of V1Vo. V-ATPase reassembly which
restores vacuolar pH also contributes to sustaining cytosol pH homeostasis (MartinezMunoz and Kane 2008).

An important finding resulting study is that stimulation of glycolysis is not sufficient to
resume proton transport. Thus, glucose-dependent reassembly and vacuolar acidification
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are independently controlled processes. Our data indicate that both are linked to
glycolysis. However, V1Vo reassembly could be communicated through RAVE in the
cytosol, and V1Vo reactivation through Pgk1p at the vacuolar membranes. The Pfk2p-ov
cells reassemble V1Vo normally but cannot acidify the vacuolar lumen. Pfk2p-ov exhibits
~80% of the wild-type NADH synthesis rate but reduced Pgk1p levels at the vacuolar
membranes (not shown). The fact that Pfk2-ov reassemble V1Vo normally is in support of
the concept that ~50% metabolic reactivation is the threshold for V1Vo reassembly.
Addition of 4% glucose to Pfk2p-ov restores the acidic vacuolar pH (not shown).
Therefore, 4% glucose promotes different signal(s) downstream of stimulating the
glycolysis flow; the signal for reassembly (e.g., RAVE-V1 binding) and the signal for
reactivation (e.g., Pgk1p at the vacuolar membrane).

We detected Pgk1p at vacuolar membrane fractions from wild-type, pfk1Δ, and pfk2Δ
cells. In every instance, Pgk1p levels increased when the cells were grown in 4% glucose,
despite that Pgk1p cellular levels did not increase. We proposed that Pgk1p at the vacuole
could facilitate activation of V-ATPase proton transport in vivo. In support of this
hypothesis, we found that yeast Pgk1p co-immunoprecipitates with V-ATPase pumps
from wild-type cells (not shown). Experiments addressing the glucose-dependency of this
interaction are not yet conclusive. To our knowledge this is the first study to report the
glycolytic enzyme Pgk1p at vacuolar membrane fractions and to co-immunoprecipitate
with the V-ATPase complexes.
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Our data strongly argue against direct regulation of V-ATPase through its physical
interaction with phosphofructokinase-1, but we do not exclude the possibility that other
glycolytic enzymes may perform this function (Lu, Holliday et al. 2001; Lu, Sautin et al.
2004; Lu, Ammar et al. 2007). In vitro reconstitution experiments will help demonstrate
functional coupling between a super-complex of glycolytic enzymes and V-ATPase at the
vacuolar membrane. Whether such supercomplex can supply V-ATPase with glycolytic
ATP in vivo has to be determined (Lu, Holliday et al. 2001; Su, Zhou et al. 2003; Lu,
Sautin et al. 2004; Lu, Ammar et al. 2007; Su, Blake-Palmer et al. 2008). As a precedent,
Pgk1p associated with the synaptic vesicle membranes forms a functional complex with
the glycolytic enzyme GAPDH that drives glutamine uptake by locally generating
glycolytic ATP (Ikemoto, Bole et al. 2003).

We showed that Pgk1p co-purifies with yeast vacuolar membranes; Pgk1p also coimmunoprecipitates with V-ATPase (not shown). Whether Pgk1p could influence VATPase proton transport has not been shown. Pgk1p syntheses ATP in glycolysis and the
levels of Pgk1p at vacuolar membranes could be important for stimulating V-ATPase
proton transport in vivo. ATP locally made at the membranes could reach concentrations
high enough to support both reassembly and V-ATPase proton transport. Re-binding of
V1 subunit C to V1Vo at the membrane during reassembly is likely an energy consuming
process (Oot and Wilkens 2010), which may justify why reassembly (not disassembly)
requires its own V-ATPase specific chaperone, RAVE.
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Is RAVE-V1-C binding responsive to glycolytic flow changes? Is glycolytic ATP made
at the membrane? Is the Pgk1p reaction coupled to V-ATPase proton transport? These
are questions that remain to be addressed to understand the mechanisms linking VATPase function and glycolysis? This study was brought new insights to our
understanding of the mechanisms by which the presence of glucose is communicated to
V-ATPases. We showed that glucose-dependent V-ATPase reassembly can be
disengaged from V-ATPase reactivation. Reassembly is not sufficient to reactivate VATPase proton transport in vivo because V1Vo reassembly and its reactivation are
independently

controlled.

Reassembly,

but

not

V-ATPase-mediated

vacuolar

acidification, requires sufficient glycolytic flow (measured as the NADH synthesis rate
and ethanol levels). Our data indicate that reactivation of V-ATPase proton transport
following reassembly (measured as vacuolar acidification) requires additional down
stream signals also linked to glycolysis. A correlation between vacuolar acidification and
Pgk1p at vacuolar membrane fractions is suggestive of a role for Pgk1p-mediated
substrate-level phosphorylation for V1Vo reactivation and proton transport. Clearly, our
understanding of glucose-dependent V-ATPase regulation is not complete, despite of its
significance implications in cancer (Michel, Licon-Munoz et al. 2013; Kubisch, Frohlich
et al. 2014; Schempp, von Schwarzenberg et al. 2014; von Schwarzenberg, Lajtos et al.
2014), viral infections (Kohio and Adamson 2013), antigen maturation (Blander and
Medzhitov 2006), and amino acid homeostasis (Zoncu, Bar-Peled et al. 2011; Efeyan,
Zoncu et al. 2012; Jewell, Russell et al. 2013).
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Chapter IV: Conclusions and future directions

95	
  

4. Conclusions and future directions

The acidification of intracellular compartments distributed throughout the endomembrane
system plays essential roles in a number of biological processes including membrane
trafficking, protein processing, protein degradation, membrane fusion, and autophagy
(Forgac 2007). Viral entry and uptake of therapeutic drugs also require a differential
luminal pH among of endosomal and lysosomal compartments. V-ATPase pumps present
in these organelles are crucial for maintenance of the pH gradients. V-ATPase at the
plasma membrane of certain specialized cells acidifies extracellular environment and is
necessary for sperm maturation, pH homeostasis in kidney, bone resorption and tumor
metastasis (Forgac 2007).

The membrane localization and activity of V-ATPase pumps are accurately controlled,
given the importance and diversity of physiological processes that require V-ATPase
proton transport. Understanding the molecular mechanisms and cellular factors that
modulate these proton pumps can have long-term implications for treatment of diseases
involving V-ATPase pumps such as osteoporosis (Hinton, Bond et al. 2009; Thudium,
Jensen et al. 2012), cancer (Sennoune, Bakunts et al. 2004; Perez-Sayans, Somoza-Martin
et al. 2009; Fan, Niu et al. 2012; Garcia-Garcia, Perez-Sayans Garcia et al. 2012;
Schempp, von Schwarzenberg et al. 2014), distal renal acidosis (Stehberger, Schulz et al.
2003; Ochotny, Van Vliet et al. 2006), and several infectious diseases (Huang, Tsai et al.
2006; Kohio and Adamson 2013; Rane, Bernardo et al. 2013; Hayek, Lee et al. 2014).
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The reversible disassembly of V-ATPase is an important mechanism that controls VATPase activity in response to various extracellular stimuli. This study focused on the
reassembly. Glucose-dependent regulation of V-ATPase is conserved in yeast, insects,
and human renal epithelial cells (Kane 1995; Sumner, Dow et al. 1995; Nakamura 2004;
Sautin, Lu et al. 2005). Our findings support the notion that dissociation of V1 from Vo
and its reassembly are independently controlled mechanisms. Prior studies have shown
that: 1) The disruption of microtubules only blocks the dissociation of the V-ATPase but
not its reassembly, suggesting that the complete microtubular system is only required for
V-ATPase disassembly (Xu and Forgac 2001); 2) Deletion of Rav1p, a subunit of RAVE
complex (V-ATPase assembly factor), suppresses glucose-dependent reassembly but not
disassembly (Seol, Shevchenko et al. 2001), and 3) Up-regulation of

the

cAMP/Ras/PKA pathway prevents V1 dissociation from the Vo complex (Bond and
Forgac 2008). Our own findings (Chapter II) indicate that the yeast phosphofructokinase1 subunit Pfk2p is necessary for reassembly, not for disassembly.

V1Vo reversible disassembly does not require new protein synthesis (Kane 1995) and
preserves energy (ATP consumption) under low energy state. So, it is important to
understand how V1Vo responds to low nutrient environments (low glucose and poorly
fermentable carbon sources such raffinose and galactose). This and other studies have
indicated that glycolysis is important for V1Vo reassembly (Kane 1995; Parra and Kane
1998). Glucose metabolism is the main energy source for yeast, but the interplay between
the energy state of a cell and reversible disassembly is still unclear. The cellular
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mechanisms and signals involved are not understood and they may be different in
different cell types.

The glycolytic enzymes, aldolase, GAPDH and phosphofructokinase-1, associate with VATPase and these interactions are important for V-ATPase function in yeast and
mammalian cells (Lu, Holliday et al. 2001; Ikemoto, Bole et al. 2003; Su, Zhou et al.
2003; Lu, Sautin et al. 2004; Dhar-Chowdhury, Harrell et al. 2005; Lu, Ammar et al.
2007; Su, Blake-Palmer et al. 2008). Aldolase-V-ATPase binding is glucose-dependent
and required for V1Vo reassembly (Lu, Holliday et al. 2001; Lu, Sautin et al. 2004; Lu,
Ammar et al. 2007). However, the factors that control interactions with aldolase are still
unknown. Human phosphofructokinase-1 also binds to Vo subunit a4 of V-ATPase and
mutants of Vo subunit a4 that interfere with this binding also cause distal renal acidosis
(Su, Zhou et al. 2003; Su, Blake-Palmer et al. 2008).

Until now, the role of

phosphofructokinase-1 in V-ATPase function was unclear. Our studies demonstrated that
phsphofructokinase-1 is dispensable for V-ATPase functions if the glycolytic flow is
restored.

We addressed the role of each phosphofructokinase-1 subunit for V-ATPase activity
separately. We studied single deletion strains of the yeast PFK1 and PFK2 genes to
determine the interplay between phosphofructokinase-1, V-ATPase, and glycolysis. Each
single deletion strain supports glucose metabolism and was suitable for studying the role
of phosphfructokinase-1 in regulating V-ATPase.
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The first part of this dissertation (Chapter II) focused on the role of individual yeast
phosphofructokinase-1 enzymes in V-ATPase function at steady state and during
glucose-dependent reversible V1Vo disassembly. First, we demonstrated that both the
Pfk1p subunit and Pfk2p subunits of phosphofructokinase-1 co-precipitate with VATPase in pfk2Δ and pfk1Δ cells, respectively. This suggests that individual Pfk1p and
Pfk2p can bind to V-ATPase. Those studies did not exclude the possibility that Pfk1p and
Pfk2p may interact with V-ATPase through other proteins (eq. other glycolytic enzymes).
Notably, each phosphofructokinase-1 single deletion strain displayed Vma- phenotypic
traits in vivo, including alkalinized vacuoles, partial loss of V-ATPase activity in purified
vacuolar membranes, and acidified cytosol at steady state. These phenotypes suggest that
the pfk1Δ and pfk2Δ mutants have defective V-ATPase pumps. Overall the pfk2Δ cells
exhibited more dramatic phenotypes than pfk1Δ cells.

After glucose re-addition, pfk2Δ cells failed to reassemble 50% of the V1Vo complexes
and did not acidify the vacuolar lumen. In addition, pfk2Δ exhibited enhanced V1-RAVE
binding in the cytosol. Since the glucose-induced vacuolar acidification is the direct
consequence of V1Vo re-activation, we concluded that pfk2Δ cells couldn’t reactivate VATPase and transport protons across the vacuolar membranes.

We reasoned that Pfk2p is the subunit mainly responsible for the interaction between
phosphofructokinase-1

and

V-ATPase.

The

crystal

structure

of

the

yeast

phosphofructokianse-1 enzyme shows the four α (Pfk1p) subunits and four β (Pfk2p)
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subunits arranged in a stable hero-octamer complex (α4β4), where α subunits localize in
the center surrounded by the β subunit. This conformation makes the β subunits (Pfk2p)
more accessible to other proteins, including V-ATPase. Nonetheless, we addressed other
possibilities in Chapter III of my dissertation.

The Chapter III investigated the factors that cause V-ATPase functional defects in the
pfk2Δ strain. Our results provide new evidence that V-ATPase function is closely linked
to the glycolytic flow. Increasing the amount of glucose in the media from 2% to 4%
reversed the growth defects, glucose-dependent V1Vo reassembly defects, and vacuolar
pH defects in the pfk2Δ cells. The pfk2Δ cells exposed to 4% glucose mimicked the wildtype strain grown in 2% glucose. As expected, glucose at 4% stimulated glycolysis in
pfk2Δ, we detected an ~15 % increase in the rate of NADH formation after 4% glucose
addition relative to 2% in both strains, wild-type and pfk2Δ. This modest increase
allowed pfk2Δ to reach about 50% of the wild-type rate with 2% glucose. In addition,
ethanol levels increased by 40% – 50% in pfk2Δ cells.

The glycolytic flow is reduced in pfk2Δ cells. The rate of NADH formation after glucose
re-addition to glucose-deprived pfk2Δ cells is significantly reduced (by ~ 70%),
compared to wild-type cells. Likewise, the concentration of ethanol is 30 - 40% lower.
Theses finding are supported by independent studies in pfk2Δ showing reduced level of
fructose 1,6 bisphosphate (the reaction product of phosphofructionase-1), accumulation
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of fructose-6-phosphate (subtract of phosphofructokinase-1) (Heinisch 1986), and longer
growth doubling times (120 minutes vs 90 minutes in wild type cells) (Arvanitidis and
Heinisch 1994). Our data indicate that reaching ~50% of the wild-type glycolytic flow
could be a metabolic threshold to reassemble V1Vo normally. Thus, the level of V1Vo
reassembly correlates with the glycolytic rate.

The RAVE complex mediates V-ATPase re-assembly through its interactions with V1-C
in the cytosol (Smardon, Tarsio et al. 2002), free subunit C (Smardon and Kane 2007),
and the Vo subunit a at the membrane (Smardon, Diab et al. 2014). We showed in
Chapter II that the binding of RAVE to cytosolic V1 is enhanced in pfk2Δ cells (Chan and
Parra 2014), suggesting that lower V1Vo reassembly is the consequence of the enchanced
V1-RAVE association in pfk2Δ. In Chapter III we demonstrated that Pfk2p itself is not
required for normal reassembly, and that stimulation of the glycolytic flow is sufficient.
Thus, together our results suggest that the glycolytic flow itself could communicate the
presence of glucose to RAVE to drive V-ATPase reassembly. However, understanding
the role of glycolysis in RAVE-dependent V1Vo reassembly will require additiomal
studies.

For

example,

measuring

V1-Rav1p

interaction

at

4%

glucose

in

pfk2Δ, wild type and Pfk2-ov cells. Those studies will establish whether glucose at 4%
rescues normal V1-RAVE association to help determine if involvement of the glycolytic
flow is the signal that regulates glucose-dependent RAVE-mediated V1Vo reassembly.
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Interestingly, we found the glycolytic enzyme Pgk1p to co-purify with vacuolar
membrane fractions. Elevated Pgk1p levels were isolated with membranes at 4% glucose,
which correlated with vacuolar acidification in vivo. Pgk1p lies downstream of aldolase,
and GAPDH in glycolysis. At the vacuolar membrane these enzymes could form a
functional complex with Pgk1p that provides glycolytic ATP to V-ATPase pumps. The
fact that the glycolytic function of aldolase is independent of its role for V-ATPase
assembly (Lu, Ammar et al. 2007), does not exclude the possibility that Pgk1p activity
(ATP synthesis) could stimulate reactivation of V-ATPase function in vivo.

V1 Vo

disassembly occurs if aldolase cannot bind to V-ATPase, even if glycolysis is fully
functional. In vitro reconstitution experiments will help determine whether Pgk1p at the
vacuolar membrane is sufficient to promote V-ATPase activity.

Neither Pfk2p excess (pfk2-ov cells) or absence (pfk2Δ cells) is sufficient to prevent
V1 Vo

dissociation

or

reassociation,

suggesting

that

the

glycolytic

enzyme

phosphfructokinase-1 itself is not required for V-ATPase reversible disassembly. This
study brings new insight into our understanding of how glucose signals are
communicated to V-ATPases. We separated glucose-dependent V-ATPase reassembly
from V-ATPase reactivation; reassembly is not sufficient to reactivate V-ATPase proton
transport in vivo. Thus, we conclude that V1Vo reassembly and its reactivation are
independently controlled events. V1Vo Reassembly is controlled by glycolytic flow
possibly through its effect on V1-RAVE binding. On the other hand, V-ATPase proton
transport may require locally made glycolytic ATP by Pgk1p at membrane. The Fig. 1
below summarized a model compatible with our results.
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Figure 1. A model for the regulation of V-ATPase reassembly and function by glycolysis.
In this model, glucose-dependent yeast V1Vo reassembly is controlled by glycolysis via the
RAVE complex. Glycolysis drives V1Vo reassembly but not V-ATPase activation (proton
transport). The V-ATPase activation involves Pgk1p, which generates glycolytic ATP. Arrows
represents positive interactions. Dashed arrows: proposed interactions supported by these
studies. PFK-1: phosphofructokinase-1. Pgk1p: phosphoglycerate kinase. RAVE: Regulator

of ATPase of Vacuoles and Endosomes.
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Appendix A
Inhibitors of V-ATPase Proton Transport Reveal Uncoupling Functions of Tether
Linking Cytosolic and Membrane Domains of Vo Subunit a (Vph1p)
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Membrane Biology:
Inhibitors of V-ATPase Proton Transport
Reveal Uncoupling Functions of Tether
Linking Cytosolic and Membrane Domains
of V 0 Subunit a (Vph1p)
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Inhibitors of V-ATPase Proton Transport Reveal Uncoupling
Functions of Tether Linking Cytosolic and Membrane
Domains of V0 Subunit a (Vph1p)*□
S

Received for publication, November 12, 2011, and in revised form, December 16, 2011 Published, JBC Papers in Press, January 3, 2012, DOI 10.1074/jbc.M111.321133

Background: Vacuolar ATPase (V-ATPase) proton pumps maintain pH homeostasis.
Results: We discovered new V-ATPase inhibitors that uncouple the proton transport and ATPase activity of the pump.
Conclusion: Residues at the tether connecting V0 subunit a to the membrane give uncoupling potential to V-ATPases.
Significance: The tether may offer new mechanisms to regulate V-ATPase and cellular pH in vivo by uncoupling the pump.
Vacuolar ATPases (V-ATPases) are important for many
cellular processes, as they regulate pH by pumping cytosolic
protons into intracellular organelles. The cytoplasm is acidified when V-ATPase is inhibited; thus we conducted a highthroughput screen of a chemical library to search for
compounds that acidify the yeast cytosol in vivo using
pHluorin-based flow cytometry. Two inhibitors, alexidine
dihydrochloride (EC50 ! 39 "M) and thonzonium bromide
(EC50 ! 69 "M), prevented ATP-dependent proton transport in
purified vacuolar membranes. They acidified the yeast cytosol
and caused pH-sensitive growth defects typical of V-ATPase
mutants (vma phenotype). At concentrations greater than 10
"M the inhibitors were cytotoxic, even at the permissive pH (pH
5.0). Membrane fractions treated with alexidine dihydrochloride and thonzonium bromide fully retained concanamycin
A-sensitive ATPase activity despite the fact that proton translocation was inhibited by 80 –90%, indicating that V-ATPases
were uncoupled. Mutant V-ATPase membranes lacking
residues 362– 407 of the tether of Vph1p subunit a of V0 were
resistant to thonzonium bromide but not to alexidine dihydrochloride, suggesting that this conserved sequence confers
uncoupling potential to V1V0 complexes and that alexidine
dihydrochloride uncouples the enzyme by a different mechanism. The inhibitors also uncoupled the Candida albicans
enzyme and prevented cell growth, showing further specificity
for V-ATPases. Thus, a new class of V-ATPase inhibitors
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□
S

(uncouplers), which are not simply ionophores, provided new
insights into the enzyme mechanism and original evidence supporting the hypothesis that V-ATPases may not be optimally
coupled in vivo. The consequences of uncoupling V-ATPases in
vivo as potential drug targets are discussed.

Endogenous V-ATPase proton pumps are present throughout the endomembrane system where they energize the membranes, acidify organelles, and contribute to regulating the
cytosolic pH (1–3). V-ATPases carefully control the acidic pH
essential for endocytic and exocytic vesicular transport, zymogen activation, and protein sorting and degradation. Cells specialized for active proton secretion also express V-ATPases at
the plasma membrane, where the efflux of cytosolic protons
sustains the acidic luminal pH necessary for sperm maturation
(4), urinary acidification (5), and bone resorption (6).
Maintaining pH homeostasis by V-ATPases6 entails the
active transport of protons at the expense of ATP. The two
domains forming the V-ATPase complex, V1 and V0, functionally and structurally couple ATP hydrolysis and proton transport via a rotational mechanism of catalysis. V1 is bound
peripherally to the cytosolic side of the membrane and catalyzes
the hydrolysis of ATP inside a hexameric structure consisting
of subunits A and B (A3B3) (1–3). V0 is membrane-bound
and forms the path for proton transport, which involves subunit a and a proteolipid ring structure (3, 7). During catalysis,
hydrolysis of ATP in A3B3 of V1 drives rotation of a central
rotor connected to the proteolipid ring of V0. Protons are
transferred from the cytosol to a hemichannel in the V0 subunit a and from subunit a to the proteolipid ring. Hydrolysis
of three molecules of ATP in V1 drives a 360° rotation of the
ring, allowing the exit of protons. Exiting protons are transferred to a second hemichannel, located in the luminal side
6

The abbreviations used are: V-ATPase, vacuolar proton-translocating
ATPase; DMSO, dimethyl sulfoxide; SC, synthetic complete; ACMA,
9-amino-6-chloro-2-methoxyacridine.
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V-ATPase Uncouplers and Role of Vph1p
cytometry platform (32), we identified two V-ATPase inhibitors, alexidine dihydrochloride and thonzonium bromide. They
acidified the yeast cytosol, inhibited ATP-dependent proton
transport in vacuolar membrane fractions, and caused pH-sensitive growth defects characteristic of yeast cells with impaired
V-ATPase function.
We showed that these inhibitors functionally uncoupled
V-ATPase pumps and that a mutant V-ATPase lacking the
tether (residues 362– 407) of V0 subunit a Vph1p was resistant
to thonzonium bromide. This finding revealed novel roles for
the tether connecting the N- and C-terminal domains of subunit a. The tether confers uncoupling potential to V1V0 complexes and a mechanism for regulating V-ATPase coupling
efficiency in vivo. We showed further that alexidine dihydrochloride and thonzonium bromide uncouple V-ATPase pumps
of the pathogenic fungi Candida albicans and inhibit cell
growth providing evidence for the universal nature of this regulatory mechanism.

EXPERIMENTAL PROCEDURES
Materials and Strains
Zymolase 100T was purchased from Seikagaku (Tokyo), concanamycin A from Wako Biochemicals (Richmond, VA), and
Ficoll from United Stated Biologicals (Swampscott, MA). All
other reagents were from Sigma. The yeast S. cerevisiae strains
referred to throughout the in vivo studies are BY4742 (MAT!
his3!1 leu2!0 lys2!0 ura3!0), vma2! (MAT! his3!1 leu2!0
lys2!0 ura3!0 VMA2::KanMX), and vma3! (MAT! his3!1
leu2!0 lys2!0 ura3!0 VMA3::KanMX). For flow cytometry
and pH measurements, the cells were transformed by the lithium acetate method (33) with the 2 " plasmid pHluorin under
control of the phosphoglycerate kinase promoter (31); this plasmid was created by Dr. Rajini Rao (Department of Physiology,
Johns Hopkins University). After transformation, the strains
expressing pHluorin were maintained in fully supplemented
synthetic complete (SC) medium lacking uracil (SC-Ura) buffered to pH 5.0 with 50 mM sodium phosphate and 50 mM
sodium succinate (SC-Ura pH 5.0). The pHluorin plasmid was a
generous gift from Patricia Kane (Upstate Medical University,
State University of New York, Syracuse).
The yeast S. cerevisiae strains referred to throughout the in
vitro studies involving vacuolar membranes and phenotype
analyses are SF838-1D! (MAT! ade6 leu2–3,112 ura3–52
pep4 –3 his4 –519 gal2), the vph1!stv1! strain, MM112
(MAT! his3-!200 leu2 lys2 !stvl::LYS2 ura3–52 !vphl::LEU2)
(34), and the vph1!stv1! strain transformed with the CEN
plasmid pRS316 carrying either the wild-type VPH1 gene or the
tether-less VPH1 gene (vph1–362-407!) (35). MM112 was a
gift from Dr. Morris Manolson (University of Toronto,
Toronto, Ontario, Canada), and pRS316-HA-VPH1 was a gift
from Michael Forgac (Tufts University, Boston). The C. albicans strain referred to throughout the study is DAY185
(ura3::#imm434/ura3::#imm434his1::his6/his1::his6::HIS1arg4::his6/arg4::his6::ARG4::URA3), a generous gift from Aaron
Mitchell, Carnegie Mellon University, Pittsburgh. DAY185
cells were maintained in YEPD, pH 5.0 (yeast extract-peptone-2% dextrose medium buffered to pH 5.0 with 50 mM
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of subunit a, and expelled to the other side of the membrane
against a concentration gradient.
V-ATPase activity is essential, and blocking of rotational
catalysis is lethal. When V-ATPase activity is impaired at physiological (neutral) pH, yeast and most eukaryotic cells are not
viable (2). However, yeast have developed a conditionally lethal
pH-sensitive growth phenotype in which cells grow under
acidic conditions. This phenotypic trait has made yeast an ideal
system for the study of the downstream consequences of genetically impairing V-ATPase function in vivo (8). Yeast V-ATPase
mutant strains have provided valuable information regarding
the molecular mechanism of catalysis and the broad spectrum
of physiological processes in which V-ATPases are involved.
It is precisely because V-ATPases are critical for many
cellular events that yeast V-ATPase mutants often develop
compensatory mechanisms that can mask important VATPase functions (9 –11). In this context, V-ATPase inhibitors
are important research tools for studies requiring sudden inhibition of V-ATPases. The most commonly used V-ATPase
inhibitors, bafilomycin A and concanamycin A, have been fundamental to the understanding of V-ATPase catalysis, regulation, and cellular functions (12–15). Bafilomycin A and concanamycin A are now indispensable research tools for the study of
important processes in which V-ATPases are involved, including autophagy (16, 17) and membrane fusion (18) under normal
physiology and pathophysiology.
It has been proposed that bafilomycin A and concanamycin
A act as a stone in a gear, blocking rotation when they bind to
the proteolipid ring of V0 (19, 20). A new kind of V-ATPase
inhibitors, archazolids (12), also bind to the proteolipid ring to
block rotation (21). By ending rotation, bafilomycin A, concanamycin A, and archazolids inhibit ATPase activity in V1 and
proton transport in V0 simultaneously. Unfortunately, they
cannot offer information regarding the mechanisms by which
proton transport and ATP hydrolysis are coupled. Mutagenesis
studies of individual V1 and V0 subunits in yeast indicate that
coupling is accomplished by the contribution of multiple subunits (22–26). However, exactly how proton transport and ATP
hydrolysis are coupled in the V-ATPase complex is not known.
Changing the coupling efficiency of V-ATPase may regulate
the pump by offering a mechanism for control of organelle acidification in vivo (27, 28). The hypothesis that V-ATPase may
not couple proton transport and ATP hydrolysis optimally is
supported by the fact that increased coupling efficiency is
observed at lower ATP concentrations (27) and in some genetic
mutants (25). An intrinsic uncoupling potential argues against
the energetic efficiency of the V-ATPase machine, and intrinsic
uncoupling is poorly understood. As such, to gain new insights
into this important regulatory mechanism of V-ATPase proton
transport, it would be beneficial to find specific V-ATPase
inhibitors that modulate coupling of the enzyme.
We took advantage of the fact that V-ATPase inhibition prevents the redistribution of protons and lowers the cytosolic pH
(29) to screen the Prestwick Chemical Library of small compounds. We searched for drugs that acidified the yeast cytosol
in vivo as a means of identifying new V-ATPase inhibitors. By
using Saccharomyces cerevisiae cells expressing a cytosolic
pHluorin (29 –31) and the HyperCyt! high-throughput flow

V-ATPase Uncouplers and Role of Vph1p
sodium phosphate and 50 mM sodium succinate), supplemented with uridine (80 !g/ml).
Assay Validation

High-throughput Screening
Polypropylene 384-well plates were configured with 32 control wells and 32 wash wells. Column 1 contained the negative
control (1% DMSO), column 2 contained the positive control
(67 !M disulfiram), and columns 23 and 24 were the wash wells
containing 2-fold diluted SC medium plus 0.1% BSA. This left
320 wells (columns 3–22) to which test compounds were
added. The SC medium (2-fold diluted) was distributed into
columns 1 and 3–22 (10 !l/well). An equal volume of 134 !M
disulfiram or 2% DMSO was distributed into columns 2 and 1,
respectively. Compounds of the Prestwick Library were added
using the Biomek NX robotic liquid handler with a 200-nl pin
tool attachment (V&P Scientific) to a final concentration of 0.1
mg/ml in 1% DMSO. Overnight cultures of the yeast S. cerevisiae expressing pHluorin were pelleted and resuspended in
2-fold diluted fresh SC medium to a cell density of 0.4 A600/ml
(1–2 ! 107 cells/ml). Cells (0.004 A600) were transferred to columns 1–22 and incubated for 60 min at 30 °C in a rotator, and
the FL1/FL7 ratio was calculated as described above. Compounds that lowered the cytosolic pH (increased the FL1/FL7
ratio) were retested in single-point confirmation assays and
dose-response assays (between 1 and 100 !M).
Cytosolic pH Measurement
Yeast cells expressing pHluorin were grown overnight to
mid-log phase (0.4 – 0.6 A600) in SC-Ura or SC-Ura, pH 5.0
(vma2" and vma3"). Cultures were collected, washed three
times in SC-Ura, pH 5.0, and resuspended in the same medium
to 0.5 A600/!l. Aliquots of cells (10 A600) were treated with 0.2%
DMSO or the indicated compounds (100 !M in 0.2% DMSO)
for 30 min at 30 °C with shaking. The cells were harvested,
washed, resuspended in SC-Ura, pH 5.0 (0.5 A600/ml), and
transferred to cuvettes containing 1 mM HEPES/MES, pH 5.0,
and 2% glucose (5 A600/ml). The fluorescence intensity was
monitored (ex 405, ex 485; em 508) for 10 min at 30 °C with

Proton Transport
Vacuolar membranes were purified by Ficoll density gradient
centrifugation (23), and proton transport was measured by
monitoring 9-amino-6-chloro-2-methoxyacridine (ACMA)
quenching after the addition of MgATP as described previously
(36). Briefly, membrane vesicles (10 !g of vacuolar protein)
were preincubated with 1% DMSO, 0.1 !M concanamycin A, or
the indicated concentrations of the compounds on ice for 10
min. The membranes were transferred to 1.8 ml of reaction
buffer (20 mM HEPES, pH 7.0, 50 mM NaCl, 30 mM KCl, 1 !M
ACMA), and fluorescence was monitored (ex 410 nm, em 490
nm) for 60 s. MgATP (0.5 mM ATP, 1 mM MgSO4) was added,
and fluorescence quenching was monitored for an additional
40 s in a FluoroMax 4 spectrofluorometer (Horiba Jobin Yvon
Inc.). The proton transport rates were estimated for the initial
15 s following the addition of MgATP. Proton transport measurements involving C. albicans were conducted as described
above, except that 30 !g of vacuolar protein was used. To calculate EC50 values, the vacuolar membranes were preincubated
with 0.4, 1.2, 3.6, 11.1, 22.2, 33.3, 50, 100, 200, and 300 !M
alexidine dihydrochloride and thonzonium bromide on ice for
10 min, and then proton transport was measured.
ATP Hydrolysis
Vacuolar membranes (4 !g of vacuolar protein) were preincubated with 0.1 !M concanamycin A, 1 !M nigericin, or test
compounds (100 !M) on ice for 10 min in the presence of 1%
DMSO. ATP hydrolysis was followed spectrophotometrically
by using an enzymatic assay coupled to the oxidation of NADH
(37). ATPase assays involving C. albicans were conducted as
described for yeast, except that each reaction contained 20 !g
of vacuolar membrane protein. The protein concentration was
measured as described by Bradford (38).
Growth Phenotype
Cell cultures of the yeast S. cerevisiae were grown overnight
to 0.5–1.0 A600/ml in YEPD, pH 5.0, at 30 °C. Cells were pelleted, resuspended to 0.5 A600/ml, and incubated in YEPD, pH
5.0 (no treatment), 1% DMSO, or 100, 50, 10, or 1 !M alexidine
dihydrochloride, thonzonium bromide, or disulfiram at 30 °C
with shaking for 1 h. The cells were harvested, resuspended in
200 !l of sterile ddH2O, and transferred to a 96-well plate.
Serial dilutions (1:3) were stamped on YEPD, pH 5.0 and 7.5,
plates and incubated at 30 and 37 °C for 48 h. A growth phenotype analysis of C. albicans was conducted as described above,
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Overnight mid-log phase cultures of yeast S. cerevisiae
(BY4742) expressing pHluorin were resuspended in 2-fold
diluted fresh SC medium to an optical density of 0.4 A600/ml
(1–2 ! 107 cells/ml). Cells (0.004 A600) were transferred to
polypropylene 384-well plates (Greiner, Frickenhausen, Germany) containing an equal volume of disulfiram (134 and 26
mM) in 2% DMSO or 2% DMSO alone prepared in the same
medium. Wash wells (columns 23 and 24) contained the same
volume (10 !l) of 2-fold diluted SC medium plus 0.1% BSA.
After incubation (0 –120 min) at 30 °C with rotation, the plates
were read using a CyAn flow cytometer (Beckman Coulter) and
HyperCyt automation (IntelliCyt) (32) on filter sets 1 (ex
488/em 530) and 7 (ex 405/em 530), referred to as FL1 and FL7
hereafter. The ratio of these two measurements (FL1/FL7) was
calculated. Cytosolic acidification was monitored as an increase
of the FL1/FL7 ratio resulting from a simultaneous increase of
the mean intensity at FL1 and a decrease of the mean intensity
at FL7.

constant stirring, and fluorescence units were converted into
pH units by using calibration curves as described previously
(29, 30). For calibration curves, the cells were resuspended (5
A600/ml) in calibration buffers (50 mM MES, 50 mM HEPES, 50
mM KCl, 50 mM NaCl, 0.2 M ammonium acetate, 10 mM sodium
azide, 10 mM 2-deoxyglucose, 75 !M monensin, 10 !M nigericin) at pH 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, and 8.0 for 30 min at 30 °C
after which the fluorescence measured. The background signals
(cells without pHluorin) were subtracted, and cytosolic pH values were calculated. A calibration curve was constructed for
each strain used.

V-ATPase Uncouplers and Role of Vph1p

except that the cells were resuspended in 1 ml of sterile H2O
before stamping.
Other Methods
Western Blot—Vacuolar membrane protein was separated by
SDS-PAGE in 8% polyacrylamide gels and transferred to a
nitrocellulose membrane, and V-ATPase subunits a, A, and B
were visualized with the monoclonal antibodies 10D7, 8B1, and
13D11 as described previously (35).
Microscopy—S. cerevisiae cells transformed with the pHluorin plasmid were grown to mid-log phase (0.5 A600/ml), harvested, and washed in SC medium three times by centrifugation. Cells (0.5 A600/ml) were transferred to microscope slides
and observed with a Zeiss LSM 510 confocal microscope (Zeiss)
at !63 magnification by differential interference contrast
microscopy and FITC lens. All images were taken using the
same settings on the microscope.

RESULTS
Cytosolic pH Changes Monitored by pHluorin-based High
Throughput—V-ATPase inhibition prevents redistribution of
cytosolic protons into the vacuolar lumen (29), resulting in
acidification of the cytosol. Thus, to search for new V-ATPase
inhibitors we used yeast cells expressing a pH-sensitive GFP
(pHluorin) in the cytosol (30, 31). We transformed yeast cells
with pHluorin, confirming its cytosolic localization by fluorescence microscopy (Fig. 1A). We sorted the cells with the brightest fluorescence signal by flow cytometry (data not shown) and
used those cells to develop a pHluorin-based high-throughput
flow cytometry assay, which would allow us to identify molecules that acidify the yeast cytosol.

We took advantage of the pH-sensitive emission spectrum of
pHluorin in which the dual excitation wavelength (405 and 488
nm) of pHluorin exhibits opposite pH-dependent fluorescence
responses despite both emitting at 535 nm (39). As the pH
drops, the intensity of the fluorescent signal from 405 nm excitation decreases, whereas the intensity of the signal from excitation at 488 nm increases. Therefore, cytosolic acidification
corresponds to a raise in the excitation 488/405 nm ratio
(referred to as FL1/FL7). The benefit of a response that changes
the signal on two filter sets is an automatic control for false
positives in which fluorescent compounds that increase FL1
independent of cytosolic pH changes were excluded.
Concanamycin A and bafilomycin A are not suitable for studies involving high-throughput screenings in vivo (40). Inhibition of yeast V-ATPase pumps with concanamycin A requires 3
orders of magnitude larger concentrations of concanamycin A
in vivo (EC50 " 2.10 –2.27 !M) (40) than in vitro (EC50 " 1 nM)
(20, 21). Likewise, bafilomycin A exhibits poor permeability.
We tested the responsiveness of pHluorin to cytosolic acidification by treating yeast cells with disulfiram (tetraethylthiuram
disulfide). Disulfiram (EC50 " 26 !M) exhibits both lower specificity and lower potency than concanamycin A and bafilomycin A in vitro (20, 40), but disulfiram is suitable for studies
involving high-throughput screening. Disulfiram is stable and
readily incorporated into yeast cells (40).
We treated the cells with an inhibitory concentration of disulfiram (67 !M) (40) and monitored the FL1/FL7 ratio. An
increased FL1/FL7 ratio relative to control cells treated with 1%
DMSO was measured (Fig. 1B). The cells had a FL1/FL7 ratio of
1.2 to 1.6 after 1 h of incubation with disulfiram at 30 °C com-
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FIGURE 1. Yeast cytosolic acidification monitored with pHluorin by high throughput. A, stable expression of pHluorin in the cytosol. Wild-type yeast
S. cerevisiae cells expressing pHluorin were grown overnight to mid-log phase (0.6 A600/ml) and observed with a Zeiss LSM 520 confocal system. Cells were
excited at 488 nm and emission detected with a 505-nm long pass filter (left); the same field was viewed at !63 differential interference contrast (middle), and
with images merged (right). B, pHluorin is responsive to V-ATPase inhibition in vivo. Cells expressing pHluorin were grown overnight to mid-log phase (0.6
A600/ml), harvested, resuspended at 0.4 A600/ml in 2-fold diluted SD medium containing 0.1% BSA, and distributed into 384-well plates to which SD medium
alone, 1% DMSO, or disulfiram (DSF) at 13 and 67 !M was added for 60 –120 min before sampling started. Plates were rotated at 30 °C and sampled with a
HyperCyt! autosampler for flow cytometry pHluorin fluorescence measurements. After excitation with both the 488 and 405 nm lasers, fluorescence emission
was collected using a 530/40-nm filter set and data files processed using IDLQuery software programs. The mean fluorescence intensity for each sample was
calculated and used for subsequent analysis. Each point represents the ratio of FL1/FL7 from a single well.
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dine dihydrochloride (pHcyt 6.10 " 0.04), and thonzonium bromide (pHcyt 6.22 " 0.02), significantly lowered the pH. A second group, consisting of bisoprolol fumarate (pHcyt 7.18 "
0.08) and dyclonine hydrochloride (pHcyt 7.33 " 0.05), induced
only subtle pH changes (Fig. 2B).
Alexidine Dihydrochloride and Thonzonium Bromide Functionally Uncouple V-ATPase Proton Pumps—Benzbromarone,
alexidine dihydrochloride, and thonzonium bromide acidified
the cytosol to different extents, suggesting that they may lower
the pH by inhibiting the V-ATPase pump with different efficacy
or, alternatively, by affecting different targets. To address these
two possibilities, we measured proton transport in vacuolar
membrane fractions fluorometrically by monitoring ACMA
quenching after the addition of MgATP in the presence of each
compound. As anticipated, V-ATPase proton transport was
very sensitive to concanamycin A treatment in vitro. At 100 nM
concanamycin A, ACMA quenching was blocked, indicating
that a pH gradient could not be formed across the vacuolar
membrane because the V-ATPase pump was inhibited (Fig.
3A). Alexidine dihydrochloride and thonzonium bromide
inhibited proton transport in a dose-dependent manner. We
estimated an EC50 at 39 and 69 !M for alexidine dihydrochloride and thonzonium bromide, respectively (Fig. 3B). Benzbromarone, however, did not inhibit proton transport (Fig. 3A),
suggesting that it acidified the cytosol by V-ATPase-independent mechanisms. None of the remaining drugs blocked proton
transport at the highest concentration tested (100 !M), consistent with their negligible effects on cytosolic pH (Fig. 2B).
Because V-ATPases couple active transport of protons and
ATP hydrolysis, we measured ATP hydrolysis as well. We could
discriminate between V-ATPase inhibitors, which block both
proton transport and ATP hydrolysis, and uncouplers, which
block proton transport preferentially. As expected (40), disulfiram inhibited ATP hydrolysis in vacuolar membranes, albeit
with less potency than concanamycin A (Fig. 3C). None of the
hit compounds inhibited ATP hydrolysis (Fig. 3C), including
alexidine dihydrochloride and thonzonium bromide, even at
concentrations that completely blocked proton transport (100
!M). Alexidine dihydrochloride and thonzonium bromide
therefore uncoupled V-ATPase proton pumps.
The ATPase activity was not stimulated by alexidine dihydrochloride and thonzonium bromide, suggesting that they do
not simply act as ionophores that uncouple V-ATPase pumps
by dissipating the proton gradient across the membrane (41).
To distinguish between V-ATPase-specific uncoupling and
unspecific ionophore effects, we treated vacuolar membranes
with 1 !M nigericin. Nigericin also uncoupled the enzyme; it
abolished proton transport (Fig. 4B) but stimulated concanamycin A-sensitive ATP hydrolysis (by 1.4-fold) (Fig. 4A). We
additionally showed that lower concentrations of alexidine
dihydrochloride and thonzonium bromide (1–75 !M) did not
stimulate ATPase activity (Fig. 4C). This disproves the possibility that the inhibitors act as proton ionophores at low concentrations while inhibiting activity at high concentrations, such
that at 100 !M the two effects (stimulation and inhibition of
ATP hydrolysis) cancel each other out. These results indicate
that alexidine dihydrochloride and thonzonium bromide did
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pared with a FL1/FL7 ratio of 0.9 with 1% DMSO. The FL1/FL7
ratio was dose-dependent, stable for at least 2 h, and exhibited
an average Z! of 0.76 ("0.036) for the 60 –120-min time period
(supplemental Table 1). The Z! is a statistical parameter used in
high-throughput screening to evaluate the quality of an assay;
Z! establishes whether significant differences exist between the
controls. An assay with a Z! value greater than 0.5 is considered
appropriate for screening, that is, where consistent significant
differences between the controls, in this case DMSO and disulfiram, are observed. We concluded that cells expressing pHluorin could be used to assay for pharmacological inhibition of
V-ATPase pumps in vivo and that disulfiram-treated cells
would be an appropriate positive control for identification of
molecules (or compounds) that lower the cytosolic pH of yeast
cells.
High-throughput Screening of the Prestwick Chemical Library—
The yeast cells expressing pHluorin were used to screen a collection of 1120 off-patent drugs (Prestwick Chemical Library).
For controls, we treated the cells with either 1% DMSO alone or
67 !M disulfiram. The hit cutoffs were set at a FL1/FL7 ratio of
0.86, which corresponded to the average plus 3-fold the standard deviation of the test compounds. All compounds that
resulted in an increased ratio and satisfied the hit cutoff were
scrutinized further to confirm that they enhanced fluorescence
at 488 nm (FL1) and lowered fluorescence at 405 nm (FL7)
concurrently, indicating an actual pH change.
One representative plate is shown in Fig. 2A. We identified
nine compounds that met the cutoff criteria. Seven of these hits
were validated (hit rate of 0.63%) These drugs differentially
altered the magnitudes of the FL1/FL7 ratio, suggesting that
some hits acidified the cytosol more significantly than others.
Disulfiram, the positive control used, is also a test compound in
the Prestwick Chemical Library. The fact that disulfiram itself
was identified as a hit (Fig. 2A) validated the cutoff criteria
applied and demonstrated the effectiveness of the pHluorinbased assay in high-throughput screening for inhibitors of
V-ATPase proton pumps.
Benzbromarone, Alexidine Dihydrochloride, and Thonzonium Bromide Acidify the Yeast Cytosol—To verify that lack of
V-ATPase function acidifies the cytosol, we measured fluorometrically the cytosolic pH of yeast V-ATPase mutant strains
that do not assemble functional V1V0 complexes and lack all
V-ATPase function (2). Yeast vma2# (pHcyt 6.68 " 0.081) and
vma3# (pHcyt 6.81 " 0.044) exhibited lower cytosolic pH than
wild-type cells (pHcyt 7.5 " 0.04) (Fig. 2B). These results are
consistent with other studies (29) and with the notion that
V-ATPases are key players in maintaining yeast cytosolic pH
homeostasis.
We treated wild-type cells expressing pHluorin with the hit
compounds and measured the cytosolic pH to confirm that the
increased FL1/FL7 ratio was the direct outcome of cytosolic
acidification. The cells treated with disulfiram (pHcyt 6.78 "
0.13) resembled vma2# and vma3# cells (Fig. 2B), whereas
DMSO treatment had no effect (pHcyt 7.4 " 0.01), thus confirming that the positive and negative controls responded properly during the high-throughput screening. Treatment of yeast
cells with the hit compounds revealed two groups of drugs. One
group, consisting of benzbromarone (pHcyt 6.03 " 0.07), alexi-
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not uncouple V-ATPase pumps by simply dissipating the membrane proton gradient.
Yeast Cells Exposed to V-ATPase Uncouplers Develop Growth
Defects—To further assess the specificity of alexidine dihydrochloride and thonzonium bromide for V-ATPases in vivo, we
asked whether yeast cells treated with the drugs would develop
growth defects that could be attributed to impairment of V-

ATPase function. Lack of yeast V-ATPase activity leads to pHsensitive growth (42, 43); cells grow at pH 5.0 but cannot grow
at pH 7.5 (Fig. 5A). This growth defect is known as the vma
(vacuolar membrane ATPase) mutant growth phenotype (2).
We addressed whether exposure to alexidine dihydrochloride
and thonzonium bromide leads to a vma growth phenotype by
treating the cells with varied concentrations of the drugs for 1 h
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FIGURE 2. High-throughput screening using a pHluorin-based assay identified drugs that acidify the cytosol. A, high-throughput screening of the
Prestwick Chemical Library revealed drugs that increase the FL1/FL7 (488/405 nm) ratio of pHluorin. Mid-log phase cultures of cells expressing pHluorin were
distributed in 384-well plates (0.2 A600/ml) to which test compounds, 1% DMSO (negative control), or 67 !M disulfiram (positive control) was added. Test
compounds were added by robotic pintool and incubated in a rotator at 30 °C for 60 min, and sampling was started. Sampling, data collection, and processing
were as described in the legend for Fig. 1B. One representative plate of compounds that enhanced the FL1/FL7 ratio is shown. The x axis displays each well; time
bins were drawn automatically around the clusters by using the IDLQuery software program. B, cytosolic pH measurement. Yeast cells expressing pHluorin
were grown overnight to mid-log phase (0.4 – 0.6 A600/ml) and preincubated with 0.2% DMSO or with 100 !M drug in 0.2% DMSO. Following 30-min incubations at 30 °C, cells were transferred to 1 mM HEPES/MES buffer, pH 5.0, containing 2% glucose at a cell density of 5.0 A600/ml; fluorescence was measured for
6 min at 1-min intervals, and pH values were averaged. The cytosolic pH was estimated using calibration curves made in parallel (pH values ranging from 5.0
to 8.0). Data are presented as average pH values. Error bars ! " S.D., n ! 2; *, p # 0.05; **, p # 0.01; and ***, p # 0.001 compared with DMSO as measured by
two-tailed paired Student’s t test.
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co-transformed the vph1"stv1" cells with VPH1–362-407"
and subunit d (VMA6), each of them expressed from a CEN
plasmid (pRS316) under control of their natural promoters as
described previously (35). We compared the mutant vph1–362407" vacuolar membranes with isogenic wild-type membranes
obtained in parallel from vph1"stv1" cells expressing the wildtype allele of VPH1 from pRS316. As expected, the tether-less
mutant assembled wild-type levels of V1 (A and B) and V0 (a)
subunits at the vacuolar membrane and retained about 90% of
the wild-type concanamycin A-sensitive ATP hydrolytic activity (Fig. 6A). The tether-less V1V0 also retained wild-type levels
of proton transport (Fig. 6, A and B), suggesting that the length
of the tether does not affect coupling efficiency when the physical connection between the N- and C-terminal domains of subunit a is maintained.
Tether-less V1V0 complexes were resistant to uncoupling by
thonzonium bromide (Fig. 6B). Whereas 80% of the wild-type
proton transport was inhibited by 100 !M thonzonium bromide, tether-less V1V0 was inhibited by only 40%, suggesting
that the tether is involved in uncoupling by thonzonium bromide. Partial-to-no resistance against alexidine dihydrochloride suggests that uncoupling by alexidine dihydrochloride may
entail other uncoupling mechanisms.
Next, we asked whether cells expressing tether-less V1V0
would be resistant to the uncouplers in vivo. We assessed cell
growth at pH 7.5, the nonpermissive growth condition for vma
mutants, after preincubation with varied concentrations of
alexidine dihydrochloride and thonzonium bromide (at 1–100
!M). The vph1–362-407" cells required 2–2.5-fold larger concentrations of drugs to decrease growth than the isogenic wildtype cells (Fig. 6C), further suggesting that the tether plays an
uncoupling function.
Alexidine Dihydrochloride and Thonzonium Bromide
Uncouple C. albicans V-ATPase Proton Pumps and Impair Cell
Growth—The tether constitutes the most conserved sequence
at the N-terminal end of subunit a. It has 47–51% identity (63–
72% conserved) between yeast and human isoforms. Based on
the previous results, which indicate that this conserved
sequence of Vph1p confers uncoupling potential to V-ATPase
pumps, we extended our studies to C. albicans. This pathogenic
fungi contains Vph1p with 67% sequence identity (83% conserved) with yeast at the tether region of the protein. We isolated vacuolar membrane fractions from C. albicans and measured proton transport and ATP hydrolysis in the presence of
the uncouplers. The results in C. albicans (Fig. 7) mirrored the

FIGURE 3. Alexidine dihydrocloride and thonzonium bromide uncouple V-ATPase pumps in vitro. A, ATP-dependent proton transport is inhibited by
alexidine dihydrocloride and thonzonium bromide. Purified vacuolar membrane vesicles (10 !g of protein) were preincubated for 10 min on ice with 1% DMSO
alone or concanamycin A (100 nM) or with drugs at the indicated concentrations in the presence of 1% DMSO. Fluorescence quenching of ACMA was monitored
(ex 410 nm, em 490 nm) upon the addition of 0.5 mM ATP and 1 mM MgSO4. Initial velocities were calculated for 15 s following addition of MgATP (n # 2). The
apparently enhanced rate measured with benzbromarone and tolazamide was not dose-dependent and was sustained in the controls, when the drugs were
added to the reaction mixture prior to the membrane vesicles. *, p $ 0.05; **, p $ 0.01; and ***, p $ 0.001 for decreased transport compared with DMSO as
measured by two-tailed paired Student’s t test. B, V-ATPase inhibition by alexidine dihydrocloride and thonzonium bromide is dose-dependent. Purified
vacuolar membrane vesicles (10 !g of protein) were incubated with alexidine dihydrochloride or thonzonium bromide at the indicated concentrations for 10
min on ice. ATP-dependent proton transport was measured as described in A. EC50 values were estimated using GraphPad Prism 5.0. The structures of alexidine
dihydrochloride (left) and thonzonium bromide (right) are shown. C, ATP hydrolysis is resistant to alexidine dihydrochloride and thonzonium bromide treatments. Purified vacuolar membranes (4 !g of total protein) were preincubated for 10 min on ice with the indicated drug concentrations in 0.2% DMSO or with
0.2% DMSO alone. Following each treatment, ATP hydrolysis was measured spectrophotometrically using an enzymatic assay coupled to oxidation of NADH
(340 nm) (59). Data are expressed as the average % S.D.; n # 3 separate vacuolar purifications. Relative averaged values were used to express percentage
activity. The specific activity of the concanamycin A-sensitive ATPase activity of the vacuoles was 1.3–1.5 !mol of ATP/min/mg of protein. **, p $ 0.01; and ***,
p $ 0.001 for decreased ATPase activity (2-fold or more) compared with DMSO as measured by two-tailed paired Student’s t test.
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at 30 °C and plating the cells on medium buffered to pH 5.0 and
7.5. Yeast cell growth was then monitored at 30 and 37 °C for
48 h.
Predictably, cells treated with DMSO and disulfiram did not
show a vma phenotype (Fig. 5B), as DMSO did not inhibit the
enzyme and disulfiram only partially inhibited V-ATPase activity (by about 50%) at the highest concentration used (Fig. 3, A
and C). Cells treated with the lowest concentration (1 !M) of
alexidine dihydrochloride and thonzonium bromide exhibited
normal cell growth (Fig. 5B). However, exposure to 10 !M alexidine dihydrochloride resulted in a markedly slow growth at pH
5.0 and 7.5, with cells developing the typical vma mutant
growth phenotype at 37 °C. Likewise, 10 !M thonzonium bromide reduced cell growth, with the cells developing a mild vma
phenotype at 37 °C. Alexidine dihydrochloride and thonzonium bromide completely prevented yeast growth at 50 and 100
!M concentrations. Previous work has shown that yeast cells
must lose at least 75% of their wild-type V-ATPase function to
develop a vma growth phenotype (23, 37). Thus, we concluded
that V-ATPase function was significantly impaired in vivo by
treatment with 10 !M uncouplers and that larger concentrations were cytotoxic.
Tether Connecting the Cytosolic Domain of Subunit a
(Vph1p) to the Membrane Has Uncoupling Functions—V0 subunit a consists of two domains: a cytosolic N-terminal domain
(!45 kDa) that interacts with several V1 subunits to allow rotation of rotor-forming subunits during catalysis and a membrane-bound C-terminal domain (!50 kDa) that contributes to
the path of proton transport (3). Cleavage of Vph1p at the
tether connecting the two domains uncouples yeast V-ATPase
complexes (26), suggesting that Vph1-mediated assembly of
the two domains is necessary for coupling. We asked whether
residues forming the tether were necessary for the observed
pharmacological uncoupling.
To gain insight into the mechanisms by which alexidine
dyhydrochloride and thonzonium bromide uncouple VATPase pumps, we expressed a truncated allele of Vph1p
lacking residues 362– 407 of the tether (vph1–362-407") in
vph1"stv1" cells. Yeast vph1"stv1" does not express endogenous subunit a, because the gene VPH1 and its functional homolog, STV1, are deleted (34). Previously, we showed that biosynthetic assembly of tether-less V1V0 (vph1–362-407") complexes is complete when cells modestly overexpress V0 subunit
d (Vma6p) and that the assembled vph1–362-407" V1V0 fully
retains ATP hydrolytic activity (35). Thus, we simultaneously
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studies in S. cerevisiae. Alexidine dihydrochloride and thonzonium bromide inhibited proton transport in a dose-dependent
manner (Fig. 7A) but had no effect on ATP hydrolysis (Fig. 7B),
showing that alexidine dihydrochloride and thonzonium bromide also uncoupled C. albicans V-ATPase pumps.
For in vivo analyses, C. albicans was exposed to various concentrations of the inhibitors for 1 h at 30 °C, and growth was
assessed at pH 5.0 and 7.5 at both 30 and 37 °C (Fig. 7C). Like
the yeast S. cerevisiae, C. albicans cells exposed to 1 !M alexi-

dine dihydrochloride, 1 !M thonzonium bromide, and up to
100 !M disulfiram mimicked the untreated and DMSO control
cells. Although the cells did not develop a vma growth phenotype, they exhibited significant general growth defects after
treatment with 10 !M alexidine dihydrochloride or thonzonium bromide at both pH 5.0 and 7.5. Alexidine dihydrochloride was more toxic than thonzonium bromide, but both drugs
completely blocked growth at the higher concentrations tested
(50 and 100 !M).
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FIGURE 4. Uncoupling by alexidine dihydrocloride and thonzonium bromide differs from ionophore-mediated uncoupling. A, nigericin stimulates ATPase activity. Concanamycin A-sensitive ATPase specific activity was measured as described in the legend for Fig. 3C, except that 1 !M nigericin
in 0.1% ethanol was added to the reaction. An equal concentration of ethanol in the reaction had no effect on the activity. Shown is the average activity
relative to untreated controls (None) of three independent vacuolar purifications. Error bars ! " S.D. ***, p # 0.001 compared with no treatment as
measured by two-tailed paired Student’s t test. B, nigericin inhibits proton transport. Proton transport was monitored in three independent vacuolar
membrane preparations (10 !g of protein) by measuring ACMA quenching as described in the legend for Fig. 3A, except that nigericin (1 !M) was added
90 s after the addition of MgATP, and florescence was measured for an additional 50 s. C, ATP hydrolysis is not stimulated by lower concentrations of
alexidine dihydrochloride and thonzonium bromide. Concanamycin A-sensitive ATPase specific activity was measured as described in the legend to Fig.
3C. Data are expressed as the average " S.D.; n ! 3 separate vacuolar purifications. Relative averaged values were used to express percentage
activity.
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DISCUSSION
We screened a chemical library using a pHluorin-based
high-throughput flow cytometry assay to identify compounds that acidify the yeast cytosol as a means of identifying new in vivo inhibitors of S. cerevisiae V-ATPase proton
pumps. We identified two drugs, alexidine dihydrochloride
and thonzonium bromide, which selectively target the
V-ATPase complex in vitro and in vivo by blocking proton
transport. Our studies indicate that they are bona fide
uncouplers of V-ATPase pumps.
New Inhibitors of V-ATPase Pumps Acidify the Cytosol and
Uncouple the Enzyme—This unbiased screen identified six
drugs that lower the yeast cytosolic pH, albeit to different
extents (Fig. 2B). Benzbromarone, alexidine dihydrochloride,
thonzonium bromide, and disulfiram showed the strongest
effects, whereas dyclonine hydrochloride and bisoprolol fumarate induced smaller pH changes. Only disulfiram, alexidine
dihydrochloride, and thonzonium bromide acidified the cytosol through inhibition of V-ATPase pumps. The remaining
drugs did not inhibit ATP hydrolysis and/or proton transport in
purified yeast vacuolar membranes, indicating that they act on
different targets and acidify the cytosol through V-ATPase-independent mechanisms.
Yeast cytosolic pH is maintained through a concerted movement of protons out of the cytosol by the V-ATPase and Pma1p
pumps, the major electrogenic pumps at the vacuolar and
plasma membranes, respectively (13, 29). Whereas V-ATPase
transfers protons into the vacuolar lumen, Pma1p moves cytosolic protons out of the cell, helping yeast to sustain a favorable
acidic growth environment. Therefore, by using the pHluorin

system to monitor cytosolic acidification, we anticipated the
identification of inhibitors of Pma1p in addition to V-ATPase
inhibitors. We also most likely identified general inhibitors of
protonophore activity, because they would be expected to dissipate cellular proton gradients, accelerate the leakage of protons from organelles, and result in net cytosolic acidification.
Disulfiram was identified previously as a V-ATPase inhibitor
in a high-throughput screen of the Prestwick Chemical Library,
and we showed that disulfiram treatment alkalinizes the yeast
vacuoles (40). In that study, we characterized the inhibitory
effect of disulfiram on ATP hydrolysis (40). Here, we have further shown that disulfiram treatment acidified the yeast cytosol
in vivo (Fig. 2B) and inhibited V-ATPase proton transport (Figs.
3A and 7A) in addition to ATP hydrolysis (Figs. 3C and 7B) in
vitro.
Alexidine dihydrochloride and thonzonium bromide inhibited proton transport in vacuolar membrane fractions without
inhibiting ATP hydrolysis. At high concentrations (100 !M),
proton transport was significantly impaired (by 80 –90%),
whereas ATP hydrolysis remained intact. Our results indicate
that alexidine dihydrochloride and thonzonium bromide are
not simply ionophores, because they do not stimulate ATP
hydrolysis, in contrast with nigericin, which both inhibits proton transport and stimulates hydrolysis of ATP (Fig. 4). Alexidine dihydrochloride and thonzonium bromide selectively
uncouple V-ATPase pumps.
Although less potent than concanamycin A (EC50 ! 1 nM),
uncouplers such as alexidine dihydrochloride (EC50 ! 39 !M)
and thonzonium bromide (EC50 ! 69 !M) are anticipated to be
highly toxic. In addition to disturbing cytosolic and vacuolar pH
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FIGURE 5. Alexidine dihydrochloride and thonzonium bromide treatments lead to growth defects in S. cerevisiae. A, yeast vma mutants cannot grow at
neutral pH. Overnight mid-log phase cultures of vma2" and vma3" cells (lacking all V-ATPase function) and an isogenic wild type were diluted to 0.5 A600/ml
in YEPD medium, pH 5.0, and serial dilutions (1:3) were stamped on YEPD plates adjusted to pH 5.0 and 7.5 and incubated at 30 and 37 °C. B, alexidine
dihydrochloride and thonzonium bromide prevent growth. Overnight yeast cell cultures were diluted to 0.5 A600/ml in YEPD medium, pH 5.0. Cells were rotated
at 30 °C for 1 h with the drugs at the indicated concentrations containing 1% DMSO. Controls included cells resuspended in 1% DMSO alone or an equal volume
of YEPD, pH 5.0 (None). Serial dilutions (1:3) were stamped on YEPD, pH 5.0 and pH 7.5, plates and incubated at 30 and 37 °C. Cell growth was monitored for 48 h.
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homeostasis, alexidine dihydrochloride and thonzonium bromide should deplete the energy reserves of the cell, because
uncoupled V-ATPase pumps will hydrolyze cytosolic ATP continuously. In a global sense, V-ATPase uncouplers hinder mul-

tiple cellular processes and constitute a quick acting way to
block vital functions.
As anticipated, yeast was more sensitive to treatment with
the uncouplers in vivo than in vitro. Treatment with alexidine
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dihydrochloride and thonzonium bromide was cytotoxic at
concentrations (50 !M) that inhibited proton transport by only
40% in vitro (Figs. 3A and 5B). Yeast cells treated with a lower

concentration of the drugs (10 !M) developed a vma growth
phenotype, despite the fact that proton transport was barely
inhibited (by 20 –25%) in vitro. Therefore, a fine threshold (20 –

FIGURE 6. The tether of subunit a (Vph1p) is crucial for functional uncoupling by thonzonium bromide. A, tether-less V1V0 complexes are coupled
functionally. Left, vacuolar membrane vesicles were purified from vph1!stv1! cells transformed with either wild-type VPH1 or VMA6 plus mutant (Vph1p-362–
407!). Protein separated by SDS-PAGE (5 !g of total vacuolar protein) was analyzed by Western blot using antibodies against V0 subunit a and V1 subunits A
and B. Concanamycin A-sensitive ATPase activity (10 !g of total protein) was measured as described in the legend for Fig. 3C. Right, proton transport was
measured as described in the legend for Fig. 3A. B, tether-less V1V0 complexes are resistant to thonzonium bromide-induced uncoupling. Wild-type (Vph1p-WT)
and tether-less mutant (vph1p-362– 407!) vacuolar membranes were treated with 100 !M thonzonium bromide or alexidine dihydrochloride, and ATP
hydrolysis and proton transport were measured as described in the legend for Fig. 3, A and C. **, p " 0.01 compared with Vph1p-WT treated with thonzonium
bromide, as measured by two-tailed paired Student’s t test. C, tether-less V1V0 yeast mutants show growth resistance to thonzonium bromide and alexidine
dihydrochloride. Wild-type and tether-less mutant cells were grown overnight to 0.5 A600/ml in SC-Ura medium, pH 5.0, treated with the indicated concentrations of drugs as described in the legend for Fig. 5, and plated on YEPD, pH 7.5 (1:3-fold serial dilutions). Plates were incubated at 37 °C for 72 h.
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FIGURE 7. Alexidine dihydrocloride and thonzonium bromide uncouple C. albicans V-ATPase pumps and prevent growth. A, C. albicans ATP-dependent
proton transport is inhibited by the uncouplers. Fluorescence quenching of ACMA was measured as described in Fig. 3A, except that 30 !g of vacuolar membrane
protein was used for each treatment. B, ATPase activity is resistant to the uncouplers. ATP hydrolysis was measured as described in the legend for Fig. 3C, except that
20 !g of purified vacuolar membrane protein was used for each treatment. In both A and B, the indicated concentrations of drugs were present in 1% DMSO. Data are
expressed as the average # S.D. for n $ 3–5 independent vacuolar purifications. The specific activity of the concanamycin A-sensitive ATPase activity of the vacuoles
was 0.2– 0.4 !mol of ATP/min/mg of protein. *, p " 0.05; **, p " 0.01; ***, p " 0.001; and ****, p " 0.0001 by two-tailed paired Student’s t test. C, uncouplers reduced
the growth of C. albicans. Cultures of C. albicans were grown overnight and treated as described in the legend for Fig. 5B.
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tional coupling of the enzyme. Our results indicate instead that
the intact tether facilitates uncoupling. Amino acid residues
362– 407 of the tether conferred uncoupling potential to VATPases, as their truncation made the enzyme resistant to
treatment with thonzonium bromide. In the presence of thonzonium bromide, the coupling efficiency (the ratio of relative
proton transport to relative ATPase activity) of tether-less
V1V0 was greater than that of the wild-type enzyme (Fig. 6B).
In line with the idea that the tether of Vph1p confers sensitivity to thonzonium bromide, wild-type strains SF838-1D"
(Fig. 5B) and Vph1p-WT (Fig. 6C), which express Vph1p,
showed similar sensitivity to thonzonium bromide. Both strains
had reduced growth at pH 7.5 and 37 °C (vma phenotype) after
exposure to 10 !M thonzonium bromide. The additional finding that only SF838-1D" developed the vma growth phenotype
when the cells were challenged with alexidine dihydrochloride
further supports this notion. The major difference between
these two strains is that SF838-1D" expresses both isoforms of
subunit a (the vacuolar isoform, Vph1p, and the Golgi isoform,
Stv1p), whereas Vph1p-WT expresses only Vph1p. Thus, if
alexidine dihydrochloride additively uncoupled Stv1p- and
Vph1p-containing V-ATPases, the absence of Stv1p could
explain Vph1p-WT growth resistance.
The presence of a structural element that gives uncoupling
potential to V-ATPase complexes is consistent with the
hypothesis that wild-type V-ATPase pumps may not be coupled optimally (27, 28) and that the tightness of coupling may be
adjusted in vivo to modulate organelle acidification (2, 28). The
tightness of coupling of proton transport and ATPase activity
has been shown to be modulated by ATP concentrations (27)
and by the nonhomologous region of V1 subunit A (25). The
mutation P217V in the nonhomologous region of subunit A
generates more tightly coupled complexes because it stimulates
proton transport and reduces ATPase activity. As the nonhomologous region of the V1 subunit A interacts with V0 subunit
a (25), such tightness of coupling could be explained if structural changes are transmitted from subunit A to the tether of
subunit a.
Other uncoupling elements may exist in addition to the
tether of the V0 subunit a. Our results indicate that alexidine
dihydrochloride uncouples the enzyme by a mechanism unique
from thonzonium bromide, despite their similar EC50. Alexidine dihydrochloride is an amphipathic bisbiguanide that binds
to lipopolysaccharides (49) and is used as an antibacterial agent
(50), whereas thonzonium bromide is a monocationic detergent surface-active agent. Although both may have adverse
effects on lipid domains (51), and we cannot eliminate the possibility that they could affect V-ATPase function by altering V0
interactions with membrane lipids, our results indicate that
thonzonium bromide and alexidine dihydrochloride selectively
inhibited V-ATPase proton transport in vitro. Arguing against
unspecific effects are the fact that ATP hydrolysis was kept
intact even at high concentrations of the drugs (100 !M); that
uncoupling by thonzonium bromide and alexidine dihydrochloride was demonstrated in two different sources of vacuolar
membranes (S. cerevisiae and C. albicans); that uncoupling by
thonzonium bromide and alexidine dihydrochloride differed
from uncoupling by ionophores such as nigericin; and that
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40% uncoupling) delineates conditional growth (vma phenotype) and cell death following uncoupling of the proton transport and ATPase activity by alexidine dihydrochloride and
thonzonium bromide.
Yeast V-ATPase mutants develop the vma phenotype when
V-ATPase function (proton transport and ATP hydrolysis) is
impaired by about 75% (23, 37). Yet, a more modest loss of
proton transport (by about 60%) leads to vma growth phenotype if the pump is uncoupled (44). The fact that yeast died after
40% proton transport inhibition by the uncouplers (Figs. 3 and
5) indicates that the cells are more susceptible to pharmacological (acute) than genetic (chronic) V-ATPase uncoupling. Perhaps, V-ATPase mutants can develop compensatory ATP conservation mechanisms that will allow yeast to survive in the face
of uncoupling. In addition, alexidine dihydrochloride and thonzonium bromide at concentrations greater than 50 !M could
have additional targets and effects unrelated to V-ATPase that
could also contribute to cytotoxicity.
Nonetheless, the vma growth phenotype as defined by significantly slow growth (thonzonium bromide) or no growth (alexidine dihydrochloride) at pH 7.5 showed selectivity of the drugs
for V-ATPase (Fig. 5B). The vma phenotype is the hallmark
trait of yeast cells with impaired V-ATPase function (8, 43) and
is a legitimate indicator of V-ATPase defects in yeast. In line
with this notion, we found that 1 !M alexidine dihydrochloride
or thonzonium bromide does not inhibit the pumps or affect
cell growth at pH 7.5. Additionally, benzbromarone (100 !M),
which does not inhibit V-ATPase pumps (Fig. 3, A and Fig. C),
does not inhibit cell growth at pH 7.5 (data not shown), despite
acidifying the cytosol (Fig. 2B). Thus, cytosolic acidification
alone is not enough to develop vma mutant growth phenotype;
V-ATPase function also must be impaired.
Uncoupling Roles of the Cytosolic Tether Connecting Vph1p to
the Membrane—V0 subunit a structurally bridges the V0 and V1
domains of the V-ATPase complex. Subunit a interacts with V1
subunits E, G, C, H, and A at its N terminus (cytosolic domain)
and the proteolipid ring at its C terminus (integral membrane
domain) (45– 48). Its unique topography makes subunit a an
attractive candidate for the coupling of proton transport in V0
and ATP hydrolysis in V1. Subunit a is the only stator subunit
anchored in the membrane. By holding the three peripheral
stators (EG dimers) at its cytosolic domain, subunit a secures
the steady catalytic sites in the A3B3 hexamer while transferring
protons through its membrane domain. Providing evidence
that the V1V0 association facilitated by subunit a is necessary
for coupling of the enzyme, separation of the N terminus from
the C terminus of Vph1 by cleavage at residue 376 of the tether
partially uncouples V-ATPases (26). Cleavage reduces proton
transport by 2-fold without affecting ATPase activity. We
showed in an earlier study that the tether of the subunit a
Vph1p is a flexible element and that Vph1p tether-less mutant
V1V0 complexes are functional, as they retain concanamycin
A-sensitive ATP hydrolytic activity and disassemble and reassemble normally (35).
Here we show that tether-less V1V0 completely retained
wild-type levels of proton transport activity. Wild-type levels of
both proton transport and ATPase activity in tether-less V1V0
indicate that the length of the tether is not essential for func-
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vph1–362-407! mutants showed selective resistance to uncoupling by thonzonium bromide only.
V-ATPase Uncouplers as Potential Anti-V-ATPase Drugs—
Alexidine dihydrochloride and thonzonium bromide effectively inhibit V-ATPase proton transport in vacuolar membranes from C. albicans (Fig. 7). Although uncoupling in vitro is
very similar between C. albicans and S. cerevisiae, C. albicans
does not develop the vma growth phenotype. In vivo, the
uncouplers significantly reduce cell growth at 10 !M and are
cytotoxic at greater concentrations. This may be because complete inactivation of V-ATPase activity appears to be necessary
for development of the vma phenotype in C. albicans (52), as
cells expressing genetic mutations that partially inactivate
V-ATPase function do not develop pH-sensitive growth.7 Our
results indicate that V-ATPase uncoupling must be lethal,
because deletions of V-ATPase subunits that prevent enzyme
function leading to the vma growth phenotype do not cause
general cytotoxicity in C. albicans (52).
Fungi need vacuolar and trafficking functions to infect their
hosts, and genetic inactivation of V-ATPase prevents virulence
of C. albicans and other pathogenic fungi (52–54). We have
provided evidence that V-ATPase uncoupling would be a
highly effective mechanism to control virulence, because in
addition to preventing proton transport, uncouplers are
expected to deplete the energy reserve of the cell. Although
V-ATPase inhibitors that have therapeutic applications have
yet to be identified, the Prestwick Chemical Library is a useful
resource for drug repurposing, as most of the compounds have
known safety and toxicity profiles. In fact, cytotoxicity by alexidine dihydrochloride has been shown previously in Cryptococcus neoformans, C. albicans, and Paracoccidioides brasiliensis
(55, 56). Together, those studies and our current findings make
alexidine dihydrochloride and thonzonium bromide attractive
candidates to evaluate for repurposing as potential antifungal
therapeutic drugs. Further studies will specifically assess the
anti-virulence mechanisms behind these drugs and the efficacy
of combining these uncouplers with other antifungal therapeutics such as azoles, which also alter V-ATPase activity (57).
In conclusion, alexidine dihydrochloride and thonzonium
bromide disengaged proton transport and ATPase activity, and
to our knowledge, they are the only uncouplers of V-ATPase
proton pumps described. This study revealed new information
regarding the mechanisms of V-ATPase coupling, a region
within V0 subunit a (the tether) that confers “uncoupling
potential” to V-ATPase pumps, supporting the hypothesis that
wild-type V-ATPase complexes may not be optimally coupled
in vivo (27, 28). Uncouplers of V-ATPase pumps may offer new
knowledge to the understanding of the mechanisms governing
rotational catalysis and V-ATPase regulation, and they may be
useful as potential therapeutic drugs. Because alexidine dihydrochloride and thonzonium bromide uncouple C. albicans
V-ATPase, additionally they can help to elucidate the cellular
processes pertaining to fungal infection and virulence in pathogens like C. albicans, the single most important cause of opportunistic mycoses worldwide for which available treatment
methods remain suboptimal (58).
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V

acuolar H!-ATPases (V-ATPases) are ATP-driven proton
pumps distributed throughout the endomembrane system of
all eukaryotic cells (1, 2). V-ATPase proton transport acidifies
organelles and energizes secondary transport systems. Zymogen
activation, protein processing and trafficking, and receptor-mediated endocytosis are fundamental cellular processes that require
V-ATPase activity. Cells specialized for active proton secretion
express also V-ATPases at the plasma membrane. Proton transport by plasma membrane V-ATPases in osteoclasts, epididymal
clear cells, and renal intercalated cells is necessary for bone resorption, sperm maturation, and maintenance of the systemic acidbase balance, respectively (3, 4). V-ATPase has been implicated in
several pathological states, including osteopetrosis, distal renal tubular acidosis, male infertility, and cancers (2). Not surprisingly,
studies of V-ATPase function and regulation are increasing, as is
our knowledge of these dynamic proteins.
V-ATPase structure and function are highly conserved and
well characterized in Saccharomyces cerevisiae (referred to here as
yeast). Lack of V-ATPase function leads to a conditionally lethal
phenotype that is characterized by pH sensitivity in yeast; complete lack of V-ATPase function is lethal in higher eukaryotes (5).
Recent atomic- and pseudo-atomic-resolution structures of VATPase and its subunits have helped shed light on the molecular
dynamics that regulate V-ATPase function (6, 7). V-ATPases are
large multisubunit complexes structurally organized into two major domains, V1 and Vo (Fig. 1). Eight peripheral subunits (A to H)
form the V1 domain, where ATP hydrolysis takes place. Six subunits (a, c, c=, c", d, and e) comprise Vo, the membrane intrinsic
domain that forms the path for proton transport. An important
mechanism by which cells control organelle acidification is by
disassembling and reassembling the V-ATPase complex (1, 2, 8,
9). Disassembly rapidly inactivates the pumps, resulting in three
constituents: V1 subunit C, V1 (without subunit C), and Vo (Fig.
2). Disassembly is reversible, and reassociation of the three components rapidly restores ATP hydrolysis and proton transport
across membranes. Catalytic inactivation and reactivation entail
conformational changes in V1 subunit H (Fig. 2) (12, 13). This
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subunit is necessary to silence cytosolic V1 and activate V1Vo complexes (11, 15).
Yeast V-ATPase inactivation by disassembly is a response to
glucose deficit (10). V1Vo disassembly prevents energy depletion
(e.g., loss of ATP). Reassembly is a response to glucose readdition
following a brief period of glucose deprivation; it rapidly restores
vacuolar acidification. Because Vo is not an open proton pore and
cytosolic V1 cannot hydrolyze MgATP (7, 11–14), protons do not
leak across membranes and cellular ATP is not depleted. Thus,
disassembly can be sustained for a long time. Long-term disassembly is also rapidly reversed by addition of glucose (8), indicating
that the structural and functional integrity of the V1 and Vo domains is preserved in the midst of scarcity.
All eukaryotic V-ATPases may be built with the potential to
reversibly disassemble. However, not all V-ATPases appear to
disassemble and reassemble. V-ATPase subunit isoforms and
V-ATPase interactions with an assembly factor (RAVE; discussed below) in the cytosol and phosphoinositides at the
membrane can dictate which pumps reversibly disassemble in
response to environmental cues (16, 17). Recent studies have
begun to elucidate the mechanisms that allow cells to communicate extracellular signals to intracellular V-ATPases located
at the vacuolar membrane. In yeast, V-ATPase assembly is regulated by glucose, pH, and osmotic stress, and it is intertwined
with glycolysis, RAS/cyclic AMP (cAMP)/protein kinase A
(PKA), and phosphatidylinositol-(3,5)-bisphosphate [PI(3,5)
P2] (16, 18–21). In insects, starvation and hormone stimulation influence V1Vo assembly by mechanisms involving cAMP/
PKA signaling (9, 22, 23). In higher eukaryotes, glucose (renal
epithelial cells) and mechanical stimulation (dendritic cells)
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Vacuolar H!-ATPases (V-ATPases) are highly conserved ATP-driven proton pumps responsible for acidification of intracellular
compartments. V-ATPase proton transport energizes secondary transport systems and is essential for lysosomal/vacuolar and
endosomal functions. These dynamic molecular motors are composed of multiple subunits regulated in part by reversible disassembly, which reversibly inactivates them. Reversible disassembly is intertwined with glycolysis, the RAS/cyclic AMP (cAMP)/
protein kinase A (PKA) pathway, and phosphoinositides, but the mechanisms involved are elusive. The atomic- and pseudoatomic-resolution structures of the V-ATPases are shedding light on the molecular dynamics that regulate V-ATPase assembly.
Although all eukaryotic V-ATPases may be built with an inherent capacity to reversibly disassemble, not all do so. V-ATPase
subunit isoforms and their interactions with membrane lipids and a V-ATPase-exclusive chaperone influence V-ATPase assembly. This minireview reports on the mechanisms governing reversible disassembly in the yeast Saccharomyces cerevisiae, keeping
in perspective our present understanding of the V-ATPase architecture and its alignment with the cellular processes and signals
involved.

Minireview

have been shown to modulate V-ATPase assembly by a process
that requires PIP 3-kinase and mTOR activation (24–27).
This review reports on the mechanisms of reversible disassembly in yeast, particularly in regard to our present understanding of
the V-ATPase architecture. Next, we summarize recent structural
discoveries on the yeast V-ATPase, their interrelation with VATPase regulation by reversible disassembly, and our current understanding of the mechanisms and signals involved.
ARCHITECTURE OF EUKARYOTIC V-ATPase

ATPase rotary motors include F-ATP synthase, archaeal A-type
ATP synthase, bacterial A/V-like ATPase, and eukaryotic
V-ATPase (28). V-ATPase and other members in this family share
common structural features essential for the mechanical rotation
of protein subunits during ATP catalysis. They all have (i) a protuberant globular domain peripherally attached to the membrane

that houses three catalytic sites, (ii) a membrane domain that
forms the path for ion transport, (iii) a centrally located rotor that
couples ATP hydrolysis and ion transport across membranes, and
(iv) one or more peripheral stalks that connect the peripheral and
membrane domains.
Rotationofrotor-formingsubunitsrelativetothesteadycatalyticsites
is driven by hydrolysis of ATP inside the globular structure of V1 (A3B3)
(Fig. 1). ATP hydrolysis promotes rotation of the rotor’s shaft (subunits
D, F, and d) at the center of the A3B3 hexamer. The shaft is connected to
a hydrophobic proteolipid ring inside the membrane (c-ring), which
consists of subunits c, c=, and c! and transfers the protons. Active transport requires entrance of cytosolic protons to the Vo subunit a in order to
reach the c-ring. The protons bind to an acidic residue in the c-ring, and
after a 360° rotation, protons exit the other side of the membrane, traveling through Vo subunit a. This general mechanism of rotational catalysis is shared with all rotary ATPases (28).
ec.asm.org 707
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FIG 1 The V-ATPase complex: subunit composition and organization. V-ATPase is composed of 14 different subunits, organized into two major
domains: V1 is the catalytic ATPase domain and Vo is the proton translocation domain. Active transport of protons across the membrane entails rotation
of a rotor (subunits F, D, d, c, c=, and c!) that is driven by ATP hydrolysis in V1 (subunits A). Three elongated peripheral stalks (subunits EG) connect the
V1 and Vo domains and allow relative rotation of subunits during catalysis, by working as stators. Three stators are necessary for regulation of V-ATPase
by disassembly and reassembly. Shown are mutations in the peripheral stalk subunits E (G44A) and G (R25A/L) and the catalytic subunit A at its
nonhomologous domain (P177V and R219A/K). These mutations simultaneously alter V1Vo disassembly and catalysis, suggesting that disassembly
requires wild-type catalytic activity (rotation). The mutation D157E in subunit A, which also prevents V1Vo disassembly, does not affect catalysis; it is
proposed that D157E acts by stabilizing subunit-subunit interactions.

Minireview

subunit C separate. Disassembly is reversible, and reassembly of the three components restores ATP hydrolysis and proton transport. Yeast cells adjust the
number of assembled V-ATPases in response to environmental stressors, including changes in glucose, pH, and salts. These extracellular cues are communicated
to V-ATPases by several signals and unknown mechanisms that require an assembly factor (RAVE) and are intertwined with glycolysis and glycolytic enzymes,
RAS/cAMP/PKA components, cytosolic pH (pHCyt) homeostasis, and PI(3,5)P2.

Eukaryotic V-ATPases distinguish themselves from other rotary ATPases in three ways. First, V-ATPases are dedicated proton
pumps. Second, V-ATPases are regulated by reversible disassembly. Third, V-ATPases contain three peripheral stalks. In contrast,
the A and bacterial A/V-ATPases have two peripheral stalks and
F-ATPases have one (28). The V-ATPase peripheral stalks are
made of a heterodimer of E and G subunits; reversible disassembly
requires the third peripheral stalk (EG3) (Fig. 3) (6, 29). It also
requires a soluble subunit that is absent in other rotary ATPases
(subunit C). The yeast subunit C contains two globular domains,
the head (Chead) and foot (Cfoot) (30). The Chead domain interacts
with EG3 with high affinity (6, 31). Through its Cfoot domain,
subunit C interacts with the second peripheral stalk (EG2) and the
N terminus of the Vo subunit a (a-NT). These subunit interactions
708

are broken and reformed when V-ATPases disassemble and reassemble.
Subunit C is released to the cytosol during disassembly (8).
Reassembly requires the subunit C to be rapidly reincorporated
into the complex and its interactions with EG3, EG2, and a-NT to
be restored. Reintroduction of subunit C into V1Vo requires significant bending of the third peripheral stalk (6, 29). This compression imposes physical stress in its coiled-coil structure, like
“spring-loading.” The EG3 tension, which persists within assembled V1Vo complexes, is released when V1Vo disassembles. Thus, it
is proposed that spring-loading requires energy for reassembly
and primes V-ATPases to easily disassemble after glucose depletion, when ATP must be preserved.
These new structural discoveries hopefully will lead to a better
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FIG 2 Reversible disassembly of V-ATPase: extracellular stimuli and intracellular signals. V-ATPase disassembly breaks the complex apart, as V1, Vo, and the V1

Minireview

understanding of how glucose and other cellular signals regulate
V-ATPase function and assembly. The spring-loading mechanism
of reversible disassembly is compatible with our current understanding of the structural architecture of the eukaryotic V-ATPase
complex. It is also consistent with our knowledge of the major
cellular processes associated with V1Vo disassembly and reassembly. Below, we discuss our view of the alignment of the V-ATPase
architecture with these cellular processes and signals.
CONNECTING GLUCOSE METABOLISM TO V-ATPase
ASSEMBLY

The concept of spring-loading requires energy to bend EG3 and
reestablish proper binding of subunit C in V1Vo (6). Glucose, the
primary energy source for most organisms, is an important driver
of reassembly, suggesting that glucose oxidation could provide the
necessary chemical energy (e.g., ATP). In addition to glucose, reassembly of V1Vo can be triggered by fructose and mannose, other
rapidly fermentable sugars, suggesting that glycolysis itself may be
necessary for V1Vo reassembly and spring-loading of EG3 (19).
Further evidence that glucose metabolism is involved includes the
facts that (i) conversion of glucose-6-phosphate to fructose-6
phosphate is necessary for reassembly and (ii) the intracellular
pool of assembled V1Vo complexes is proportional to the concentration of glucose in the growth medium, demonstrating that
V1Vo reassembly is not an all-or-none response (19).
The glycolytic enzymes aldolase (21), phosphofructokinase-1
(32), and glyceraldehyde-3-phosphate dehydrogenase (33) interact with V-ATPase. These enzymes coimmunoprecipitate with VATPases and can be detected in yeast vacuolar membrane fractions. Aldolase binding to V-ATPase is glucose dependent and
necessary for stable V1Vo complex formation (21, 34). Lu et al.
(21) were able to differentiate the function of aldolase in glycolysis
from its function for V-ATPase assembly. The authors showed
reduced V1Vo complex formation in an aldolase mutant that retained catalytic activity in vitro. These studies suggest that aldolase
may play a direct role in V1Vo reassembly. Whether the same holds
true for other glycolytic enzymes is not known. Glycolytic mutants
cannot efficiently utilize glucose, which suppresses glycolysis and
glucose-dependent signals, altering V1Vo assembly. This makes it
challenging to study the interplay of V-ATPase with other glycolytic enzymes. Nonetheless, these studies merit additional examination because phosphofructokinase-1 can directly bind yeast and

human V-ATPase subunits (24), suggesting that several aspects of
this mechanism are conserved.
The interrelation between V-ATPase and glycolysis cannot be
overlooked; it is conserved in yeast (1, 19, 35, 36), plants (37), and
mammals (38, 39). Moreover, V-ATPase mutations that impair
binding to phosphofructokinase-1 are associated with distal renal
tubular acidosis (24), and V-ATPase regulation by glycolysis plays
a role in viral infections (40) and the metabolic switch in cancers
(41, 42). It has been proposed that glycolytic enzymes form a
supercomplex with V-ATPase that funnels ATP directly to VATPase and propels proton transport (21, 24, 32, 34, 37, 43). A
similar molecular machinery has been described at synaptic vesicle membranes where ATP synthesized by phosphoglycerate kinase supports glutamate uptake (44); this process is energized by
V-ATPase proton pumps. A model of this kind will require glycolytic ATP production at the yeast vacuolar membrane, but functional interactions of phosphoglycerate kinase or pyruvate kinase
(glycolytic enzymes that produce ATP) with V-ATPase have yet to
be demonstrated. However, it is clear that ATP levels modulate
V-ATPase coupling efficiency in vitro (45). ATP-dependent modifications of V-ATPase proton transport in vivo will probably need
to work tightly coupled with glycolysis, the main source of ATP;
glycolytic enzymes at the membrane could produce the ATP that
fine-tunes the number of protons transported per ATP hydrolyzed. Collectively, these data suggest that V-ATPase reassembly
and/or V-ATPase activity can be controlled by interactions with
glycolytic enzymes and the ATP that they produce.
ONE “RAVE” PATH TOWARD V1Vo REASSEMBLY

The regulator of ATPase of vacuoles and endosomes (RAVE)
complex is a V-ATPase-exclusive assembly factor. It is required
for V1Vo assembly at steady state (biosynthetic assembly) and reassembly in response to glucose readdition to glucose-deprived
cells (46–48). The RAVE complex chaperones loading of subunit
C into V1Vo, a job that requires aligning Chead with the EG3 and
EG2 peripheral stalks in addition to introducing structural stress
in EG3 (Fig. 3) (6). In the absence of RAVE, V-ATPases at the
vacuolar membrane are unstable and inactive, with V1 and subunit C loosely associated (48). Importantly, although several assembly factors are required for V-ATPase assembly (49–54), only
RAVE appears to be involved in V-ATPase reversible disassembly.
The RAVE complex has three components, the adaptor protein
ec.asm.org 709
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FIG 3 Spring-loading: a model for disassembly and reassembly. The V1 domain and subunit C detach from Vo at the membrane and are released into the cytosol
during disassembly. Reassembly requires reassociation of subunit C with the peripheral stalks EG3 and EG2 and the N terminus domain of the Vo subunit a
(a-NT). Restoration of the native complex probably requires bending of EG3, like spring-loading, which is accomplished with the assistance of the chaperone
complex RAVE. The tension contained in EG3 within the assembled V1Vo complex, is then released when V1Vo disassembles.

Minireview
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IS ATP HYDROLYSIS NECESSARY FOR V-ATPase
DISASSEMBLY AND REASSEMBLY?

How energy can be used to reassemble V1Vo is virtually unknown.
ATP facilitates in vitro reconstitution of V1 and Vo (73–75), suggesting that ATP could promote reassembly in vivo. Genetic
screens aimed at identifying V-ATPase mutants defective in V1Vo
reassembly are challenging because V1Vo disassembly is not absolute. There is a cellular fraction of V-ATPase complexes that does
not disassemble in response to glucose depletion; it probably
yields basal V-ATPase activity necessary to support critical cellular
functions (1, 10). These pumps constitute about 30% of the total
V1Vo and likely include V-ATPases at nonvacuolar membranes
(Stv1p-containing V-ATPase pumps) (19, 60). Coincidentally, 25
to 30% of V-ATPase activity is sufficient to support wild-type
growth, which makes the growth phenotype of these types of mutants very subtle. A few mutants, primarily disassembly mutants,
have been identified by site-directed mutagenesis experiments.
Intriguingly, many of those mutations also alter V-ATPase catalysis. Those studies suggest that peripheral stalks may regulate rotational catalysis by influencing ATP binding, chemical reaction,
or release of ADP/Pi (76–78).
As expected, site-directed mutations at conserved amino acids
of the peripheral stalk subunits E and G can suppress glucosedependent disassembly (Fig. 1) (76, 79). The mutations vma4D44A and vma10-R25A/L in subunits E and G, respectively, suppress disassembly; they also stimulate the enzyme activity (76, 79).
The vma4-T202A mutation near the C terminus enhances Vmax by
about 2-fold without significantly affecting the Km of the enzyme
(77), resembling the mutant vma4-D44A (76). Although the ability of vma4-T202A to reversibly disassemble has not been determined, these studies indicate that the peripheral stalks can communicate with the catalytic sites inside the A3B3 hexamer and they
can affect disassembly and catalysis.
Paradoxically, the rate of ATP hydrolysis by V-ATPase can
alter V1Vo disassembly (Fig. 1). Pharmacologic inhibition of VATPase pumps with the V-ATPase inhibitor concanamycin A reduces V1Vo disassembly, without affecting reassembly (19). Inactive V-ATPases carrying mutations at a Vo proton-binding
subunit (vma11-E145L) of the c-ring (19) or the V1 catalytic subunit A (vma1-R219K) (78) are defective for disassembly. Likewise,
vma1-P177V and vma1-R219A, which are partially inactive (by
30% to 50%), also are defective in disassembly. Thus, it appears
that wild-type levels of activity are necessary to disassemble V1Vo;
hyperactive, hypoactive, and inactive pumps cannot sufficiently
disassemble (19, 45, 76). Obviously, not all disassembly mutants
are catalytically impaired. The mutations vma1-G150 and vma1D157E inhibit disassembly without affecting V-ATPase activity
(78), perhaps by stabilizing subunit interactions.
From these studies, it becomes clear how little we still know
about the intramolecular mechanisms that drive disassembly and
reassembly. Although additional studies will be necessary to determine how intrinsic subunit interactions and differential conformations impact disassembly and reassembly, it appears that
V-ATPases adopt conformations prone for disassembly during a
catalytic cycle of rotation driven by ATP hydrolysis (19). Still, we
cannot exclude the possibility that catalysis may also drive reassembly. In this context, ATP-driven subunit rotation in V1 may
stimulate its own reassembly in the presence of RAVE. This process will require the inhibitory subunit of V1 (subunit H) to be
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Skp1p and its two subunits, Rav1p and Rav2p (46). Skp1p associates with other cellular complexes. Rav1p and Rav2p are solely
found in the RAVE complex. Of the two subunits, Rav1p constitutes the central component; it binds Rav2p and Skp1p (47).
Rav1p also forms the interface between RAVE and V-ATPase subunits. In the cytosol, Rav1p binds V-ATPase subunit C and the V1
peripheral stalk-forming subunits EG (48). At the membrane,
Rav1p interacts with the N-terminal domain of Vo subunit a (17).
Genetic and biochemical data have shown that binding of Rav1p
to subunit C can occur independently of its binding to V1. Preloading RAVE with subunit C and V1 simultaneously in the cytosol may expedite reassembly, which is known to be a fast response
completed within 3 to 5 min of glucose readdition (19, 55). Importantly, formation of RAVE-C and RAVE-V1 subcomplexes in
the cytosol is not glucose dependent, indicating that RAVE binding is not the signal for V1Vo reassembly.
Deletion of the genes RAV1 and RAV2 leads to growth defects
characteristic of V-ATPase mutants (46, 47); the vacuolar membrane ATPase (vma) growth phenotype displays growth sensitivity at pH 7.5 and in the presence of calcium (1). The rav1! and
rav2! mutant cells also exhibit temperature sensitivity, but the
vma traits are detected at 37°C. This phenotype is more substantial
in rav1! than rav2! cells (46, 47), likely because Rav1p constitutes
the functional subunit of the RAVE complex. The rav1! mutant
has major V-ATPase assembly and functional defects in vivo, although its vma growth phenotype is fairly mild and considered
“partial.”
The rav1! mutant resembles the yeast mutant strain vph1!,
which lacks the isoform Vph1p of the Vo subunit a (56). The Vo
subunit a is the only yeast V-ATPase subunit encoded by two
functional homologs, VPH1 and STV1 (56, 57); VPH1 encodes the
vacuolar isoform and STV1 has sorting information for the Golgi/
endosomal compartments (58). Genome-level synthetic genetic
analyses (17) showed that a synthetic vma growth phenotype can
be generated after combining the rav1! mutation with class E
mutants of endosomal and vacuolar transport (59), suggesting
that the physiological basis for the rav1! partial vma phenotype is
that RAVE is a Vph1p-specific chaperone. The discovery that
RAVE assists in the assembly of Vph1p-containing V-ATPases but
that Stv1p-containing complexes do not need RAVE to properly
assemble is in agreement with prior studies showing that Vph1pcontaining V-ATPases are more responsive to glucose than are
Stv1p-containing pumps (60). Since Vph1p targets V-ATPase to
the vacuole and Stv1p to the Golgi and endosomal compartments,
these results also suggest that only vacuole-associated pumps reversibly disassemble.
The functions of the RAVE complex are likely conserved in
other eukaryotes. The Rav1p sequence homologs, rabconnectins,
are necessary for acidification of endosomes and synaptic vesicles
(61–63). The human Vo subunit a exists in four different isoforms;
mutations in particular isoforms cause osteopetrosis and renal
tubular acidosis (64). Identifying the Vo subunit a isoform(s) recognized by rabconnectins could help in understanding these and
other pathologies associated with V-ATPases. The RAVE subunit
Rav2p is found only in fungi and does not have human homologs.
Therefore, Rav2p offers unique opportunities to selectively disrupt RAVE complex functions in fungal human pathogens for
which V-ATPase pumps are desirable targets (65–72).

Minireview

feedback loops control glucose-dependent yeast V-ATPase assembly by promoting cytosol pH alkalinization and protein kinase A (PKA) activation. Glucose
readdition after glucose depletion activates PKA and alkalinizes the cytosol, which promotes V-ATPase reassembly. More assembled V-ATPase helps maintain
alkalinized cytosol pH. The reassembled V-ATPase may activate PKA signaling, which enhances V-ATPase assembly, upregulates glycolysis, and mediates the
rapid transition from respiratory to fermentative growth. Arrows and bars represent positive and negative interactions, respectively. Dashed lines represent
putative or indirect interactions.

released from its rotor-locking inhibitory position during reassembly (Fig. 3) (7, 11, 12, 80).
YEAST V-ATPase: AT THE CROSSROADS OF MULTIPLE
INTRACELLULAR SIGNALS

In support of the spring-loading hypothesis, there are no known
chaperones that aid in V-ATPase disassembly; V-ATPase may be
primed to disassemble (29). In addition to glucose depletion, exposure to less preferred carbon sources (galactose, glycerol/ethanol, and raffinose) causes disassembly (8, 19). These data further
argue that little or no glucose is the driving signal of disassembly.
There is evidence indicating that the Ras/cAMP/PKA pathway
probably mediates reversible disassembly (18, 20). Ras/cAMP/
PKA signaling controls metabolism in response to sudden availability of rapidly fermentable sugars (81), compatible with a role
for Ras/cAMP/PKA during V1Vo reassembly (Fig. 2). Constitutively active Ras and PKA suppress disassembly by glucose depletion (18). These studies suggest that the Ras/cAMP/PKA pathway
acts upstream of V-ATPase. In an independent study linking VATPase reassembly to cAMP and PKA, reassembly appeared to
be an upstream activator of PKA (20). That study suggested
that alkalization of the cytosol after glucose readdition is the
signal for reassembly. Although these results seem contradictory, the possibility that a positive feedback mechanism may
regulate V-ATPase assembly cannot be excluded (Fig. 4). The
reassembled V-ATPase may activate PKA signaling, which in
turn enhances the V-ATPase assembly.
Cytosolic pH is emerging as a key regulator for various cellular
functions (82), and V-ATPase affects cytosolic pH homeostasis

(83). In addition to activating V-ATPase catalysis and proton
transport, readdition of glucose activates the plasma membrane
ATPase, Pma1p, which is the main efflux pump responsible for
yeast cytosolic pH regulation (83, 84). V-ATPases are necessary
for cytosolic pH homeostasis because (i) active V-ATPases are
necessary for normal Pma1p levels to be present at the plasma
membrane, and (ii) cytosolic pH homeostasis is maintained by the
coordinated action of V-ATPase and Pma1p (83). In the evaluation of the signals for reassembly, the contribution of cytosolic pH
merits additional investigation. Addressing whether glucose-dependent Pma1p activation precedes glucose-dependent V-ATPase activation may help clarify the role of cytosolic pH for reassembly.
Fungi grow more rapidly at acidic than neutral pH (85). It
should come as no surprise that V1Vo disassembly in response to
glucose depletion is affected by environmental stress signals, such
as elevated pH (86). At pH 7.0, V-ATPase disassembly is significantly suppressed compared to disassembly at pH 5.0, the optimal
pH for yeast growth. Although the mechanisms involved in the
prevention of disassembly by pH remain elusive, adaptation to
high pH appears to have both PI(3,5)P2-dependent and -independent components (16). Knowing whether glucose and pH use
common mechanisms to regulate V1Vo disassembly requires additional studies. Notably, it may help in the understanding of fungal pathogenicity; Candida albicans adaptation to neutral-to-alkaline pH environments in the host stimulates cellular signals that
trigger its morphological change from the yeast form (nonpathogenic) to the hyphal form (pathogenic) (65, 68, 72, 87).
V-ATPase function is necessary for adaptation to stress condiec.asm.org 711
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FIG 4 Hypothetical positive feedback for the regulation of V-ATPase assembly by cytosolic pH and Ras/cAMP/PKA signaling. In this model, two positive

Minireview

CONCLUDING REMARKS

Structural data are beginning to support a collection of studies
investigating how glucose signals are communicated to VATPases. The new concept is that V1Vo may be structurally built
with an inherent facility to disassemble but that its reassembly
imposes energetic constrains. This concept has reinforced our
view of disassembly and reassembly as two independently controlled events. A variety of extracellular cues that control VATPase assembly and/or disassembly are emerging, although glucose is the main and strongest external stimulus. We do not know
what is the glucose sensor or the mechanism involved in this communication. Our understanding of V-ATPase regulation by reversible disassembly is incomplete. The spring-loading hypothesis
has not been experimentally tested. If all V-ATPases are structurally suited to reversibly disassemble, why do not all of them do so?
Vph1p-containing V-ATPases disassemble and reassemble, but
not Stv1p-containing V-ATPases. There are many questions that
remain unanswered regarding the roles of glycolysis, RAS/cAMP/
PKA, and V1 catalysis. Some of these questions include the following: (i) do glycolytic enzymes and/or glycolysis control V-ATPase
at steady state and during glucose depletion/readdition; (ii) are
glycolysis and RAS/cAMP/PKA elements of a common pathway
or different pathways that work in parallel to control V-ATPase
assembly and function; (iii) is V-ATPase upstream of PKA or
downstream; (iv) what is the yeast V-ATPase subunit that is phosphorylated, if any; and (v) what phosphatase enzyme is involved.
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